Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005785	p-ck-mbm	ug/l (ug/l)	27530	63798	0.03%
3005785	p-ck-mbm	— (—)	6349	9333	100.00%	Distribution not available
3005785	p-ckmbm	ug/l (ug/l)	282	361	0.00%
3005785	s-ck-mbm	— (—)	29	30	100.00%	Distribution not available
3005785	p-kreatiinikinaasi,mb-alayksikkö,massa	ug/l (ug/l)	27	36	0.00%
3005785	p-ck-mb	ug/l (ug/l)	25	25	0.00%
3005785	s-ck-mbm	ug/l (ug/l)	25	32	0.00%
3005785	b-cardiac,ckmb	— (—)	10	10	100.00%	Distribution not available
3005785	p-ckmbm	— (—)	9	9	100.00%	Distribution not available
3005785	b-cardiac,ckmb	ng/ml (ug/l)	6	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

First line medication for Crohn's disease

6586

21141

1.75

322.61

2.5

2.2

7.85

7.34

ug/l

0.72

5699

18392

Complications of medical and surgical care

4754

24519

1.88

320.10

2.7

2.2

7.49

7.13

ug/l

0.45

4124

21214

Vocal cord dysfunction

703

1273

5.36

319.82

2.4

1.4

8.16

3.81

ug/l

3.95

596

1079

Spinal stenosis

3684

14378

2.09

318.03

2.7

2.2

5.83

8.26

ug/l

9.45

3140

12421

Transient ischemic attack

3879

16713

2.02

307.75

2.8

2.3

6.29

7.38

ug/l

2.66

3435

14281

Metabolic disorders

6594

19755

2.17

307.65

2.6

2.1

7.56

7.30

ug/l

0.41

5726

17220

Pain in limb

5097

17993

1.99

307.65

2.7

2.2

6.04

7.92

ug/l

7.63

4448

15570

Pacemaker

3193

13088

2.68

307.65

3.2

2.4

10.59

6.86

ug/l

6.75

2844

10966

Asthma (only as main-diagnosis), excluding more controls

3921

10734

2.19

307.65

2.6

1.9

5.73

7.37

ug/l

6.37

3427

9480

Other special examinations and investigations of persons without complaint or reported diagnosis

4152

9106

2.44

307.65

2.5

2.0

6.87

8.55

ug/l

3.82

3633

7952

Dialysis, with operation codes

1257

3979

3.82

307.65

3.1

2.3

20.23

7.38

ug/l

11.62

1163

3516

Codeine or tramadol medication

6981

22455

1.77

307.65

2.5

2.2

6.49

7.61

ug/l

3.77

6058

19480

Major coronary heart disease event excluding revascularizations

6266

10875

4.52

307.65

3.0

1.9

10.82

3.89

ug/l

48.02

5597

8856

Lower back pain or/and sciatica

6995

24609

1.96

307.65

2.6

2.2

5.19

7.86

ug/l

27.57

6110

21325

Hypertension, essential

4733

12224

2.32

307.65

2.5

2.0

7.57

7.43

ug/l

0.15

4198

10650

Symptoms and signs involving the circulatory and respiratory systems

6707

13326

2.68

307.65

2.5

1.9

6.92

8.09

ug/l

3.03

5836

11477

Calcific aortic valvular stenosis, diagnosis (helper)

3296

11975

3.19

307.65

2.8

2.4

9.67

6.72

ug/l

13.85

3011

9955

Aortic valve malfunction, age under 60 years

950

2527

4.66

307.65

2.5

2.3

15.47

8.78

ug/l

9.85

910

2295

Pneumonias (Asthma/COPD co-morbidities)

6627

22806

2.06

307.65

2.7

2.1

7.76

7.28

ug/l

0.83

5717

19992

Ischaemic heart disease, wide definition

7432

14210

3.72

307.65

2.8

1.9

10.56

5.88

ug/l

28.97

6717

12082

Valvular heart disease excluding rheumatic fever

5240

8616

5.27

307.65

2.7

1.9

12.77

5.90

ug/l

56.55

4797

7284

Implicit bacterial Sepsis

3673

13615

2.68

307.65

3.1

2.2

8.24

7.05

ug/l

1.69

3121

11733

Left ventricular outflow tract obstruction (LVOTO), broad definition

1003

2672

4.61

307.65

2.5

2.3

15.53

8.71

ug/l

10.47

957

2426

Condition for Implicit Sepsis (Organ dysfunction codes)

6802

20027

2.53

307.65

2.7

2.1

9.60

6.84

ug/l

8.73

5905

17511

Implicit bacterial Sepsis

3982

14351

2.68

307.65

3.0

2.2

8.42

7.10

ug/l

2.00

3390

12386

Heart failure and antihypertensive medication

2689

2472

8.70

307.65

3.2

1.7

13.27

5.66

ug/l

13.52

2428

2050

Operations 2 for CAVS

3296

11975

3.19

307.65

2.8

2.4

9.67

6.72

ug/l

13.85

3011

9955

Other arrhythmias

4754

11324

3.48

307.65

2.7

1.8

7.84

5.55

ug/l

6.73

4195

9659

Heart failure and bmi 25plus

3054

8122

2.88

307.65

2.9

2.1

10.37

7.30

ug/l

4.93

2616

6868

Other bacterial diseases

6800

22482

2.17

307.65

2.6

2.2

7.58

7.35

ug/l

0.30

5842

19620

Calcific aortic valvular stenosis, including rheumatic fever

3302

12005

3.18

307.65

2.8

2.4

9.67

6.71

ug/l

13.99

3016

9978

Persons encountering health services for examination and investigation

3868

9107

2.23

307.65

2.4

2.0

7.67

8.55

ug/l

1.01

3367

7952

Calcific aortic valvular stenosis

3303

11986

3.19

307.65

2.8

2.4

9.71

6.72

ug/l

14.25

3018

9966

Examination and observation for other reasons

4921

8922

3.51

307.65

2.8

2.0

6.61

8.61

ug/l

5.86

4338

7826

Percutaneous Coronary Intervention

8817

12060

5.34

307.65

2.8

1.8

11.85

3.82

ug/l

96.54

8081

9978

Symptoms and signs involving the digestive system and abdomen

6143

17420

1.84

307.65

2.5

2.1

6.14

8.46

ug/l

13.08

5351

15094

Medical observation and evaluation for suspected diseases and conditions

4777

9097

2.88

307.65

2.5

2.0

6.90

8.55

ug/l

4.16

3992

7947

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5936

17570

2.17

307.65

2.7

2.1

7.77

7.30

ug/l

0.71

5117

15385

Renal failure

3782

16640

2.20

307.65

2.9

2.4

9.72

7.08

ug/l

5.30

3254

14208

Hypothyroidism, levothyroxine purchases

1011

994

6.04

307.65

2.3

1.2

7.98

3.17

ug/l

5.94

903

859

Presence of cardiac and vascular implants and grafts

5563

12512

4.03

307.65

3.0

2.3

12.95

6.48

ug/l

39.49

5033

10684

Implicit Sepsis

6411

19832

2.69

307.65

2.9

2.1

8.76

7.00

ug/l

4.39

5492

17295

Myocardial infarction, strict

4727

8643

4.62

307.65

3.0

1.8

11.89

3.96

ug/l

44.64

4226

7031

Symptoms and signs involving cognition, perception, emotional state and behaviour

6923

22745

2.21

307.65

2.6

2.2

6.33

7.72

ug/l

5.15

5929

19891

All-cause Heart Failure

5641

15568

2.93

307.65

3.0

2.2

9.31

7.02

ug/l

6.28

4943

13411

Heart failure, strict

5805

15794

2.97

307.65

3.1

2.2

9.91

7.07

ug/l

8.72

5098

13619

Viral Sepsis

1720

6485

3.01

307.65

3.5

2.2

9.78

6.75

ug/l

2.82

1501

5578

Pain, not elsewhere classified

1926

7149

2.94

307.65

3.1

2.0

6.13

8.13

ug/l

2.63

1692

6229

Any gastric operation

4394

11390

2.01

307.65

2.4

2.1

7.53

7.46

ug/l

0.06

3752

10006

Pure hypercholesterolaemia

5018

17806

1.95

307.65

2.5

2.2

7.82

7.29

ug/l

0.91

4288

15540

Codeine

5705

15819

2.06

307.65

2.5

2.1

6.27

7.88

ug/l

6.18

4956

13878

Cardiomyopathy

1434

4132

3.99

307.65

3.1

1.9

16.86

6.48

ug/l

10.76

1311

3482

Other bacterial diseases

7001

21893

2.16

307.65

2.6

2.2

7.54

7.34

ug/l

0.27

6049

19091

Cardiac arrhythmias

4667

5558

6.09

307.65

2.6

1.5

10.02

3.74

ug/l

31.46

4195

4628

Oral corticosteroids

6827

22823

1.86

307.65

2.6

2.2

7.91

7.17

ug/l

1.30

5961

19762

Other neurological diseases

5280

21841

2.03

307.65

2.7

2.3

6.37

7.37

ug/l

2.86

4639

18773

Major coronary heart disease event

9015

13210

4.83

307.65

2.8

1.8

11.70

3.91

ug/l

92.88

8244

10889

Bleeding

6097

22053

2.11

307.65

2.7

2.2

7.41

7.36

ug/l

0.05

5306

19098

Abnormalities of heart beat

2553

8855

3.09

307.65

2.8

1.9

6.70

7.75

ug/l

1.08

2205

7540

Other intervertebral disc disorders

5147

16951

1.92

307.65

2.4

2.2

5.94

8.33

ug/l

13.52

4529

14731

Other heart diseases

4270

3700

8.65

307.65

2.7

1.4

12.60

3.12

ug/l

52.81

3927

3114

Abdominal and pelvic pain

6240

17420

1.88

307.65

2.6

2.1

5.95

8.46

ug/l

15.63

5460

15094

Opioids

5816

16007

1.97

307.65

2.4

2.1

7.03

7.85

ug/l

1.60

5007

14014

Coronary revascularization (ANGIO or CABG)

8823

12063

5.33

307.65

2.8

1.8

11.87

3.82

ug/l

97.17

8097

9980

Low back pain

4932

17204

2.18

307.65

2.6

2.2

5.11

8.28

ug/l

28.73

4253

14947

Parasetamol

4537

9293

2.61

307.65

2.5

1.9

6.74

8.85

ug/l

6.02

3952

8192

Angina pectoris

5180

9859

4.03

307.65

3.1

1.8

8.16

3.89

ug/l

35.17

4629

8054

Septicaemia

3379

14643

2.37

307.65

2.8

2.3

8.04

7.27

ug/l

0.88

2889

12623

Cardiovascular diseases (excluding rheumatic etc)

3628

4380

5.12

307.65

2.4

1.4

9.65

3.01

ug/l

27.02

3272

3697

Tramadol

5639

15405

2.41

307.65

2.6

2.1

6.97

7.93

ug/l

2.17

4871

13512

Oxycodone

2898

11949

2.39

307.65

3.0

2.2

5.23

8.08

ug/l

12.43

2402

10446

Concussion

2905

10111

2.48

307.65

2.7

2.0

5.73

8.61

ug/l

10.38

2498

8907

Other soft tissue disorders, not elsewhere classified

5690

18325

1.90

307.65

2.6

2.2

6.04

7.91

ug/l

8.31

4974

15848

Abnormalities of breathing

6661

13310

3.14

307.65

2.7

1.9

6.52

8.10

ug/l

5.23

5794

11462

Hypertensive diseases

4692

12377

2.26

307.65

2.4

2.0

8.43

7.41

ug/l

1.68

4179

10776

Sciatica+with lumbago

3470

14477

2.37

307.65

2.7

2.2

5.04

8.38

ug/l

21.03

3135

12659

Dizziness and giddiness

5431

20743

2.23

307.65

2.8

2.2

5.81

7.63

ug/l

8.39

4680

18073

Heart failure and coronary heart disease

4710

8362

4.85

307.65

3.3

1.9

10.93

3.96

ug/l

36.89

4213

6679

Dorsalgia

6444

17631

2.06

307.65

2.5

2.2

5.47

8.22

ug/l

22.78

5621

15278

Syncope and collapse

3494

12372

2.64

307.65

2.9

2.1

6.66

8.14

ug/l

2.97

2989

10721

Cardiac arrest

621

669

9.61

307.65

3.4

1.5

18.50

4.03

ug/l

7.85

568

528

Headache

4075

14529

2.37

307.65

2.8

2.0

5.61

7.97

ug/l

7.22

3527

12718

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1831

2897

3.32

307.65

2.3

1.8

6.93

10.45

ug/l

6.70

1639

2571

Hypothyroidism and >3 levothyroxin purchases

1011

994

6.04

307.65

2.3

1.2

7.98

3.17

ug/l

5.94

903

859

Implicit viral Sepsis

2403

9647

2.79

307.65

3.2

2.2

9.03

6.71

ug/l

2.75

2083

8306

Pain in throat and chest

7283

13195

3.66

307.65

2.8

1.9

6.89

8.13

ug/l

3.20

6386

11365

Calcific aortic valvular stenosis, operated

3303

11986

3.19

307.65

2.8

2.4

9.71

6.72

ug/l

14.25

3018

9966

Haemorrhage from respiratory passages

2535

9183

2.72

307.65

2.8

2.0

8.46

8.39

ug/l

0.04

2179

7822

Influenza and pneumonia

6953

22217

2.10

307.65

2.7

2.1

7.65

7.31

ug/l

0.51

6011

19475

Hypertensive heart and/or renal disease

2282

6334

3.03

307.65

2.8

2.2

6.39

7.56

ug/l

2.51

1960

5378

General examination and investigation of persons without complaint and reported diagnosis

4867

9047

3.03

307.65

2.8

2.0

6.08

8.57

ug/l

8.26

4316

7911

Malaise and fatigue

4091

12804

2.82

307.65

3.0

2.1

5.72

7.96

ug/l

8.51

3430

11103

Statin medication

3752

8881

2.50

307.65

2.5

1.9

9.25

5.64

ug/l

8.85

3310

7530

Fever of other and unknown origin

4062

14649

2.67

307.65

2.9

2.0

7.59

8.14

ug/l

0.60

3506

12789

Diverticular disease of intestine

5047

17248

1.99

307.65

2.6

2.2

5.94

8.00

ug/l

9.43

4390

15021

All kidney diseases

6495

22891

2.05

307.65

2.6

2.2

8.28

7.11

ug/l

2.56

5584

19989

Valvular operations

2393

3503

10.18

307.65

2.6

1.9

19.33

6.63

ug/l

72.13

2310

2915

Bacterial Sepsis

4061

14740

2.62

307.65

3.0

2.2

8.19

7.11

ug/l

1.61

3449

12746

Complications of procedures, not elsewhere classified

5458

23633

2.03

307.65

2.7

2.2

7.00

7.29

ug/l

0.42

4801

20453

Asthma, excluding more controls

4131

10734

2.10

307.65

2.6

1.9

6.25

7.37

ug/l

3.09

3625

9480

Non-ischemic cardiomyopathy

2307

6535

3.18

307.65

2.5

1.9

9.02

5.12

ug/l

6.81

1967

5387

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2063

3433

4.02

307.65

2.3

1.4

7.73

3.07

ug/l

10.44

1822

2889

Erysipelas

4962

20032

2.01

307.65

2.6

2.2

6.90

7.43

ug/l

0.94

4325

17466

Conduction disorders

2419

6146

3.60

307.65

3.0

1.9

9.12

6.05

ug/l

5.07

2081

5113

Other diseases of intestines

6229

20147

1.83

307.65

2.5

2.1

6.52

7.89

ug/l

3.92

5387

17561

Atrial fibrillation and flutter

2914

2567

8.60

307.65

2.8

1.4

11.49

3.17

ug/l

34.42

2681

2152

Intracranial trauma

3510

10167

2.57

307.65

2.6

2.0

5.89

8.59

ug/l

10.91

3038

8960

Paroxysmal tachycardia

1705

2167

7.49

307.65

2.9

1.4

12.21

3.09

ug/l

13.12

1541

1790

Coronary artery bypass grafting

3526

5315

6.48

307.65

2.8

1.9

12.64

4.06

ug/l

89.63

3303

4239

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6393

24213

1.92

307.65

2.6

2.2

8.34

7.01

ug/l

3.16

5472

21092

Continuous positive airway pressure

1068

2021

4.86

307.65

2.2

1.5

10.86

3.97

ug/l

8.90

845

1669

Antihypertensive medication - note that there are other indications

2821

4456

3.52

307.65

2.3

1.6

7.25

4.89

ug/l

5.75

2521

3743

Explicit Sepsis

3453

14364

2.46

307.65

2.8

2.2

7.95

6.98

ug/l

1.28

2950

12387

Cerebrovascular diseases (FINNGEN)

2463

2696

7.35

307.65

2.5

1.4

7.92

3.19

ug/l

20.93

2205

2258

Myocardial infarction

5199

9012

4.85

307.65

3.1

1.8

11.91

3.92

ug/l

47.22

4636

7340

Renal tubulo-interstitial diseases

6091

22647

2.14

307.65

2.7

2.2

8.32

7.05

ug/l

2.80

5230

19710

Other dorsopathies, not elsewhere classified

6165

17650

1.91

307.65

2.5

2.2

5.67

8.22

ug/l

18.51

5348

15296

All chronic kidney diseases

3980

16165

2.17

307.65

2.8

2.3

8.25

7.28

ug/l

1.29

3437

13989

Heart failure,strict

5373

12711

3.47

307.65

3.1

2.1

10.32

6.99

ug/l

10.11

4747

11038

Implicit Sepsis

6812

20250

2.69

307.65

2.8

2.1

9.08

6.92

ug/l

6.16

5863

17675

Atrial fibrillation and flutter with reimbursement

2469

2058

9.07

307.65

2.8

1.4

10.65

3.23

ug/l

24.72

2259

1707

General symptoms and signs

7111

16575

2.27

307.65

2.5

2.0

6.84

8.06

ug/l

3.48

6192

14504

5936

17570

2.17

307.65

2.7

2.1

7.77

7.30

ug/l

0.71

5117

15385

Other heart diseases, wide

7695

12830

4.07

307.65

2.6

1.8

10.49

5.47

ug/l

32.60

6928

10982

AV-block

1642

4145

4.03

307.65

3.1

1.9

10.07

6.39

ug/l

4.30

1439

3386

Other CVD (FINNGEN)

1020

1024

9.25

307.65

3.3

1.5

6.55

3.59

ug/l

4.31

836

822

Diseases of arteries, arterioles and capillaries

5410

19486

2.24

307.65

2.7

2.3

8.75

7.10

ug/l

5.34

4746

16758

Hypertension

4691

12370

2.26

307.65

2.4

2.0

8.43

7.41

ug/l

1.68

4178

10769

Hypertensive diseases (excluding secondary)

2953

3671

5.04

307.65

2.4

1.4

8.70

3.10

ug/l

24.08

2666

3094

Bacterial infection, other or unspecified

3926

17238

2.13

307.65

2.8

2.2

7.12

7.30

ug/l

0.20

3281

14933

Dyspnoea

7528

22695

2.68

307.65

2.9

2.1

6.47

7.61

ug/l

3.93

6534

19672

Asthma, unspecified (mode)

3293

11985

2.19

307.65

2.6

2.0

5.79

7.77

ug/l

8.50

2835

10561

Unstable angina pectoris

3547

8108

4.03

307.65

3.5

1.9

6.92

3.91

ug/l

14.33

3155

6488

Pneumonia, organism unspecified

6236

21588

2.15

307.65

2.7

2.1

7.48

7.37

ug/l

0.13

5366

18935

Diseases of oesophagus, stomach and duodenum

6733

22893

1.84

307.65

2.6

2.2

6.40

7.64

ug/l

4.39

5804

19933

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6492

22939

2.04

307.65

2.7

2.1

7.62

7.36

ug/l

0.36

5599

20111

Asthma, unspecified (mode), excluding more controls

3148

10244

2.44

307.65

2.6

1.9

5.88

7.36

ug/l

4.90

2723

9034

ILD medications: prednisolone, methylprednisolone, prednisone

6879

21797

1.85

307.65

2.5

2.2

8.00

7.12

ug/l

1.68

5945

18958

Anaemias

1203

949

8.95

307.65

2.5

1.2

10.36

3.18

ug/l

10.67

1082

819

Complications of surgical and medical care, not elsewhere classified

6926

24315

2.07

307.65

2.7

2.2

7.16

7.28

ug/l

0.16

6049

21022

Hard cardiovascular diseases

8345

11498

5.02

307.65

2.7

1.8

11.41

3.86

ug/l

79.23

7619

9485

Hypertensive Heart Disease

2077

6037

3.05

307.65

2.8

2.2

6.15

7.58

ug/l

3.69

1781

5114

Cerebrovascular diseases

5658

20108

2.14

307.65

2.6

2.3

7.08

7.52

ug/l

0.80

4915

17441

GASTRO-related operations

4394

11390

2.01

307.65

2.4

2.1

7.53

7.46

ug/l

0.06

3752

10006

Infections, IBD-co-morbidities

1029

1823

4.41

307.65

2.5

1.9

8.58

10.93

ug/l

1.39

902

1617

Cardiovascular diseases

3129

3518

5.09

307.65

2.3

1.4

8.60

2.96

ug/l

21.84

2802

2984

Stroke, including SAH

4738

17842

2.08

307.65

2.6

2.3

6.71

7.57

ug/l

2.13

4124

15339

Inflammatory bowel disease treatment related agents

6993

23061

1.77

307.65

2.6

2.2

8.06

7.16

ug/l

1.64

6091

19966

ILD medications

6893

21916

1.78

307.65

2.5

2.2

8.25

7.11

ug/l

2.47

5956

19061

Myocardial infarction, without ST-elevation

4588

14880

3.35

307.65

3.1

2.3

9.06

7.00

ug/l

6.49

4015

12632

Depression medications

1114

1051

5.57

307.65

2.4

1.2

6.72

3.13

ug/l

3.75

975

905

Implicit viral Sepsis

1718

6474

3.01

307.65

3.5

2.2

9.79

6.75

ug/l

2.84

1499

5568

Hypothyroidism (congenital or acquired)

1022

998

6.08

307.65

2.3

1.2

7.94

3.17

ug/l

5.98

914

862

Coronary atherosclerosis

6667

10548

4.71

307.65

2.9

1.8

10.26

3.86

ug/l

57.92

6032

8675

STROKE

4364

7507

4.43

307.65

2.6

1.6

7.13

3.71

ug/l

23.47

3895

6168

Heart failure, not strict

6985

16425

3.28

307.65

2.9

2.0

10.29

6.82

ug/l

15.13

6196

14366

Status post-ami

2451

5466

3.99

307.65

3.3

1.9

9.06

4.05

ug/l

14.84

2133

4353

Emergency coronary revascularization (for ACS)

9666

14248

4.88

307.65

2.8

1.9

11.46

4.07

ug/l

94.33

8827

11692

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7215

20051

2.52

307.65

2.7

2.1

11.32

5.95

ug/l

37.87

6419

17296

Stroke, excluding SAH

4493

17313

2.04

307.65

2.6

2.3

6.75

7.56

ug/l

1.83

3905

14841

Spondylopathies

5293

16585

2.02

307.65

2.6

2.2

5.93

8.26

ug/l

10.08

4578

14373

Disorders of lipoprotein metabolism and other lipidaemias

5803

18524

2.07

307.65

2.5

2.2

7.87

7.39

ug/l

0.85

5021

16179

Bacterial infection, other or unspecified

4242

17902

2.16

307.65

2.7

2.2

7.21

7.30

ug/l

0.09

3560

15530

Diseases of arteries, arterioles and capillaries (FINNGEN)

2338

2029

9.51

307.65

2.8

1.4

10.88

3.23

ug/l

35.59

2125

1681

Episodal and paroxysmal disorders

6572

19135

1.82

307.65

2.5

2.1

6.08

7.97

ug/l

9.34

5681

16502

Non-rheumatic valve diseases

5187

8586

5.23

307.65

2.7

1.9

12.62

5.91

ug/l

53.79

4746

7262

Ischemic heart diseases

8455

12336

4.79

307.65

2.7

1.8

11.72

3.86

ug/l

87.72

7719

10224

Other septicaemia

3038

13537

2.37

307.65

2.9

2.3

8.19

7.26

ug/l

1.03

2598

11631

Persons encountering health services for specific procedures and health care

6856

22280

1.94

307.65

2.5

2.2

8.14

7.16

ug/l

1.77

6001

19271

All pneumoniae

6667

22789

2.07

307.65

2.7

2.1

7.79

7.29

ug/l

0.86

5753

19982

Condition for Implicit Sepsis (Organ dysfunction codes)

6881

20164

2.62

307.65

2.8

2.1

9.49

6.83

ug/l

8.30

5952

17610

Any reimbursement code in KELA

2571

5503

2.43

303.48

2.4

1.7

7.81

6.77

ug/l

0.98

2294

4743

Other disorders of skin and subcutaneous tissue

4575

22956

1.87

300.65

2.5

2.3

6.76

7.21

ug/l

0.60

3927

19831

Cardiomyopathies, Primary/intrinsic

983

2820

4.03

300.62

3.3

1.8

18.73

6.60

ug/l

9.00

909

2389

Asthma (only as main-diagnosis)

4111

12608

1.97

297.55

2.6

2.0

5.68

7.79

ug/l

10.63

3584

11130

Ischaemic Stroke, excluding all haemorrhages

4140

16855

1.96

296.86

2.6

2.3

6.71

7.49

ug/l

1.66

3589

14414

Other postsurgical states

681

1537

5.61

295.39

2.8

2.1

5.10

6.07

ug/l

0.71

625

1345

Nephropathy related operations

1172

3861

3.65

294.09

3.1

2.4

19.41

7.61

ug/l

10.17

1090

3430

Type 2 diabetes, wide definition

5078

18742

1.82

291.05

2.6

2.2

7.17

7.62

ug/l

0.66

4402

16221

Other disorders of fluid, electrolyte and acid-base balance

2390

10520

2.37

288.43

3.2

2.2

6.16

7.07

ug/l

1.37

1997

9034

Neurological diseases

4647

12949

1.87

280.38

2.4

2.1

6.53

8.36

ug/l

5.80

4022

11395

Injuries to the head

6535

24929

1.67

278.99

2.5

2.2

6.58

7.49

ug/l

2.66

5588

21727

Cardiomyopathy (excluding other)

1001

3052

3.77

278.53

3.4

1.9

18.61

6.52

ug/l

9.29

927

2590

COPD/asthma/ILD related infections

5874

17570

1.74

276.33

2.6

2.1

6.91

7.30

ug/l

0.57

5088

15385

COPD/asthma related infections

5874

17570

1.74

276.33

2.6

2.1

6.91

7.30

ug/l

0.57

5088

15385

Erysipelas

3803

18543

1.93

271.46

2.7

2.2

7.11

7.54

ug/l

0.54

3280

16154

Peripheral artery disease

3423

14542

2.03

270.84

2.9

2.3

6.85

6.97

ug/l

0.13

2947

12371

Asthma

4354

12608

1.88

270.32

2.6

2.0

6.15

7.79

ug/l

6.42

3809

11130

Type 2 diabetes

5769

20430

1.72

267.55

2.5

2.2

7.42

7.35

ug/l

0.07

5057

17687

Other symptoms and signs involving cognitive functions and awareness

3210

15380

2.04

267.41

2.6

2.2

5.65

7.59

ug/l

7.08

2629

13326

Diabetes mellitus

5868

20900

1.70

266.14

2.5

2.2

7.41

7.36

ug/l

0.05

5142

18092

Diabetes, varying definitions

5847

20903

1.70

264.64

2.5

2.2

7.40

7.37

ug/l

0.03

5124

18090

Dorsopathies

5767

17692

1.71

261.30

2.4

2.2

5.96

8.22

ug/l

11.84

4999

15332

6746

21954

1.64

260.84

2.7

2.1

6.60

7.32

ug/l

1.49

5792

19019

Pain (limb, back, neck, head abdominally)

4182

11508

1.89

260.59

2.4

2.1

6.38

9.07

ug/l

10.44

3634

9937

Atherosclerosis, excluding cerebral and coronary sclerosis

3254

13796

2.03

255.13

2.9

2.4

6.89

6.93

ug/l

0.05

2788

11707

Acute tubulo-interstitial nephritis

3887

18930

1.86

253.22

2.7

2.2

6.19

6.81

ug/l

1.25

3243

16358

Other antidepressants

6171

19672

1.67

250.43

2.5

2.2

6.83

7.86

ug/l

2.23

5237

17347

Endocrine, nutritional and metabolic diseases

4092

11449

1.87

249.73

2.4

2.0

7.49

7.61

ug/l

0.11

3610

10023

Acute renal failure

1856

8295

2.52

249.72

3.0

2.4

13.12

6.94

ug/l

8.15

1611

7112

Factors influencing health status and contact with health services

1785

3543

2.66

249.00

2.5

1.9

8.16

8.21

ug/l

0.02

1572

3116

Neurological diseases, wide definition

1356

2307

3.08

247.15

2.5

1.8

6.67

10.81

ug/l

5.54

1190

2034

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5529

20434

1.69

246.67

2.5

2.2

6.94

7.40

ug/l

0.75

4848

17683

Asthma (mode)

4206

12693

1.84

245.83

2.6

2.0

5.90

7.80

ug/l

8.41

3671

11207

Transplanted organ and tissue status

801

2324

4.04

242.34

3.1

2.1

29.84

6.62

ug/l

17.77

753

2072

Lumbar disc prolapse

3684

15782

1.88

241.83

2.4

2.2

6.05

8.42

ug/l

10.50

3255

13847

Other headache syndromes

2347

11442

2.17

241.31

2.7

2.1

4.73

7.85

ug/l

14.80

2033

9924

Shoulder lesions

4705

16908

1.76

239.94

2.5

2.2

6.09

8.03

ug/l

6.55

4168

14703

Certain infectious and parasitic diseases

5444

16618

1.70

236.77

2.5

2.1

7.63

7.35

ug/l

0.31

4707

14531

Myocarditis

335

464

8.34

234.69

3.2

1.4

16.55

3.78

ug/l

4.37

300

381

Diabetes, insulin treatment (Kela reimbursement)

5942

22749

1.64

232.68

2.5

2.2

6.76

7.55

ug/l

1.87

5198

19663

Other pulmonary diagnosis

4395

12722

1.79

232.07

2.4

2.0

7.56

7.81

ug/l

0.23

3837

11232

Cervicobrachial syndrome

1436

5860

2.66

229.93

2.8

2.1

4.71

8.51

ug/l

9.68

1310

5132

Secondary hypertension

445

829

5.89

227.55

2.5

1.5

6.23

3.55

ug/l

2.65

380

670

Excluding asthma or asthma-COPD overlap

4368

12722

1.78

225.73

2.4

2.0

7.52

7.81

ug/l

0.28

3813

11232

Hyperlipidaemia, other/unspecified

2760

13500

2.03

225.10

2.6

2.2

7.43

7.41

ug/l

0.01

2407

11724

Left ventricular outflow tract obstruction, narrow definition

515

1161

5.67

224.57

2.4

2.2

17.49

7.57

ug/l

11.43

498

1044

Cough

2143

9778

2.18

224.47

2.7

1.9

5.57

7.94

ug/l

7.01

1832

8424

Symptoms and signs involving the nervous and musculoskeletal systems

3587

20649

1.83

224.22

2.7

2.3

5.76

7.37

ug/l

5.20

3183

17836

Polyarthropathies

3922

14761

1.81

224.15

2.5

2.2

7.44

8.23

ug/l

0.92

3403

12895

Chronic kidney disease

2416

12162

2.13

223.39

3.0

2.4

9.24

6.81

ug/l

3.04

2084

10292

All influenza

1760

7986

2.39

222.30

3.2

2.2

6.97

7.38

ug/l

0.28

1507

6925

Visual disturbances and blindness

3241

18171

1.89

222.26

2.7

2.3

7.13

6.99

ug/l

0.11

2727

15706

Dental caries

1692

7232

2.43

221.60

2.7

2.2

11.54

8.00

ug/l

4.25

1464

6338

Caries of dentine

1549

6475

2.53

220.75

2.7

2.2

11.33

8.25

ug/l

3.21

1334

5678

COPD differential diagnosis

4337

12693

1.77

220.34

2.4

2.0

7.62

7.80

ug/l

0.15

3795

11207

Congenital malformations of aortic and mitral valves

469

1000

6.17

220.12

2.4

2.3

18.05

7.59

ug/l

11.03

456

893

ILD differential diagnosis

4336

12693

1.77

220.09

2.4

2.0

7.62

7.80

ug/l

0.15

3794

11207

Type 2 diabetes, definitions combined

5446

20124

1.65

217.88

2.5

2.2

7.48

7.38

ug/l

0.10

4767

17414

Type 2 diabetes, strict (exclude DM1)

5467

20238

1.64

217.18

2.5

2.2

7.52

7.42

ug/l

0.10

4785

17514

Nerve, nerve root and plexus disorders

6192

24763

1.59

213.42

2.5

2.3

6.25

7.55

ug/l

4.19

5411

21430

Symptoms and signs involving the skin and subcutaneous tissue

4098

24203

1.73

213.34

2.5

2.3

6.18

7.32

ug/l

2.83

3577

21007

Oedema, not elsewhere classified

2017

9642

2.21

213.32

2.7

2.1

6.04

7.95

ug/l

4.59

1673

8347

Insulin medication

3762

18600

1.79

212.25

2.7

2.3

6.75

7.72

ug/l

2.06

3282

16046

Benzodiazepine use

5788

25784

1.60

211.97

2.5

2.2

6.11

7.50

ug/l

4.36

4772

22619

Type 2 diabetes, definitions combined, including avohilmo

5408

19931

1.64

210.92

2.5

2.2

7.41

7.44

ug/l

0.02

4731

17253

Hypothyroidism, drug reimbursement

487

663

5.44

210.41

1.9

1.3

10.23

3.31

ug/l

3.64

428

570

Hernia

5434

23285

1.62

209.22

2.5

2.2

6.48

7.54

ug/l

3.44

4735

20131

Migraine

2296

9324

2.08

209.19

2.5

2.0

5.33

7.84

ug/l

6.77

2042

8128

Nausea and vomiting

1748

7914

2.32

208.55

3.1

2.2

5.87

7.51

ug/l

2.78

1476

6680

Bronchitis

6104

25202

1.58

206.93

2.8

2.2

7.06

7.19

ug/l

0.14

5261

21841

Soft tissue disorders

5646

18523

1.62

206.78

2.5

2.2

6.51

7.89

ug/l

4.16

4916

15995

Cardiodefibrillation

2681

14640

1.99

205.32

2.8

2.4

12.05

7.25

ug/l

11.20

2448

12635

Spondylosis

3287

15280

1.85

205.22

2.6

2.2

5.18

8.32

ug/l

21.41

2911

13316

Congenital malformations of the circulatory system

982

3423

3.10

203.29

2.3

15.98

7.59

ug/l

13.82

912

3040

Aplastic and other anaemias

3220

17261

1.85

203.12

2.8

2.4

7.49

6.94

ug/l

0.62

2747

14694

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3726

22006

1.75

201.94

2.6

2.3

7.78

7.07

ug/l

0.94

3230

19045

Congenital malformations of heart and great arteries

896

2990

3.26

200.73

2.4

2.3

16.21

7.73

ug/l

13.14

839

2654

Diabetes medication

5773

22258

1.59

200.65

2.5

2.2

6.89

7.53

ug/l

1.34

5062

19263

Asthma, hospital admission 2, infections

3479

20036

1.78

199.59

2.8

2.2

5.85

7.28

ug/l

5.25

3026

17192

Asthma-related infections

3479

20036

1.78

199.59

2.8

2.2

5.85

7.28

ug/l

5.25

3026

17192

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3731

17852

1.77

199.57

2.7

2.3

6.66

7.69

ug/l

2.01

3199

15445

Familial hypercholesterolemia, with ischemic heart disease

792

2594

3.59

198.96

3.3

2.0

7.57

5.63

ug/l

2.07

670

2141

Endocarditis

379

728

6.71

198.63

2.8

1.9

15.53

6.24

ug/l

7.21

353

610

Any mental disorder

6188

20337

1.57

198.42

2.5

2.2

6.82

7.56

ug/l

1.47

5248

18027

Iron deficiency anaemia

2811

15451

1.91

197.13

2.7

2.4

7.92

6.66

ug/l

1.59

2332

13186

Bicuspidal aortic valve syndrome

426

927

6.13

196.12

2.5

2.3

17.99

7.75

ug/l

9.55

415

839

Intracranial injury

3518

19709

1.77

195.78

2.7

2.3

5.82

7.45

ug/l

5.98

2974

17096

Ulcer of lower limb, not elsewhere classified

1245

5222

2.73

194.98

2.8

2.4

6.68

7.47

ug/l

0.78

1082

4488

Visual disturbances

2916

16528

1.86

192.96

2.7

2.3

7.09

7.04

ug/l

0.04

2506

14337

Migraine with aura

1162

4644

2.65

190.79

2.7

2.0

5.15

7.73

ug/l

5.19

1045

4047

Other CVD

1642

7821

2.34

188.78

3.3

2.4

7.03

6.46

ug/l

0.49

1336

6614

Diarrhoea and gastroenteritis of presumed infectious origin

3998

22183

1.69

188.56

2.8

2.2

6.65

7.35

ug/l

0.95

3446

19171

Other/unspecified dorsalgia

2182

11242

2.03

188.45

2.7

2.2

5.24

8.00

ug/l

11.23

1887

9651

L04AD Calcineurin inhibitors

808

2746

3.36

188.25

3.1

2.2

29.31

7.67

ug/l

16.01

761

2475

Psychiatric diseases

5546

18009

1.59

187.71

2.5

2.2

7.05

7.80

ug/l

1.27

4767

15987

Mood disorders, excluding more controls

5125

19672

1.61

187.14

2.5

2.2

6.55

7.57

ug/l

2.06

4321

17464

Aortic aneurysm

1818

8820

2.22

186.91

2.6

2.3

12.12

7.64

ug/l

8.74

1641

7622

Cardiomyopathy, other and unspecified

596

1684

4.09

186.81

3.6

1.8

20.68

6.26

ug/l

6.25

541

1431

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1047

3939

2.83

185.61

2.3

14.91

7.38

ug/l

13.60

972

3495

Disorders of thyroid, IBD co-morbidities

824

1861

3.28

184.33

2.4

1.9

10.02

11.27

ug/l

0.39

714

1652

Pain in joint

2976

10649

1.85

183.51

2.3

2.1

5.89

9.25

ug/l

12.31

2511

9307

Disorders of gallbladder, biliary tract and pancreas

5702

23874

1.56

183.22

2.5

2.3

5.70

7.70

ug/l

12.56

4938

20716

Finngen Rheumatological endpoints

5143

18895

1.60

181.76

2.3

2.2

6.81

7.92

ug/l

2.37

4448

16500

Substance abuse, excluding more controls

3150

15689

1.79

180.47

2.8

2.2

6.58

8.23

ug/l

4.10

2767

14025

Insulin, intermediate and long-acting

3478

20487

1.74

180.01

2.7

2.3

6.24

7.75

ug/l

5.31

3037

17747

Rotator cuff syndrome

3691

16063

1.72

179.76

2.5

2.2

6.25

8.09

ug/l

4.27

3288

14026

Peripheral arterial reconstruction

1476

6916

2.41

178.57

3.2

2.4

7.95

6.65

ug/l

1.15

1278

5913

Other anaemias

2965

16452

1.82

178.08

2.9

2.4

7.37

6.94

ug/l

0.43

2526

13988

Intestinal infectious diseases

5231

26237

1.56

176.57

2.7

2.2

6.62

7.34

ug/l

1.31

4501

22756

Provisional assignment of new diseases of uncertain etiology

3073

18078

1.78

176.20

2.9

2.3

7.15

7.21

ug/l

0.06

2621

15640

Codes for special purposes

3074

18106

1.78

175.46

2.9

2.3

7.14

7.21

ug/l

0.06

2622

15663

Hernia of abdominal wall, postoperative

1195

5077

2.55

175.45

2.8

2.2

5.38

8.19

ug/l

7.56

1055

4521

Certain infectious and parasitic diseases

4062

12422

1.69

175.45

2.4

2.1

7.39

7.51

ug/l

0.11

3526

10824

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1091

4310

2.68

175.30

2.3

14.63

7.23

ug/l

14.22

1014

3801

Other and unspecified anaemias

2934

16351

1.82

175.16

2.9

2.4

7.38

6.95

ug/l

0.43

2500

13904

Other functional intestinal disorders

2692

14161

1.85

174.75

2.9

2.2

5.52

7.30

ug/l

4.37

2249

12195

Nutritional anaemias

3157

18129

1.77

174.52

2.7

2.4

7.68

6.73

ug/l

1.20

2620

15496

Benign neoplasm of colon, rectum, anus and anal canal

4060

22326

1.66

173.71

2.5

2.3

6.10

7.47

ug/l

4.86

3513

19359

Sequelae of cerebrovascular disease

2539

12307

1.91

171.99

2.8

2.4

6.95

7.22

ug/l

0.28

2074

10469

Pain in thoracic spine

966

3762

2.80

170.75

3.1

2.1

4.06

8.31

ug/l

14.50

866

3278

Thoracic aortic aneurysm

1152

4965

2.64

169.72

2.5

2.3

13.95

7.88

ug/l

9.58

1059

4395

Depression or dysthymia

3838

12964

1.69

169.24

2.5

2.2

6.78

8.42

ug/l

3.47

3206

11630

Asthma (diagnoses ohter than nonallergic)

4800

26197

1.57

168.19

2.6

2.2

5.65

7.49

ug/l

12.13

4157

22664

Other symptoms and signs involving the nervous and musculoskeletal systems

2426

13565

1.89

167.59

2.7

2.3

5.36

7.39

ug/l

5.39

2199

11743

Osteopathies and chondropathies

3316

18814

1.72

166.54

2.6

2.3

7.25

7.03

ug/l

0.16

2712

16352

ILD medications: immunosuppressive drugs

3357

18987

1.71

166.46

2.5

2.1

12.29

7.16

ug/l

10.67

2965

16708

Non-invasive ventilation

796

2461

3.01

166.44

2.4

1.4

8.10

3.95

ug/l

5.47

643

2045

Operations for atrial fibrillation

269

475

10.80

165.66

2.7

2.5

27.78

7.54

ug/l

15.77

264

420

Covid-19 confirmed case

2375

13294

1.90

165.51

3.0

2.3

7.75

6.99

ug/l

0.89

2019

11453

Other (not insulin) diabetes medications

5425

21564

1.54

164.66

2.5

2.2

6.72

7.55

ug/l

1.94

4743

18664

Hypo-osmolality and hyponatraemia

1310

5991

2.40

162.55

3.2

2.3

5.93

6.90

ug/l

1.35

1092

5079

Amiodarone users

911

3619

2.97

162.51

3.4

2.4

15.94

7.60

ug/l

5.62

847

3151

Chronic lower respiratory diseases

6487

23926

1.48

162.07

2.5

2.2

6.43

7.67

ug/l

4.40

5634

20791

Hypotension

1422

6807

2.34

161.92

3.3

2.4

5.97

6.50

ug/l

0.46

1132

5727

Insulin, combination of fast acting with intermediate-acting or long-acting

3773

21864

1.65

160.37

2.7

2.3

6.74

7.61

ug/l

1.79

3292

18854

2434

13663

1.85

160.11

2.9

2.2

5.70

7.45

ug/l

5.07

2115

11769

Symptoms and signs involving the urinary system

4535

22689

1.58

159.81

2.6

2.3

6.29

7.40

ug/l

3.77

3792

19785

Intestinal infectious diseases

6321

25098

1.48

157.56

2.6

2.2

6.52

7.42

ug/l

2.18

5473

21781

Fall on same level

6046

22738

1.49

156.01

2.4

2.2

7.09

7.57

ug/l

0.80

5112

20111

Biguanides

5344

22062

1.52

154.84

2.5

2.2

6.30

7.59

ug/l

5.02

4657

19108

Gastrointestinal diseases

2756

7817

1.82

154.60

2.4

2.0

7.17

8.13

ug/l

1.04

2401

6813

Other diseases of pericardium

383

908

5.08

154.50

3.0

1.9

9.30

5.98

ug/l

3.49

329

771

Convulsions, not elsewhere classified

1288

5847

2.30

154.46

2.5

2.0

6.60

8.48

ug/l

2.90

1112

5140

Disorders of lens

3922

15602

1.63

152.50

2.6

2.2

7.61

8.15

ug/l

0.63

3434

13846

Other and unspecified iron deficiency

2148

11946

1.91

152.45

2.7

2.3

7.95

6.59

ug/l

1.50

1766

10205

Diseases of the skin and subcutaneous tissue

5506

18707

1.52

151.91

2.5

2.2

7.20

7.69

ug/l

0.71

4721

16285

Care involving dialysis

671

2339

3.35

151.52

2.9

2.3

12.80

7.65

ug/l

2.12

614

2079

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3367

21108

1.67

151.36

2.6

2.3

7.57

7.04

ug/l

0.60

2903

18297

Follow-up examination after treatment for conditions other than malignant neoplasms

2057

7252

1.95

150.37

2.4

2.0

6.98

8.44

ug/l

1.74

1747

6327

Other or ill-defined heart diseases

405

1014

4.59

149.80

2.9

1.8

10.67

6.09

ug/l

1.92

349

861

Asthma, hospital admissions , main diagnosis only

4379

25695

1.55

146.98

2.6

2.2

5.59

7.43

ug/l

10.51

3813

22211

Dysphagia

1576

8028

2.10

146.74

2.5

2.2

6.49

8.19

ug/l

2.11

1302

6932

Asthma/COPD (KELA code 203)

5117

23889

1.51

146.72

2.5

2.2

5.56

7.65

ug/l

15.28

4462

20761

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3961

23186

1.59

146.61

2.5

2.3

6.59

7.30

ug/l

1.38

3391

20106

Diseases of the respiratory system

3382

10357

1.69

145.57

2.4

2.0

7.15

7.66

ug/l

0.54

2952

9098

Any death

3878

18025

1.62

145.22

2.7

2.3

8.63

7.50

ug/l

1.23

3318

15950

Disorders of choroid and retina

4776

22948

1.53

144.99

2.5

2.3

6.52

7.50

ug/l

2.78

4051

19957

Other specific joint derangements/joint disorders

3636

14865

1.63

144.14

2.3

2.2

6.12

8.30

ug/l

5.83

3101

13065

Persons encountering health services in other circumstances, wide

6452

23492

1.45

143.25

2.5

2.2

7.56

7.24

ug/l

0.43

5653

20305

Care involving use of rehabilitation procedures

3491

20502

1.62

142.54

2.9

2.2

8.00

7.22

ug/l

0.76

3181

17740

Benign neoplasm: Colon

3438

21032

1.64

142.48

2.6

2.3

6.17

7.47

ug/l

3.95

2988

18245

Gastro-oesophageal reflux disease

3756

21009

1.60

142.45

2.6

2.2

5.80

7.65

ug/l

8.79

3166

18355

Asthma-related pneumonia

2310

13370

1.82

142.00

3.0

2.3

5.92

7.00

ug/l

2.44

1991

11309

Asthma-related pneumonia or sepsis

2311

13394

1.82

141.33

3.0

2.3

5.92

7.00

ug/l

2.43

1992

11328

Asthma, hospital admissions 3, pneumonia

2311

13394

1.82

141.33

3.0

2.3

5.92

7.00

ug/l

2.43

1992

11328

Nonischemic cardiomyopathy

657

2333

3.15

140.21

2.8

1.9

14.95

5.69

ug/l

4.54

591

1958

Volume depletion

774

3020

2.90

139.71

3.5

2.3

5.52

7.14

ug/l

2.38

645

2542

Personality disorders, excluding more controls

1154

5281

2.29

139.11

2.5

2.0

5.23

8.42

ug/l

5.82

991

4732

Oxicams

1593

4511

2.13

138.88

2.6

2.3

5.78

9.79

ug/l

8.08

1382

3916

Chronic ulcer of skin, not elsewhere classified

615

2155

3.37

138.46

3.3

2.4

5.47

7.44

ug/l

1.28

531

1862

COPD (mode)

1968

8546

1.92

136.97

2.7

2.1

6.79

8.06

ug/l

1.94

1667

7521

Gout

1929

9464

1.92

134.61

2.9

2.4

7.81

8.62

ug/l

0.51

1670

8212

Subjective visual disturbances

1483

7646

2.07

133.14

2.7

2.3

6.92

6.95

ug/l

0.02

1272

6648

Dermatitis

3378

21769

1.61

132.51

2.5

2.3

5.88

7.43

ug/l

5.65

2943

18916

Lung transplantation

148

169

18.17

132.19

2.8

2.5

36.22

9.19

ug/l

14.28

148

149

Other disorders of urethra and urinary system

3744

17670

1.58

132.17

2.5

2.2

5.55

7.16

ug/l

5.75

3170

15359

Gonarthrosis [arthrosis of knee](FG)

4359

16997

1.54

131.89

2.4

2.2

6.08

8.05

ug/l

5.64

3798

14850

Other retinal disorders

3886

20103

1.57

131.59

2.6

2.3

6.22

7.37

ug/l

3.61

3266

17381

Lung transplant status

147

168

18.17

131.22

2.8

2.5

36.38

9.24

ug/l

14.24

147

148

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

606

1425

3.25

130.82

2.6

2.0

11.81

11.70

ug/l

0.03

529

1267

Mood disorders

5328

24214

1.46

128.45

2.5

2.2

6.57

7.44

ug/l

1.64

4503

21203

Mood [affective] disorders

5311

24176

1.46

128.07

2.5

2.2

6.52

7.45

ug/l

1.86

4490

21171

Disturbances of skin sensation

1427

7331

2.05

127.92

2.6

2.2

5.51

7.31

ug/l

3.36

1240

6415

Gonarthrosis

3740

13906

1.59

127.88

2.3

2.2

6.20

8.30

ug/l

4.98

3256

12163

Diseases of the digestive system

2833

17721

1.67

127.34

2.8

2.3

6.60

7.32

ug/l

0.99

2452

15148

Depression

4852

22772

1.48

127.11

2.4

2.2

6.52

7.55

ug/l

1.99

4112

20008

Other acute lower respiratory infections

3014

18279

1.63

126.19

2.9

2.3

6.93

7.25

ug/l

0.28

2556

15647

Anxiety disorders, excluding more controls

4063

17670

1.54

126.09

2.6

2.1

7.01

7.53

ug/l

0.50

3437

15721

Constipation

4915

23719

1.48

125.87

2.7

2.3

5.72

7.55

ug/l

9.61

4039

20796

Mental and behavioural disorders due to psychoactive substance use

3249

19492

1.60

125.32

2.8

2.2

6.64

8.09

ug/l

3.29

2860

17186

Diseases of the musculoskeletal system and connective tissue

2514

7391

1.75

125.23

2.3

2.1

6.84

9.44

ug/l

4.93

2199

6494

Insulin, fast-acting

2111

12348

1.80

125.10

2.8

2.3

6.59

7.63

ug/l

1.63

1848

10716

Injuries to the thorax

2749

17225

1.67

124.97

2.6

2.3

6.81

7.62

ug/l

1.19

2317

14942

Senile cataract

3604

14461

1.59

124.27

2.6

2.2

7.42

8.13

ug/l

0.88

3131

12816

Other disorders of ear

5047

23168

1.47

124.07

2.5

2.3

6.39

7.65

ug/l

3.74

4295

20225

3346

19235

1.59

123.64

2.6

2.3

6.69

8.17

ug/l

3.03

2958

16918

Asthma, including avohilmo

6231

25322

1.41

123.29

2.5

2.2

5.83

7.68

ug/l

12.25

5428

21928

Injuries to the abdomen, lower back, lumbar spine and pelvis

2371

14236

1.73

122.37

2.6

2.4

6.11

7.14

ug/l

1.53

1947

12197

Infections of the skin and subcutaneous tissue

3033

19288

1.61

122.25

2.6

2.2

7.21

7.80

ug/l

0.66

2615

16914

L04AA Selective immunosuppressants

1257

6311

2.13

121.56

2.7

2.3

19.09

7.11

ug/l

13.11

1145

5559

Diaphragmatic hernia

2212

13262

1.76

120.99

2.6

2.3

5.77

7.25

ug/l

4.21

1889

11395

Disorders of eyelid, lacrimal system and orbit

4651

24644

1.48

120.39

2.6

2.3

5.73

7.42

ug/l

8.04

3934

21411

Substance abuse

3150

19216

1.60

120.37

2.8

2.2

6.58

8.14

ug/l

3.77

2767

16953

Other diseases of pleura

2926

16442

1.64

119.89

2.8

2.4

7.46

7.36

ug/l

0.08

2512

14122

GI-bleeding

2161

12923

1.77

119.86

3.0

2.4

6.70

7.31

ug/l

0.61

1892

10990

Epilepsy

1708

9475

1.89

119.54

2.6

2.2

6.06

8.23

ug/l

5.08

1454

8171

Implicit fungal Sepsis

531

1851

3.31

119.45

3.3

2.2

9.36

7.05

ug/l

0.75

443

1623

Alcohol use disorder, Swedish definition

3077

18262

1.61

119.13

2.6

2.3

6.69

8.26

ug/l

3.11

2719

16115

3207

18919

1.59

119.05

2.7

2.3

6.42

8.23

ug/l

5.61

2834

16651

Other and unspecified dermatitis

2795

17761

1.64

118.75

2.5

2.3

5.67

7.33

ug/l

5.95

2433

15395

Myocardial infarction, with ST-elevation

1348

7067

2.09

118.51

3.1

2.4

14.49

7.17

ug/l

8.93

1210

6040

Arthrosis

3924

14400

1.54

118.35

2.4

2.2

6.20

8.29

ug/l

7.18

3404

12597

Diarrhoea and gastroenteritis of presumed infectious origin

5320

25047

1.44

117.21

2.6

2.2

6.14

7.46

ug/l

4.41

4599

21723

Conductive and sensorineural hearing loss

4557

21443

1.48

116.78

2.6

2.3

6.24

7.65

ug/l

4.47

3831

18706

Peripheral artery operations in Hilmo

986

4633

2.36

116.71

3.0

2.3

6.94

7.05

ug/l

0.07

868

3931

Obesity related asthma

1887

10937

1.81

115.63

2.8

2.2

5.59

7.81

ug/l

6.66

1623

9637

Other diseases of the digestive system

2135

12852

1.76

115.54

3.0

2.4

6.76

7.34

ug/l

0.55

1853

10942

Osteoporosis

1712

9069

1.89

114.53

2.7

2.3

6.01

6.25

ug/l

0.18

1340

7638

Fitting and adjustment of other devices

2360

13138

1.71

114.06

2.4

2.3

5.02

6.91

ug/l

8.35

1910

11145

Extracorporeal dialysis

509

1790

3.35

114.01

3.0

2.4

14.83

7.95

ug/l

2.23

468

1603

Acute bronchitis

2380

14421

1.69

113.74

2.9

2.3

6.73

6.91

ug/l

0.14

1994

12263

Other joint disorders

4312

15568

1.50

113.68

2.3

2.2

6.27

8.23

ug/l

5.77

3702

13596

Heartburn

687

2777

2.70

113.02

2.8

2.2

5.03

8.38

ug/l

4.98

576

2450

Persons encountering health services in other circumstances

2108

12568

1.74

112.94

3.3

2.2

5.92

7.17

ug/l

1.90

1915

10883

Autoimmune diseases excluding thyroid diseases

5435

21261

1.43

112.90

2.4

2.2

6.92

7.63

ug/l

1.34

4739

18502

Autoimmune diseases excluding thyroid diseases, strict definition

5298

20721

1.43

112.55

2.4

2.2

6.80

7.60

ug/l

1.70

4605

18046

Sensorineural hearing loss

4402

20872

1.48

112.28

2.6

2.3

6.12

7.66

ug/l

5.26

3696

18197

Benign neoplasms

5043

19707

1.44

111.71

2.4

2.2

6.81

7.74

ug/l

2.14

4340

17226

Poisoning by drugs, medicaments and biological substances

1145

5704

2.11

111.58

2.7

2.2

5.49

7.69

ug/l

2.82

976

5048

Amputation

814

3619

2.54

111.43

2.9

2.4

7.08

7.38

ug/l

0.19

708

3086

Other gastritis (incl. Duodenitis)

1430

7764

1.97

110.56

2.9

2.3

5.84

7.64

ug/l

3.43

1236

6715

Cholelithiasis, broad definition with cholecystitis

4717

22488

1.45

110.16

2.6

2.3

5.75

7.62

ug/l

8.85

4054

19439

All influenza (not pneumonia)

888

4063

2.35

109.64

3.4

2.2

7.89

7.66

ug/l

0.09

780

3550

Anxiety (asthma-related co-morbidities)

2613

12715

1.63

109.28

2.6

2.1

6.33

7.79

ug/l

1.63

2198

11230

Other mental disorders due to brain damage and dysfunction and to physical disease

891

4145

2.41

109.19

3.4

2.4

4.81

7.03

ug/l

5.61

723

3597

Sleep disorders (combined)

5903

22627

1.40

109.04

2.5

2.2

6.14

7.66

ug/l

6.07

5052

19692

Sleep apnoea

4943

22901

1.44

108.03

2.5

2.2

6.33

7.73

ug/l

5.06

4270

20126

Familial hypercholesterolemia

1088

5461

2.18

107.78

3.0

2.3

6.72

7.38

ug/l

0.54

925

4709

Use of hypnotics and sedatives

5590

23360

1.41

107.56

2.5

2.2

6.79

7.65

ug/l

1.76

4812

20500

Mental and behavioural disorders due to alcohol

2799

17472

1.60

107.47

2.7

2.2

6.47

8.28

ug/l

4.77

2479

15410

Viral pneumonia

835

3773

2.41

107.33

3.0

2.2

8.76

7.49

ug/l

0.63

720

3288

Adjustment and management of implanted device

1354

7337

2.00

107.19

3.0

2.4

14.33

6.91

ug/l

7.58

1232

6213

Insulin, fast-acting or short human

2117

12912

1.72

107.15

2.8

2.3

6.58

7.56

ug/l

1.51

1854

11186

Acute upper respiratory infections of multiple and unspecified sites

3760

19055

1.50

106.97

2.8

2.2

7.48

7.38

ug/l

0.08

3264

16569

Other degenerative diseases of the nervous system

1521

6216

1.92

106.87

2.5

2.1

6.17

7.96

ug/l

2.94

1176

5433

Poisoning by medicine

1036

5069

2.15

106.15

2.7

2.2

5.53

7.89

ug/l

2.73

888

4496

Other cataract

2537

12167

1.65

105.37

2.6

2.2

6.86

7.93

ug/l

1.93

2212

10722

Cervical disc disorders

1938

11599

1.75

105.15

2.5

2.2

6.01

8.66

ug/l

6.91

1668

10175

Early onset COPD, excluding more controls

1166

5998

2.07

104.87

2.9

2.1

7.93

8.69

ug/l

0.47

1019

5378

Autoimmune diseases

5742

21340

1.40

104.80

2.4

2.2

7.08

7.62

ug/l

0.90

4995

18572

Abnormal findings on diagnostic imaging of lung

2958

18823

1.58

104.29

2.6

2.4

6.75

7.39

ug/l

0.90

2525

16309

Used for control exclusion in common control thyroid runs

5454

19989

1.41

103.89

2.4

2.2

7.25

7.67

ug/l

0.60

4727

17421

Gonarthrosis,primary

5082

22667

1.42

103.73

2.4

2.3

5.90

7.77

ug/l

6.73

4403

19708

Any operation in hilmo

168

10.78

103.69

2.2

1.3

10.67

3.63

ug/l

2.31

153

Acute sinusitis

2417

14114

1.64

103.48

2.6

2.1

6.89

7.58

ug/l

0.66

2087

12359

Gastroduodenal ulcer

1727

10086

1.81

103.46

2.8

2.3

6.90

7.63

ug/l

0.58

1513

8624

Carpal tunnel syndrome

3230

19180

1.54

102.94

2.4

2.3

6.08

7.46

ug/l

2.67

2851

16616

Aneurysms, operations, SAH

1039

5198

2.16

102.85

2.7

2.3

5.64

7.25

ug/l

1.66

918

4471

Mycoses

1520

8581

1.88

102.77

2.8

2.3

6.58

7.33

ug/l

0.66

1315

7474

Pericarditis

273

681

4.69

102.42

3.1

1.9

9.19

5.89

ug/l

1.29

227

579

Other nutritional deficiencies

3139

19821

1.54

102.31

2.5

2.2

6.36

7.64

ug/l

2.39

2653

17483

Other diseases of urinary system

5162

21001

1.41

102.15

2.6

2.2

6.25

7.74

ug/l

5.77

4379

18424

Migraine without aura

732

3145

2.43

102.11

2.1

1.9

5.24

7.31

ug/l

1.63

640

2753

Congenital malformations, deformations and chromosomal abnormalities

2623

16137

1.59

101.41

2.3

2.2

10.04

7.22

ug/l

6.61

2336

14122

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2462

15701

1.62

101.27

2.7

2.3

6.36

8.44

ug/l

5.62

2178

13904

Cervicalgia

1141

5896

2.05

101.25

2.6

2.2

6.04

8.02

ug/l

1.80

982

5096

Obesity and other hyperalimentation

2987

19188

1.55

100.52

2.4

2.2

6.29

7.69

ug/l

2.70

2524

16933

Other reaction to severe stress, and adjustment disorders

1536

8693

1.83

100.15

2.6

2.1

8.79

7.53

ug/l

0.75

1329

7661

Artrosis, including avohilmo

4363

16854

1.45

99.50

2.4

2.2

6.21

8.43

ug/l

9.39

3770

14744

Other anxiety disorders

1917

9947

1.72

99.48

2.6

2.1

6.19

7.58

ug/l

1.29

1598

8752

Obesity

2967

19111

1.54

99.26

2.4

2.2

6.26

7.69

ug/l

2.80

2509

16870

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1135

5833

2.01

98.89

2.5

2.0

6.08

8.06

ug/l

2.29

966

5195

Cholelithiasis

4485

22153

1.43

98.54

2.6

2.3

5.77

7.59

ug/l

7.92

3852

19129

Diseases of the eye and adnexa

3658

12453

1.50

98.50

2.4

2.1

7.74

8.35

ug/l

0.63

3222

11083

Other disorders of skin and subcutaneous tissue, not elsewhere classified

932

4557

2.22

98.48

3.0

2.3

5.64

7.44

ug/l

1.66

763

3943

Unknown and unspecified causes of morbidity

463

1648

3.10

98.13

2.7

2.1

4.19

7.89

ug/l

9.65

441

1438

Arthropathies

4364

15586

1.45

97.67

2.3

2.2

6.64

8.23

ug/l

3.56

3777

13610

Injury, poisoning and certain other consequences of external causes

2590

8198

1.62

97.57

2.4

2.1

6.64

7.94

ug/l

2.49

2260

7186

Venous thromboembolism

3171

20882

1.52

97.54

2.5

2.4

6.82

7.15

ug/l

0.28

2689

17958

Traumatic subdural haemorrhage

872

3985

2.27

97.53

2.5

2.2

6.43

8.47

ug/l

2.73

741

3469

Organic, including symptomatic, mental disorders

3198

15458

1.54

96.99

2.7

2.4

5.38

7.08

ug/l

8.01

2503

13464

Chronic periodontitis, including avohilmo

5062

24848

1.40

96.89

2.3

7.91

7.24

ug/l

1.06

4428

21686

Coxarthrosis

2922

12791

1.56

96.52

2.4

2.3

6.41

8.34

ug/l

5.92

2522

11167

Periodontitis

5068

24857

1.40

96.15

2.3

7.90

7.24

ug/l

1.04

4435

21686

Open wound of head

2987

19421

1.53

95.93

2.7

2.3

7.02

7.81

ug/l

1.14

2506

16914

Fracture of rib(s), sternum and thoracic spine

1879

11489

1.73

95.66

2.6

2.4

6.64

7.61

ug/l

1.27

1551

9948

Sleep apnoea, including avohilmo

5092

23114

1.40

95.47

2.4

2.3

6.22

7.68

ug/l

5.71

4407

20275

Missing teeth due to accident, extraction or parodontitis

3324

21672

1.50

94.30

2.6

2.3

6.54

7.35

ug/l

1.54

2829

18986

Dental operations

3650

12920

1.49

94.01

2.4

2.2

6.77

7.46

ug/l

1.21

3136

10997

Acute upper respiratory infections

5405

24686

1.38

93.76

2.7

2.2

6.70

7.22

ug/l

0.75

4650

21367

All anxiety disorders

2637

13623

1.57

93.64

2.6

2.1

6.29

7.59

ug/l

1.40

2219

12046

Coxarthrosis [arthrosis of hip](FG)

3167

15193

1.52

92.44

2.5

2.3

6.27

8.02

ug/l

5.70

2734

13229

Pulmonary heart disease, diseases of pulmonary circulation

2000

12535

1.68

92.12

2.6

2.4

8.48

7.01

ug/l

1.15

1704

10702

Alcohol use disorder, ICD-based

2252

14458

1.62

92.05

2.8

2.2

6.25

8.53

ug/l

6.07

1991

12803

Other medical care

2610

15528

1.57

91.92

2.6

2.3

6.06

7.12

ug/l

1.76

2275

13304

Injuries to the shoulder and upper arm

4460

26145

1.41

91.60

2.4

2.3

7.05

7.39

ug/l

0.38

3844

22744

Paralytic ileus and intestinal obstruction

1543

9042

1.80

91.36

2.6

2.3

5.16

7.70

ug/l

9.74

1319

7787

Presence of other functional implants

3145

14876

1.52

91.13

2.6

2.2

6.18

6.16

ug/l

0.02

2603

12723

Personality disorders

1154

6175

1.95

90.77

2.5

2.2

5.23

7.92

ug/l

4.50

991

5503

Falls/tendency to fall

5360

19834

1.38

90.75

2.4

2.2

7.31

7.62

ug/l

0.39

4564

17597

Selective serotonin reuptake inhibitors

5126

19716

1.39

89.48

2.4

2.2

6.40

7.87

ug/l

4.84

4314

17378

Cardiac murmurs and other cardiac sounds

439

1564

2.96

89.06

2.3

1.9

7.25

7.24

ug/l

0.00

386

1329

Vascular disorders of the intestines

546

2248

2.76

88.87

3.4

2.3

7.00

7.53

ug/l

0.26

497

1930

Kidney transplant status

380

1301

3.36

88.19

2.3

11.70

7.97

ug/l

0.79

357

1177

Specific personality disorders

1009

5218

2.02

88.08

2.5

2.2

5.41

7.90

ug/l

3.17

859

4648

Allergic asthma (mode), excluding more controls

906

4399

2.09

87.71

2.7

1.9

5.62

6.66

ug/l

1.13

810

3863

Disorders of adult personality and behaviour

1188

6486

1.90

87.59

2.5

2.2

5.44

8.00

ug/l

4.13

1011

5772

Dilated cardiomyopathy

855

4263

2.22

87.39

3.4

2.4

18.87

7.78

ug/l

6.50

793

3737

Neurotic, stress-related and somatoform disorders

4154

20976

1.42

86.77

2.6

2.2

7.06

7.45

ug/l

0.35

3519

18436

Anxiety disorders

4211

21232

1.41

86.62

2.5

2.2

7.04

7.47

ug/l

0.40

3569

18659

DVT of lower extremities and pulmonary embolism

2498

16591

1.57

86.62

2.5

2.4

6.68

7.19

ug/l

0.42

2113

14194

Symptoms and signs concerning food and fluid intake

621

2712

2.47

85.78

2.8

2.1

6.34

7.87

ug/l

0.71

528

2360

Recurrent or chronic depression

1748

7401

1.71

85.77

2.4

2.0

6.97

8.70

ug/l

1.51

1483

6698

Non-allergic asthma (mode), excluding more controls

929

4673

2.07

85.67

2.7

2.0

5.76

7.05

ug/l

1.99

840

4060

Gout, FINNGEN

1929

12192

1.67

85.61

2.9

2.4

7.81

7.61

ug/l

0.09

1670

10526

Disorder of lipoprotein metabolism, unspecified

898

4575

2.13

85.23

2.8

2.3

8.67

7.36

ug/l

0.93

767

3961

Diabetic nephropathy, excluding more controls

968

4124

2.10

85.10

3.0

2.3

6.34

8.01

ug/l

2.01

871

3557

Misadventures to patients during surgical and medical care

870

4373

2.15

84.99

3.0

2.3

6.46

7.30

ug/l

0.68

771

3798

Nontraumatic intracranial haemmorrhage

1288

7351

1.87

84.86

2.5

2.4

5.81

6.93

ug/l

1.86

1113

6215

Localized swelling, mass and lump of skin and subcutaneous tissue

1697

10411

1.71

84.19

2.6

2.3

6.00

7.51

ug/l

2.03

1497

9055

Gastric ulcer

1174

6547

1.92

83.85

3.0

2.3

7.36

7.50

ug/l

0.06

1032

5590

Other diseases of anus and rectum

1688

10337

1.71

83.60

2.6

2.2

6.36

7.49

ug/l

1.18

1419

8917

Unspecified haematuria

2535

14096

1.55

83.24

2.6

2.3

6.79

7.85

ug/l

2.24

2170

12322

Amputation of toe

575

2508

2.62

83.23

3.0

2.4

6.81

7.43

ug/l

0.42

505

2173

Congenital malformations, deformations and chromosomal abnormalities

2829

17821

1.50

83.11

2.4

2.2

9.86

7.18

ug/l

6.66

2508

15590

Mycoses

4192

26720

1.40

82.79

2.6

2.2

7.06

7.35

ug/l

0.29

3584

23382

Diseases of oral cavity, salivary glands and jaws

3433

12323

1.47

82.66

2.5

2.2

7.20

7.39

ug/l

0.18

2950

10504

Diseases of the ear and mastoid process

5705

21684

1.35

82.29

2.4

2.2

6.96

7.69

ug/l

1.25

4899

19018

Other arthrosis

2814

13280

1.52

81.74

2.5

2.2

6.65

8.33

ug/l

2.43

2419

11672

Fungal Sepsis

328

1085

3.55

81.54

3.6

2.2

10.57

7.63

ug/l

0.76

284

965

Other external causes of accidental injury

4100

14791

1.42

81.36

2.4

2.2

7.00

7.50

ug/l

0.66

3479

13129

Pulmonary embolism

1795

11301

1.67

81.16

2.6

2.4

7.33

7.03

ug/l

0.16

1525

9650

Caries of dentine, including avohilmo

4410

16474

1.40

81.08

2.4

2.3

6.68

7.24

ug/l

1.04

3790

14147

Dental caries, including avohilmo

4208

15629

1.41

80.88

2.4

2.3

6.74

7.13

ug/l

0.62

3626

13383

Pulmonary heart disease

1795

11322

1.67

80.54

2.6

2.4

7.33

7.08

ug/l

0.13

1525

9674

Alzheimer’s disease (Atypical or mixed), excluding more controls

612

2150

2.49

80.22

2.8

2.3

5.17

6.94

ug/l

2.07

456

1845

Type 1 diabetes, wide definition, subgroup 1

1002

5348

1.96

79.81

2.6

2.1

7.44

7.99

ug/l

0.37

880

4663

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5613

23211

1.34

79.74

2.3

2.2

7.57

7.27

ug/l

0.40

4871

20119

Chronic gastritis

1642

10156

1.70

79.73

2.6

2.3

6.26

7.19

ug/l

1.05

1357

8689

Obesity due to excess calories

2141

14014

1.58

79.35

2.4

2.2

6.00

7.76

ug/l

4.67

1814

12412

Diseases of pulp and periapical tissues and dental caries

3812

13991

1.43

79.29

2.4

2.3

6.91

7.12

ug/l

0.25

3280

11907

Hyperkalaemia

448

1778

2.87

78.87

3.4

2.3

4.97

7.50

ug/l

2.78

387

1524

Unspecified kidney failure

749

3691

2.24

78.84

3.0

2.4

7.11

6.83

ug/l

0.16

634

3118

Candidiasis

1402

8317

1.76

78.74

2.7

2.3

6.02

7.00

ug/l

0.79

1173

7178

Accidents

4078

14791

1.41

78.39

2.4

2.2

6.93

7.50

ug/l

0.83

3474

13129

Soft tissue disorders related to use, overuse and pressure

1441

8633

1.75

78.34

2.4

2.2

7.28

8.03

ug/l

0.42

1237

7516

Presence of other devices

1418

8446

1.76

78.30

2.5

2.3

4.69

6.06

ug/l

3.65

1260

7079

Implicit fungal Sepsis

305

993

3.62

78.00

3.7

2.2

11.13

7.51

ug/l

0.93

263

884

External causes of morbidity and mortality

3196

11110

1.47

77.91

2.3

2.1

6.83

7.44

ug/l

0.78

2774

9825

Cystitis

4199

18305

1.39

77.76

2.6

2.2

5.79

7.28

ug/l

5.80

3535

15931

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4987

24103

1.35

77.72

2.4

2.3

7.08

7.47

ug/l

0.45

4294

21017

Glomerular disorders in diseases classified elsewhere

763

3798

2.19

77.49

2.8

2.4

6.56

8.03

ug/l

1.46

676

3341

Alzheimer disease, excluding more controls

1051

3727

1.97

77.01

2.5

2.2

5.97

8.05

ug/l

3.08

798

3263

Myalgia

1103

6144

1.87

76.81

2.6

2.2

6.11

7.55

ug/l

1.39

927

5335

Focal epilepsy

1183

6758

1.85

76.80

2.6

2.3

5.77

7.36

ug/l

3.14

1020

5851

Focal epilepsy, mode (most common among epilepsy diagnosis)

1068

5927

1.91

76.69

2.7

2.3

5.79

7.36

ug/l

2.69

922

5143

Hernia of abdominal wall

2494

17028

1.52

76.63

2.6

2.3

5.47

7.96

ug/l

14.46

2202

14879

Other disorders of lacrimal gland

1782

11328

1.64

76.24

2.6

2.3

5.03

7.01

ug/l

5.41

1493

9793

Genitourinary diseases

2863

9796

1.50

76.15

2.4

2.1

8.87

8.45

ug/l

0.27

2532

8818

Oter anti-inflammatory and antirheumatic agents, non-steroids

1369

4363

1.82

76.10

2.5

2.4

6.03

9.62

ug/l

8.37

1151

3782

Disorders of lacrimal system

2178

14434

1.56

76.08

2.6

2.3

5.18

6.89

ug/l

4.68

1826

12464

Iron deficiency anaemia secondary to blood loss (chronic)

1026

5674

1.94

75.45

2.9

2.4

8.08

6.59

ug/l

0.86

877

4830

Injuries to the hip and thigh

2736

17230

1.49

75.27

2.5

2.4

6.57

7.08

ug/l

0.52

2269

14734

Sequelae of external causes of morbidity and mortality

1456

8871

1.73

75.00

2.6

2.3

6.91

7.25

ug/l

0.25

1311

7652

Focal epilepsy, strict definition

1120

6351

1.87

74.84

2.7

2.3

5.86

7.32

ug/l

2.53

966

5496

Obesity, other/unspecified

1515

9278

1.69

74.64

2.4

2.2

5.77

7.49

ug/l

1.79

1282

8178

COPD

2673

15143

1.50

74.53

2.8

2.3

6.75

7.91

ug/l

2.21

2257

13129

COPD related to multimorbidity

2456

14210

1.53

73.64

2.9

2.4

6.83

7.44

ug/l

0.81

2055

12275

Left bundle-branch block

419

1644

2.79

73.62

2.4

1.9

9.37

5.59

ug/l

1.53

346

1372

Endovascular or surgical operations to intracerebral aneurysms

427

1706

2.81

73.61

2.7

2.3

5.27

7.04

ug/l

1.18

390

1510

Retention of urine

2125

11585

1.57

73.45

2.9

2.4

6.69

7.63

ug/l

1.52

1768

10097

Glomerular diseases

1059

5954

1.90

73.41

2.7

2.3

6.82

7.83

ug/l

0.85

942

5195

Other systemic involvement of connective tissue (FG)

1367

8107

1.74

73.35

2.5

2.3

6.63

6.81

ug/l

0.09

1136

6949

Other chronic obstructive pulmonary disease

2584

14723

1.51

73.10

2.8

2.3

6.69

7.93

ug/l

2.45

2170

12761

Fracture of lumbar spine and pelvis

1377

8331

1.75

73.05

2.6

2.4

6.08

6.72

ug/l

0.58

1091

7028

Migraine with aura and triptan purchases

586

2655

2.31

72.66

2.3

2.1

4.99

6.47

ug/l

1.49

520

2333

Preparatory care for dialysis

351

1292

3.19

72.65

2.6

2.4

6.64

7.59

ug/l

0.44

317

1158

Deforming dorsopathies

1318

7849

1.75

72.63

2.4

2.2

8.06

8.07

ug/l

0.01

1148

6809

Alcohol abuse, main dg, excluding more controls

770

3901

2.09

72.42

3.2

2.2

5.72

8.90

ug/l

6.30

688

3521

Anosmia

100

127

8.36

72.17

2.5

1.4

5.01

3.74

ug/l

0.74

108

Nonorganic sleeping disorders, excluding more controls

825

4266

2.02

72.16

3.0

2.1

5.78

7.58

ug/l

2.04

686

3794

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

713

3506

2.14

72.15

2.7

2.3

5.93

7.81

ug/l

1.41

613

3136

Ventral hernia

1365

8263

1.74

72.08

2.7

2.3

5.22

7.37

ug/l

6.40

1192

7128

Gout, idiopatic and unspecified

1617

10256

1.67

72.06

3.0

2.4

8.35

7.55

ug/l

0.42

1396

8902

Paracetamol or NSAID medication

760

1807

2.18

71.97

2.4

2.0

6.90

10.33

ug/l

3.10

661

1566

Special screening examination for other diseases and disorders

523

2276

2.43

71.87

2.5

2.0

4.92

8.18

ug/l

5.77

488

1984

Type 1 diabetes

1213

7073

1.78

71.85

2.6

2.2

7.09

7.94

ug/l

0.81

1063

6138

Diabetic retinopathy, excluding more controls

1487

5040

1.75

71.64

2.7

2.3

7.16

7.72

ug/l

0.37

1301

4352

Cellulitis

1194

6976

1.80

71.62

2.6

2.3

7.84

7.77

ug/l

0.03

1042

6118

Superficial injury of head

1273

7587

1.76

70.61

2.7

2.3

5.89

7.14

ug/l

1.28

1063

6465

Allergic asthma (mode)

906

4743

1.93

70.59

2.7

1.9

5.62

7.47

ug/l

2.59

810

4178

Systemic connective tissue disorders

1863

12205

1.59

70.00

2.5

2.3

6.64

6.59

ug/l

0.03

1554

10425

Cardiomyopathy, Hypertrophic obstructive

160

358

5.48

70.00

5.5

1.9

29.43

5.61

ug/l

4.88

149

304

Cerebral aneurysm, nonruptured

529

2370

2.44

69.99

2.7

2.3

6.55

6.85

ug/l

0.09

468

2096

Viral infections characterized by skin and mucous membrane lesions

4154

26663

1.36

69.90

2.4

2.3

6.60

7.39

ug/l

1.50

3597

23206

Other or unspecified ileus, impaction or obstruction

1109

6409

1.83

69.54

2.7

2.3

4.94

7.66

ug/l

8.68

953

5512

Undetermined asthma, excluding more controls

623

2966

2.22

68.91

2.6

2.0

5.87

6.76

ug/l

0.75

540

2587

Exposure to other specified factors

3529

23824

1.39

68.73

2.4

2.2

7.73

7.42

ug/l

0.24

3009

20912

Dialysis

298

1035

3.33

67.87

3.0

2.4

8.50

7.39

ug/l

0.35

282

934

Cutaneous abscess, furuncle and carbuncle

1271

7658

1.73

67.40

2.8

2.3

6.91

7.73

ug/l

0.73

1086

6742

Cervicocranial syndrome

566

2635

2.30

67.08

2.9

2.1

5.91

8.20

ug/l

1.37

514

2293

ILD medications: azathioprine

715

3645

2.07

65.89

2.4

2.1

14.12

7.16

ug/l

2.84

645

3232

Benign neoplasm: Stomach

630

3119

2.22

65.31

2.8

2.3

5.16

6.81

ug/l

1.82

550

2702

Other symptoms and signs involving the digestive system and abdomen

809

4321

1.97

64.87

2.5

2.1

6.08

7.68

ug/l

1.22

665

3723

Autoimmune diseases related-to ILD

4125

26779

1.34

64.48

2.5

2.3

6.19

7.37

ug/l

3.18

3571

23241

Hypokalaemia

698

3581

2.09

64.32

3.4

2.2

5.56

6.81

ug/l

1.14

582

3071

Schizophrenia or delusion, excluding more controls

1303

7889

1.69

64.29

2.5

2.1

5.74

7.93

ug/l

3.58

1099

7006

Diseases of the myoneural junction and muscle

758

4017

2.04

64.09

2.8

2.4

13.23

7.48

ug/l

3.91

597

3513

Type 1 diabetes, wide definition

1031

5936

1.81

64.02

2.6

2.2

7.36

7.78

ug/l

0.27

905

5150

Hypertrophic cardiomyopathy

329

1252

3.05

63.73

4.1

2.5

21.11

7.57

ug/l

4.99

309

1108

Other bacterial intestinal infections

1048

6113

1.81

63.72

2.6

2.3

6.82

7.31

ug/l

0.29

874

5212

Other diseases of hard tissues of teeth

3214

12023

1.42

63.60

2.4

2.2

7.13

7.41

ug/l

0.32

2767

10317

Benign neoplasm: Sigmoid colon

1156

6959

1.77

63.44

2.7

2.4

6.55

7.51

ug/l

0.93

1017

6034

Sequelae with surgical and medical care as external cause

1164

7004

1.76

63.40

2.7

2.4

6.87

7.19

ug/l

0.21

1045

6042

Delirium, not induced by alcohol and other psychoactive substances

808

4387

1.99

63.33

3.0

2.4

5.00

6.84

ug/l

5.44

652

3771

Chronic apical periodontitis

5507

24584

1.30

63.22

2.4

2.3

8.15

6.99

ug/l

2.49

4810

21369

Gout, unspecified

1327

8292

1.70

63.18

3.0

2.4

8.62

7.66

ug/l

0.47

1152

7213

Dermatitis and eczema

5431

26410

1.30

62.84

2.5

2.3

6.20

7.50

ug/l

4.97

4721

22913

Non-allergic asthma (mode)

929

5174

1.86

62.78

2.7

2.1

5.76

7.32

ug/l

2.80

840

4508

Other complications of surgical and medical care, not elsewhere classified

544

2569

2.28

62.62

3.8

2.2

5.66

7.03

ug/l

0.95

494

2240

Other and unspecified myopathies

590

2899

2.24

62.56

2.8

2.4

14.85

7.27

ug/l

4.43

459

2522

Explicit bacterial Sepsis

620

3086

2.16

62.18

2.9

2.2

8.28

7.31

ug/l

0.39

536

2691

Other diseases of upper respiratory tract

5645

23136

1.29

62.17

2.4

2.3

6.89

7.43

ug/l

0.79

4857

20041

Intestinal stricture

1775

11840

1.57

61.93

2.7

2.4

5.76

7.16

ug/l

2.80

1532

10173

Disorders of synovium and tendon

2412

14819

1.46

61.82

2.3

2.2

5.79

8.07

ug/l

9.72

2100

12939

Heart failure and hypertrophic cardiomyopathy

190

542

4.55

61.82

5.2

2.7

26.41

7.48

ug/l

4.05

177

481

Azathioprine

715

3739

2.01

61.24

2.4

2.1

14.12

7.31

ug/l

2.73

645

3296

Other chronic obstructive pulmonary disease, including avohilmo

3058

18552

1.41

61.12

2.8

2.4

6.75

7.70

ug/l

1.80

2573

16139

Other bacterial intestinal infections

1238

7617

1.70

61.07

2.5

2.3

8.17

7.09

ug/l

0.50

1032

6503

Benign neoplasm of other and ill-defined parts of digestive system

1027

6060

1.80

60.39

2.6

2.3

5.49

6.99

ug/l

2.31

902

5225

Candidiasis

705

3700

2.03

60.37

3.1

2.3

7.36

6.78

ug/l

0.23

593

3218

Later onset COPD, excluding more controls

1277

6102

1.71

60.13

2.8

2.2

5.74

7.85

ug/l

5.85

1052

5276

Bacterial pneumoniae

2127

12960

1.49

59.93

2.7

2.2

7.25

7.39

ug/l

0.12

1829

11213

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1135

6828

1.72

59.69

2.5

2.2

6.08

7.56

ug/l

1.48

966

6051

Gout, strict definition

1185

7316

1.73

59.50

3.0

2.4

8.00

7.59

ug/l

0.17

1025

6368

Artificial joint operation, meniscal resection

4809

24358

1.31

59.38

2.3

6.00

7.68

ug/l

6.91

4167

21191

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

481

2225

2.39

59.29

2.9

2.5

5.15

6.86

ug/l

1.42

417

1895

Problems related to lifestyle

529

2515

2.23

59.25

2.9

2.1

5.73

8.50

ug/l

1.13

467

2246

Congenital malformations of cardiac septa

341

1297

2.76

59.12

2.2

2.3

15.72

7.05

ug/l

5.92

306

1139

Acute pancreatitis

1111

6719

1.74

59.09

2.6

2.3

5.13

8.18

ug/l

11.89

967

5849

Polyarthrosis

1121

6286

1.74

59.06

2.7

2.3

4.69

7.07

ug/l

4.42

908

5382

Enterocolitis due to Clostridium difficile

688

3637

2.04

58.69

2.7

2.4

7.33

6.84

ug/l

0.20

569

3080

Cholecystectomy

3581

23323

1.36

58.69

2.5

2.3

5.50

7.24

ug/l

6.26

3099

20067

Substance use, excluding alcohol

885

5010

1.84

58.61

2.9

2.2

6.81

8.28

ug/l

0.94

748

4444

Non-selective monoamine reuptake inhibitors

1902

12491

1.52

58.38

2.5

2.2

5.38

7.38

ug/l

4.10

1553

10978

Diseases of pulp and periapical tissues, including avohilmo

5278

21485

1.29

58.34

2.4

2.3

7.27

7.14

ug/l

0.14

4592

18529

Injuries to the knee and lower leg

5787

25579

1.28

57.96

2.4

2.3

6.91

7.37

ug/l

0.64

4970

22258

Alcohol dependence

1428

9205

1.62

57.93

3.0

2.3

6.07

8.58

ug/l

4.81

1251

8171

Impingement syndrome of shoulder

1211

7504

1.69

57.89

2.3

2.2

6.17

8.80

ug/l

3.96

1050

6647

Hypothyroidism, strict autoimmune

3532

17440

1.36

57.26

2.4

2.3

6.55

7.24

ug/l

0.98

3027

15107

Myocardial infarction, unclassifiable

1511

8850

1.61

56.80

3.3

2.4

9.31

6.54

ug/l

3.87

1293

7391

Streptococcal septicaemia

552

2740

2.19

56.42

2.8

2.3

8.31

8.03

ug/l

0.08

481

2400

Gonarthrosis, primary, with knee surgery

3190

18985

1.38

56.36

2.4

5.35

7.62

ug/l

10.70

2737

16442

Other diseases of intestine

819

4621

1.88

56.16

2.8

2.2

7.79

8.34

ug/l

0.27

748

4054

Maze procedure for atrial fibrillation

137

11.88

56.02

2.6

2.8

29.21

8.99

ug/l

3.92

119

Degeneration of macula and posterior pole

2781

16229

1.41

55.98

2.6

2.4

5.65

7.06

ug/l

5.60

2296

13876

Bacterial intestinal infections, IBD co-morbidities

1047

6330

1.74

55.87

2.6

2.4

7.00

7.08

ug/l

0.04

873

5399

Undetermined asthma

623

3213

2.04

55.48

2.6

2.1

5.87

7.36

ug/l

1.52

540

2814

Abnormal involuntary movements

726

3969

1.95

55.10

2.9

2.3

6.14

7.89

ug/l

1.42

606

3465

Glucagon-like peptide-1 (GLP-1) analogues

1366

8815

1.61

54.86

2.6

2.2

5.82

8.69

ug/l

5.89

1227

7891

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1366

8815

1.61

54.86

2.6

2.2

5.82

8.69

ug/l

5.89

1227

7891

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

500

2411

2.23

54.70

3.3

2.3

5.81

6.84

ug/l

0.61

446

2117

Bacterial pneumonia, not elsewhere classified

2012

12332

1.48

54.69

2.7

2.2

7.30

7.36

ug/l

0.05

1732

10660

Other symptoms and signs involving the circulatory and respiratory systems

337

1373

2.64

54.43

3.0

1.9

8.04

8.66

ug/l

0.12

265

1187

Persons encountering health services for specific procedures, not carried out

438

2007

2.34

54.17

2.4

2.2

5.90

7.21

ug/l

1.11

387

1787

Atrial septal defect

223

734

3.37

54.10

2.2

2.3

15.70

6.75

ug/l

3.82

200

641

Polycystic ovarian syndrome, consortium definition

2736

11751

1.41

54.08

2.2

5.84

5.55

ug/l

0.27

2233

10035

Alzheimer’s disease (Late onset), excluding more controls

861

3192

1.87

53.96

2.5

2.2

6.20

7.90

ug/l

1.62

643

2779

Subarachnoid haemorrhage

622

3268

2.05

53.90

2.7

2.3

4.69

6.93

ug/l

4.99

549

2783

Other and unspecified polyneuropathies, also in other diseases

1137

7105

1.69

53.79

2.9

2.4

6.98

7.46

ug/l

0.28

965

6193

Functional dyspepsia

1260

8018

1.63

53.59

2.5

2.2

5.64

7.56

ug/l

3.21

1090

6940

Dissection of aorta

265

988

3.13

53.57

2.6

2.4

17.41

6.76

ug/l

2.93

249

862

Radiculopathy

868

5042

1.81

53.38

2.8

2.2

5.06

7.98

ug/l

7.87

766

4319

Emotionally unstable personality disorder

442

2028

2.27

53.32

2.3

2.1

3.86

7.07

ug/l

5.32

369

1796

Suicide or other Intentional self-harm

1028

6224

1.71

53.19

2.6

2.2

6.46

7.87

ug/l

1.19

871

5526

Vascular syndromes of brain in cerebrovascular disorders

346

1478

2.67

52.66

3.2

2.5

5.00

6.77

ug/l

1.10

311

1297

Bipolar affective disorders

734

4050

1.88

52.58

2.3

2.2

4.83

8.03

ug/l

7.50

633

3616

Fentanyl

638

3396

2.00

52.58

2.8

2.3

5.66

7.17

ug/l

0.89

516

2899

Visual impairment including blindness (binocular or monocular)

445

2099

2.32

52.30

2.5

2.4

6.87

6.60

ug/l

0.07

312

1780

Viral hepatitis, IBD co-morbidity

201

629

3.37

52.17

2.4

1.8

10.42

13.03

ug/l

0.41

179

565

Spondylolisthesis/Spondylolysis

882

5179

1.78

51.86

2.4

2.2

5.33

8.45

ug/l

7.53

789

4520

Coxibs

1395

4699

1.61

51.14

2.3

6.07

9.66

ug/l

9.33

1146

4078

Polyneuropathies and other disorders of the peripheral nervous system

1254

8107

1.63

51.11

2.8

2.4

7.32

7.50

ug/l

0.09

1070

7052

Somatoform disorder

734

4107

1.87

50.82

2.7

2.2

5.77

7.20

ug/l

0.81

613

3611

Haemorrhoids and perianal venous thrombosis

1644

11186

1.52

50.75

2.3

2.2

5.43

7.47

ug/l

5.53

1400

9695

Panic disorder

538

2711

2.06

50.62

2.6

2.0

4.92

6.61

ug/l

1.55

452

2395

Other and unspecified drugs and medicaments

476

2335

2.20

49.99

3.3

2.4

5.81

6.84

ug/l

0.58

426

2049

Diabetic maculopathy, excluding more controls

611

3264

2.00

49.98

3.0

2.3

7.25

7.93

ug/l

0.40

544

2831

Disorders of vitreous body and globe

2603

18556

1.39

49.32

2.5

2.3

5.97

7.18

ug/l

1.94

2293

16115

Other and unspecified effects of external causes

1137

7190

1.63

49.29

2.6

2.3

5.24

7.37

ug/l

4.78

990

6274

COPD, early/later onset

2602

16267

1.39

49.12

2.8

2.4

6.67

7.69

ug/l

1.82

2181

14114

Alcohol abuse, main dg

770

4425

1.83

49.07

3.2

2.2

5.72

8.75

ug/l

5.68

688

3982

Dementia in Alzheimer disease

1180

6387

1.65

49.05

2.6

2.5

5.08

6.12

ug/l

1.38

785

5342

Other skin changes

1015

6301

1.70

48.96

2.6

2.3

6.97

7.24

ug/l

0.13

876

5427

Other dialysis

227

819

3.22

48.66

2.8

2.4

7.25

7.60

ug/l

0.11

215

739

Rheumatoid arthritis

1566

9533

1.52

48.60

2.4

2.2

6.25

7.58

ug/l

1.35

1339

8272

Acute pancreatitis (for exclusion)

1111

7064

1.65

48.41

2.6

2.4

5.13

7.78

ug/l

9.84

967

6153

Chronic sinusitis

1903

13429

1.45

48.15

2.4

2.2

7.51

7.61

ug/l

0.05

1675

11776

Coxarthrosis, primary

3293

21440

1.34

48.11

2.5

2.4

5.97

7.32

ug/l

4.56

2826

18480

Meniscus derangement

2717

13588

1.38

48.10

2.3

2.2

6.77

8.42

ug/l

2.45

2372

11969

Disorders of the thyroid gland

4531

23442

1.28

47.84

2.4

2.3

7.13

7.27

ug/l

0.15

3896

20337

Charcot foot

104

220

5.41

47.76

2.5

1.7

4.98

4.76

ug/l

0.08

186

Other congenital malformations of upper alimentary tract

197

7.05

47.58

3.7

2.3

2.91

7.25

ug/l

2.56

176

COPD, hospital admission 2, with asthma infections

1894

11507

1.47

47.54

3.0

2.4

6.93

7.42

ug/l

0.44

1575

9904

Temporomandibular joint disorders, including avohilmo

1583

10655

1.50

47.42

2.3

2.2

5.29

7.00

ug/l

1.93

1366

9343

Viral and other specified intestinal infections

1046

6296

1.64

47.24

2.7

2.1

6.55

7.23

ug/l

0.35

925

5418

Other systemic involvement of connective tissue

1385

9274

1.55

47.18

2.4

2.3

6.59

6.52

ug/l

0.03

1151

7890

Dermatophytosis

729

4197

1.85

46.94

2.7

2.3

5.62

7.85

ug/l

3.10

640

3684

COPD, hospital admissions

2567

16179

1.39

46.93

2.8

2.4

6.69

7.64

ug/l

1.61

2154

14029

Disorders of vitreous body

2514

18091

1.38

46.54

2.5

2.3

5.97

7.19

ug/l

1.90

2222

15723

Trochanteric bursitis

696

3950

1.85

46.39

2.5

2.2

6.01

7.26

ug/l

0.68

595

3382

Superficial injury of lower leg

1139

7325

1.61

46.27

2.5

2.3

6.20

7.10

ug/l

0.57

952

6315

Benign neoplasm: Transverse colon

656

3698

1.92

46.14

2.9

2.4

6.22

7.29

ug/l

0.78

591

3243

Dronedarone medication

184

603

3.48

46.12

3.4

2.0

9.57

6.11

ug/l

0.72

167

512

Other and unspecified injuries of head

409

1960

2.26

45.86

2.6

2.3

5.83

7.44

ug/l

0.87

350

1706

Noninfective enteritis and colitis

2122

15393

1.41

45.67

2.6

2.3

5.83

7.46

ug/l

4.42

1835

13361

Pleural effusion

946

5890

1.70

45.64

2.9

2.4

7.60

7.00

ug/l

0.30

823

5064

Other epidermal thickening

279

1147

2.71

45.37

2.9

2.4

6.06

7.56

ug/l

0.62

249

1018

Hypothyroidism, strict autoimmune, 3 medication purchases required

3923

20844

1.29

45.27

2.4

2.3

6.37

6.96

ug/l

0.91

3354

18010

Xerosis cutis

144

420

4.25

44.80

2.9

2.5

6.48

6.77

ug/l

0.04

128

365

Benign neoplasm: Ascending colon

825

4997

1.76

44.64

2.7

2.4

6.21

7.12

ug/l

0.81

739

4333

Gingivitis and periodontal diseases

5137

21436

1.26

44.61

2.4

2.3

7.20

7.15

ug/l

0.04

4472

18562

Viral and other specified intestinal infections

787

4527

1.75

44.58

2.7

2.1

6.70

7.08

ug/l

0.17

694

3878

Injuries to the neck

999

6288

1.65

44.51

2.3

6.78

7.42

ug/l

0.30

866

5502

Excessive, frequent and irregular menstruation

1430

5204

1.54

44.43

2.2

4.62

6.16

ug/l

3.07

1161

4433

Psychotic depression

297

1255

2.53

44.27

2.5

2.2

4.72

8.67

ug/l

4.17

254

1141

Inguinal hernia

3041

15540

1.34

44.16

2.5

2.3

7.67

8.32

ug/l

0.86

2706

13547

Haemorrhage, not elsewhere classified

265

1079

2.75

44.16

2.7

2.2

9.16

7.86

ug/l

0.44

236

930

1812

11266

1.46

44.04

2.6

2.5

5.24

6.46

ug/l

3.52

1443

9480

Viral infections characterized by skin and mucous membrane lesions

1948

14045

1.42

43.86

2.5

2.3

7.40

7.56

ug/l

0.10

1681

12213

Other and unspecified visual disturbances

529

2816

2.00

43.79

2.6

2.3

6.74

6.77

ug/l

0.01

460

2472

Migraine without aura and triptan purchases

507

2630

1.99

43.76

2.0

2.1

4.18

6.45

ug/l

2.86

445

2326

Symptoms and signs involving speech and voice

1628

11412

1.47

43.74

2.5

2.3

6.27

6.88

ug/l

0.54

1367

9837

Acute alcohol intoxication

1280

8580

1.55

43.26

3.1

2.3

5.94

8.43

ug/l

5.52

1138

7572

Mouth breathing

1877

13488

1.43

43.24

2.4

2.3

5.89

8.49

ug/l

6.35

1700

12009

Diabetic nephropathy

973

6116

1.68

43.24

3.0

2.6

6.33

7.50

ug/l

1.36

874

5274

Acute gastritis

450

2287

2.12

43.08

2.8

2.3

4.82

7.71

ug/l

4.67

387

1993

Nonorganic sleeping disorders

825

4990

1.71

43.02

3.0

2.2

5.78

7.41

ug/l

1.75

686

4394

Fracture of femur

1605

10220

1.48

42.72

2.5

6.29

6.50

ug/l

0.16

1301

8525

Other shoulder lesions

452

2292

2.08

42.71

2.4

2.1

6.55

8.71

ug/l

1.23

388

2013

Other pleural conditions

650

3739

1.87

42.56

2.9

2.4

6.16

6.98

ug/l

0.75

560

3208

Complications of cardiac and vascular prosthetic devices, implants and grafts

178

609

3.49

42.49

3.1

2.4

13.07

6.21

ug/l

1.68

158

536

Internal derangement of knee

1690

11899

1.45

42.41

2.2

6.60

8.44

ug/l

2.56

1461

10503

Zoster [herpes zoster]

2492

18517

1.36

42.18

2.5

2.3

6.42

6.85

ug/l

0.61

2142

15968

Intracerebral haemorrhage

758

4548

1.77

42.10

2.4

2.3

6.40

6.89

ug/l

0.35

650

3816

Conotruncal defects

177

5.73

42.06

1.7

2.4

23.89

8.67

ug/l

3.04

158

Decubitus ulcer and pressure area

407

2024

2.21

42.00

2.9

2.4

9.34

6.94

ug/l

1.51

321

1722

Unspecified fall

2463

18291

1.36

41.88

2.6

2.3

6.46

7.27

ug/l

1.22

2004

15783

Neoplasms

3197

13027

1.32

41.77

2.2

7.38

8.30

ug/l

1.09

2784

11532

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

929

5741

1.64

41.75

2.5

2.2

5.48

6.99

ug/l

2.07

794

5040

Complications of internal orthopaedic prosthetic devices, implants and grafts

1235

8310

1.55

41.66

2.6

2.3

5.84

6.85

ug/l

1.05

1047

7075

Hypothyroidism, other/unspecified

4149

21819

1.27

41.61

2.4

2.3

6.79

7.12

ug/l

0.38

3548

18890

Seborrhoeic keratosis

1196

8000

1.56

41.50

2.5

2.4

7.13

7.07

ug/l

0.02

1066

6876

Irritable bowel syndrome

1125

7398

1.56

41.07

2.2

2.1

5.67

7.32

ug/l

2.33

923

6439

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

549

3031

1.94

40.89

2.9

2.3

8.09

7.21

ug/l

0.34

492

2662

Hypothyreosis and Thyroxine purchase for inclusion criteria

4293

22652

1.26

40.86

2.4

2.3

6.70

7.14

ug/l

0.57

3671

19613

Disorders of vestibular function (Vertigo)

2343

17328

1.37

40.84

2.5

2.3

6.04

6.87

ug/l

0.97

1970

14967

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1447

10043

1.48

40.77

2.6

2.3

6.60

7.58

ug/l

1.11

1177

8740

Cholecystitis

813

5004

1.71

40.76

2.8

2.4

4.98

7.24

ug/l

4.33

697

4246

Early onset COPD

1166

7794

1.56

40.52

2.9

2.3

7.93

8.38

ug/l

0.25

1019

6901

Other aneurysm

353

1687

2.30

40.44

3.3

2.3

8.44

7.20

ug/l

0.50

317

1461

Disorders of muscles

513

2771

1.96

40.35

2.6

2.2

11.35

8.46

ug/l

1.36

462

2428

Hyperkinetic disorders, excluding more controls

266

1050

2.49

40.29

1.8

1.7

3.91

6.89

ug/l

3.27

231

910

Other enthesopathies

1277

8663

1.52

40.23

2.3

2.1

6.27

8.09

ug/l

1.55

1120

7578

Acetic acid derivatives and related substances

1347

4682

1.53

40.18

2.3

6.70

9.68

ug/l

4.60

1116

4062

L04AX Other immunosuppressants

2487

18879

1.35

40.00

2.3

8.92

7.12

ug/l

1.69

2173

16513

Vascular diseases of the intestine

282

1241

2.55

39.94

3.3

2.4

6.84

6.57

ug/l

0.08

252

1053

Other respiratory disorders and diseases

1171

7878

1.55

39.67

2.9

2.4

7.93

6.99

ug/l

0.79

991

6691

Other diseases of the respiratory system

1171

7878

1.55

39.67

2.9

2.4

7.93

6.99

ug/l

0.79

991

6691

Congenital malformations of great arteries

114

293

4.28

39.57

2.3

2.2

17.19

8.19

ug/l

2.97

108

253

Diplopia

678

4010

1.78

39.47

3.0

2.3

7.63

7.49

ug/l

0.05

596

3500

Disorders of oesophagus in diseases classified elsewhere

168

579

3.42

39.41

3.1

2.4

5.15

7.76

ug/l

1.79

152

500

Second line medication for Crohn's disease

2535

19340

1.34

39.31

2.3

8.89

7.13

ug/l

1.67

2214

16915

Unspecified misadventure during surgical and medical care

330

1554

2.33

39.16

3.1

2.4

5.51

7.06

ug/l

1.52

295

1380

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2334

17116

1.35

38.96

2.4

2.3

8.35

7.94

ug/l

0.23

2012

15131

Kela-code for severe mental illness

1553

10995

1.45

38.94

2.5

2.3

5.61

7.78

ug/l

4.44

1334

9620

Acute alcohol intoxication, ICD10

944

6063

1.62

38.93

3.1

2.3

5.92

8.57

ug/l

4.61

843

5427

Hydrocephalus

465

2485

2.02

38.76

2.5

2.4

4.85

7.04

ug/l

2.53

393

2107

Fracture of lower leg, including ankle

2571

19514

1.33

38.55

2.5

2.3

6.08

7.35

ug/l

2.43

2210

17004

Artificial opening status

307

1411

2.37

38.48

2.6

2.2

5.47

6.57

ug/l

0.65

269

1236

Corns and callosities

380

1895

2.17

38.48

3.1

2.4

6.34

7.34

ug/l

0.46

325

1670

Disorders of skin appendages

1952

14359

1.39

38.42

2.3

2.2

6.97

7.39

ug/l

0.30

1702

12566

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

433

2265

2.06

38.21

3.1

2.4

7.02

6.68

ug/l

0.13

381

1978

Diabetic retinopathy

1901

8670

1.42

38.15

2.8

2.5

6.68

7.27

ug/l

0.57

1636

7561

Parkinson's disease, strict definition, excluding more controls

633

3518

1.80

38.08

2.3

2.2

6.19

8.95

ug/l

3.89

479

3095

Diagnoses used for exclusion with ILD

1350

9395

1.49

38.07

2.7

2.4

9.40

7.28

ug/l

1.39

1162

8075

Post-traumatic stress disorder

265

1131

2.44

37.99

2.2

1.9

5.12

6.35

ug/l

0.76

229

999

Parkinson's disease, excluding more controls

665

3708

1.77

37.89

2.4

2.1

6.18

8.93

ug/l

4.05

510

3267

Ulcer of oesophagus

437

2308

2.06

37.89

3.2

2.3

5.52

7.72

ug/l

1.15

398

2019

Right bundle-branch block

202

772

2.87

37.78

2.4

1.9

8.13

6.27

ug/l

0.46

161

643

Amputation of thigh

242

1028

2.70

37.62

2.8

2.6

6.36

6.29

ug/l

0.02

205

862

Arterial embolism and thrombosis

373

1867

2.17

37.59

3.6

2.4

9.44

7.03

ug/l

0.98

326

1582

Exposure to unspecified factor

4616

27214

1.24

37.44

2.4

2.3

8.37

7.10

ug/l

2.20

3883

23765

Dementia, including avohilmo

2630

13929

1.34

37.35

2.5

5.60

6.76

ug/l

3.22

1990

12077

Abnormal findings on examination of blood, without diagnosis

2442

17164

1.34

37.32

2.6

2.4

7.52

7.85

ug/l

0.32

2188

14930

Enlarged lymph nodes

666

3961

1.74

37.17

2.2

2.1

6.53

8.53

ug/l

1.33

578

3466

Unspecified mental disorder

1672

12080

1.42

37.11

2.5

2.3

5.88

7.77

ug/l

3.45

1436

10578

Gangrene, not elsewhere classified

179

5.91

36.82

3.3

2.0

3.53

8.24

ug/l

2.01

149

Hypertensive Renal Disease

237

996

2.63

36.76

2.6

2.2

6.68

7.68

ug/l

0.30

200

834

Schizophrenia, schizotypal and delusional disorders

1314

9126

1.48

36.65

2.5

2.3

5.73

7.90

ug/l

3.53

1104

7996

Examination and encounter for administrative purposes

249

1065

2.52

36.57

2.9

2.1

7.87

8.45

ug/l

0.10

227

948

Mixed hyperlipidaemia

255

1115

2.53

36.30

3.0

2.2

7.36

7.51

ug/l

0.03

226

986

Intestinal adhesions without obstruction

475

2609

1.94

35.99

2.6

2.3

4.75

7.80

ug/l

6.67

403

2271

Acute posthaemorrhagic anaemia

245

1061

2.58

35.93

3.3

2.5

8.59

6.51

ug/l

0.43

204

901

Schizophrenia or delusion

1303

9072

1.47

35.88

2.5

2.3

5.74

7.90

ug/l

3.47

1099

7950

1304

8601

1.49

35.62

2.6

2.5

4.78

6.19

ug/l

4.67

1032

7137

Other diseases of arteries and capillaries

487

2703

1.92

35.61

2.8

2.3

6.61

6.93

ug/l

0.18

423

2332

Unspecified acute lower respiratory infection

736

4572

1.68

35.18

3.0

2.3

8.22

7.83

ug/l

0.11

649

4004

Urticaria and erythema

1450

10324

1.44

35.16

2.6

2.2

5.41

7.11

ug/l

3.60

1219

8972

Other symptoms and signs involving general sensations and perceptions

238

1022

2.55

35.07

2.7

2.3

6.64

7.25

ug/l

0.15

199

870

Any dementia, excluding more controls

2043

10549

1.38

35.04

2.5

2.4

5.65

6.79

ug/l

2.44

1503

9151

Other noninfective gastroenteritis and colitis

1129

7695

1.51

34.97

2.7

2.3

5.51

7.09

ug/l

3.04

958

6586

Lesion of ulnar nerve

675

4117

1.72

34.80

2.6

2.3

8.02

8.43

ug/l

0.13

599

3663

Other viral diseases

1100

7430

1.51

34.73

2.5

2.2

9.08

7.54

ug/l

0.86

970

6527

Type of accident

1321

9301

1.46

34.54

2.5

2.3

6.72

7.39

ug/l

0.58

1069

8076

Septal defects

278

1246

2.32

34.42

2.2

2.3

14.25

7.10

ug/l

4.14

246

1099

Superficial injury of abdomen, lower back and pelvis

691

4249

1.69

34.24

2.6

2.3

4.63

7.26

ug/l

7.11

596

3704

COPD, hospital admissions 3, with asthma pneumonia sepsis

1589

9890

1.42

34.15

3.1

2.4

6.53

7.34

ug/l

1.04

1306

8483

Generalized anxiety disorder

505

2836

1.83

34.11

2.1

2.0

8.48

7.06

ug/l

0.28

402

2507

severe traumatic brain injury, does not include concussion

1246

8740

1.48

34.00

2.5

2.4

6.63

7.20

ug/l

0.57

1050

7461

544

3139

1.80

33.94

2.3

2.1

17.76

7.11

ug/l

4.81

480

2745

Abdominal aortic aneurysm (AAA)

631

3794

1.75

33.85

2.9

2.3

7.37

6.62

ug/l

0.48

545

3186

Gastrojejunal ulcer

107

307

4.19

33.84

2.9

2.4

4.53

8.80

ug/l

1.59

102

268

Asthma and allergy, excluding more controls

372

1870

2.02

33.76

2.2

1.8

5.98

5.93

ug/l

0.02

329

1641

Irregular menses

1454

8172

1.43

33.70

2.0

2.1

5.43

5.84

ug/l

0.30

1238

7081

Idiopathic gout

583

3483

1.80

33.69

3.0

2.4

6.67

7.69

ug/l

0.35

499

3044

Other arthritis (FG)

1360

9666

1.44

33.59

2.4

2.3

8.05

7.71

ug/l

0.15

1187

8464

Brachial plexus disorders

370

1900

2.04

33.58

2.3

2.1

4.71

7.41

ug/l

1.67

331

1706

Propionic acid derivatives

1372

4798

1.47

33.57

2.4

2.3

5.92

9.64

ug/l

11.70

1174

4157

Congenital aortic valve stenosis

9.30

33.56

2.5

2.4

16.76

11.08

ug/l

0.56

Viral pneumonia (unknown virus, not influenza)

356

1821

2.09

33.33

3.0

2.3

11.42

7.07

ug/l

1.59

308

1619

Dementia

2451

13070

1.33

33.32

2.5

2.4

5.57

6.73

ug/l

3.00

1833

11306

Other viral diseases

1353

9532

1.44

33.11

2.4

2.2

8.50

7.57

ug/l

0.55

1188

8368

Disorders of other endocrine glands

1929

14289

1.36

32.98

2.8

2.3

6.47

6.88

ug/l

0.34

1619

12244

Extrapyramidal and movement disorders

1921

14506

1.36

32.92

2.6

2.4

5.39

7.06

ug/l

6.33

1570

12526

Insulin, fast-acting (human)

605

3629

1.73

32.85

2.6

2.2

7.37

7.67

ug/l

0.15

532

3151

Diseases of external ear

1584

11611

1.40

32.78

2.3

6.12

7.42

ug/l

2.08

1201

10153

Disorders of sclera, cornea, iris and ciliary body

2453

19110

1.31

32.77

2.5

2.3

6.30

7.44

ug/l

1.56

2151

16621

Ovarian cyst

1254

4994

1.48

32.70

2.2

4.76

6.18

ug/l

2.06

1038

4284

Umbilical hernia

1285

9104

1.46

32.68

2.6

2.3

5.61

8.71

ug/l

10.42

1154

8043

Inflammatory diseases of female pelvic organs

2157

12056

1.34

32.67

2.2

4.58

5.77

ug/l

2.93

1787

10308

Fibromyalgia

338

1699

2.08

32.50

2.2

2.0

4.18

6.10

ug/l

1.34

280

1467

Toxic effects of substances chiefly nonmedicinal as to source

506

2908

1.82

32.37

2.8

2.3

5.70

7.90

ug/l

2.75

456

2603

Other extrapyramidal and movement disorders in other diseases

1168

8166

1.48

32.25

2.6

2.4

5.20

7.08

ug/l

4.89

972

7075

Benign neoplasm: Rectum

977

6621

1.54

32.21

2.4

5.45

7.45

ug/l

3.36

839

5753

Osteomyelitis

376

1994

2.03

32.12

2.8

2.3

8.06

7.54

ug/l

0.18

322

1767

Diseases of inner ear

2644

20173

1.29

32.07

2.5

2.3

6.23

7.05

ug/l

1.04

2219

17483

Other viral diseases, not elsewhere classified

752

4773

1.62

32.07

2.6

2.2

9.13

7.46

ug/l

0.73

664

4190

Urticaria

1140

7909

1.48

31.97

2.5

2.2

5.10

7.07

ug/l

3.72

959

6913

Zoster [herpes zoster]

949

6391

1.55

31.96

2.8

2.4

6.96

6.92

ug/l

0.02

800

5457

Secondary parkinsonism, excluding more controls

153

556

3.06

31.81

3.2

2.2

4.83

7.49

ug/l

1.74

123

501

Bacterial pneumonia (organism specified)

2279

16007

1.32

31.77

2.7

2.3

7.14

7.22

ug/l

0.07

1956

13669

Sub-endpoint used in defining T1D endpoints

1352

9533

1.43

31.77

2.7

2.3

6.84

7.38

ug/l

0.51

1186

8136

Menorrhagia

1283

4962

1.47

31.76

2.2

4.86

6.24

ug/l

2.44

1035

4223

Adhesive capsulitis of shoulder

782

5050

1.61

31.70

2.4

2.2

5.17

8.15

ug/l

7.26

696

4378

Dissociative [conversion] disorders

159

584

2.90

31.66

2.9

2.1

3.77

5.98

ug/l

0.91

133

518

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

266

1235

2.26

31.64

2.3

2.1

5.80

8.26

ug/l

1.43

237

1112

Benign paroxysmal vertigo

1419

10293

1.42

31.63

2.6

2.3

6.06

6.91

ug/l

0.59

1183

8862

Persistent mood disorders

829

5421

1.58

31.46

2.8

2.2

6.17

7.35

ug/l

0.63

676

4712

Panniculitis affecting regions of neck and back

201

839

2.60

31.37

2.6

2.2

5.99

7.41

ug/l

0.55

182

746

Benign neoplasm: Rectum, anus and anal canal

1081

7508

1.50

31.30

2.4

5.62

7.35

ug/l

2.82

929

6507

Status epilepticus

210

898

2.56

31.24

2.9

2.3

7.91

7.51

ug/l

0.06

178

794

KRA_PSY_EATING, excluding more controls

207

860

2.47

31.02

2.1

1.8

5.23

5.94

ug/l

0.20

175

749

Benign neoplasm: Caecum

604

3716

1.73

30.98

2.8

2.4

5.81

7.08

ug/l

1.44

537

3236

Alzheimer’s disease (Atypical or mixed)

672

4217

1.69

30.97

2.8

2.6

5.05

5.71

ug/l

0.61

496

3454

Other specified and unspecified personality disorders

361

1895

1.99

30.80

2.5

2.2

4.87

8.06

ug/l

4.15

300

1716

Other problems related to primary support group, including family circumstances

369

1888

1.97

30.78

2.4

2.2

4.26

6.34

ug/l

3.00

320

1660

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

183

737

2.68

30.66

2.6

2.1

9.82

8.20

ug/l

0.42

166

680

Other viral diseases, not elsewhere classified

973

6572

1.51

30.42

2.5

2.2

8.48

7.27

ug/l

0.63

853

5760

Other infectious diseases

491

2871

1.81

30.14

3.8

2.4

6.66

7.04

ug/l

0.18

445

2482

Superficial injury of hip and thigh

772

5038

1.60

30.07

2.7

2.4

6.07

6.82

ug/l

0.47

636

4288

Other other unspecified disorders of the circulatory system

230

1046

2.43

30.05

3.1

2.4

12.58

7.27

ug/l

2.11

211

910

Reimbursement for rheumatic diseases

2558

20167

1.29

30.00

2.3

6.62

7.00

ug/l

0.30

2214

17443

Speech and linguistic disorders, excluding more controls

252

1091

2.25

29.99

2.3

2.1

6.76

7.00

ug/l

0.07

217

948

Failure and rejection of transplanted organs and tissues

282

4.03

29.84

2.5

2.4

29.46

6.85

ug/l

2.54

256

Chronic pancreatitis

642

4034

1.67

29.78

2.9

2.3

4.40

8.89

ug/l

16.44

558

3574

Acidosis

144

530

3.10

29.76

3.5

2.3

7.67

7.20

ug/l

0.13

125

473

Mental and behavioural disorders due to sedatives or hypnotics

304

1527

2.11

29.74

2.5

2.2

5.90

8.03

ug/l

1.40

249

1371

Other local infections of skin and subcutaneous tissue

500

2943

1.79

29.71

2.8

2.3

6.39

7.64

ug/l

0.75

435

2598

Amputation of foot

193

826

2.68

29.70

2.8

2.6

5.89

7.29

ug/l

0.83

171

737

Acute peritonitis

366

1974

1.99

29.70

3.2

2.4

7.66

7.25

ug/l

0.10

330

1728

Embolic stroke with flimmer

178

727

2.73

29.63

2.6

2.3

6.64

5.74

ug/l

0.29

152

590

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

484

2473

1.77

29.50

2.0

4.29

6.98

ug/l

4.39

423

2170

Diseases of salivary glands

1380

10060

1.41

29.49

2.4

2.3

5.96

7.15

ug/l

1.62

1173

8748

Lung diseases due to external agents

784

5169

1.59

29.46

2.8

2.4

8.67

7.11

ug/l

0.64

650

4414

Asthma and allergy

372

1960

1.92

29.44

2.2

1.9

5.98

7.00

ug/l

0.47

329

1726

Pain and other conditions associated with female genital organs and menstrual cycle

563

3109

1.70

29.39

1.7

2.1

4.94

6.47

ug/l

0.78

460

2708

Injuries to the elbow and forearm

3090

21972

1.25

29.34

2.4

2.3

7.01

ug/l

0.00

2596

19048

Other infectious diseases

428

2428

1.88

29.33

4.0

2.4

6.99

7.20

ug/l

0.08

387

2104

Voice disturbances

1192

8497

1.45

29.31

2.4

2.3

5.86

7.04

ug/l

1.23

1017

7368

Other condition

640

4023

1.66

29.17

2.5

2.3

7.37

7.78

ug/l

0.17

561

3560

Other disorders of eyelid

2249

16778

1.31

29.02

2.5

2.3

5.37

6.97

ug/l

4.88

1898

14440

Fracture of skull and facial bones

935

6383

1.51

28.89

2.7

2.3

7.70

8.07

ug/l

0.18

790

5614

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

520

3095

1.73

28.77

2.1

2.2

4.10

5.38

ug/l

1.29

441

2656

Enthesopathies of lower limb, excluding foot

875

5894

1.53

28.74

2.3

2.1

6.61

8.66

ug/l

1.71

744

5190

Viral pneumonia (known virus, not influenza)

176

729

2.72

28.67

3.3

2.4

5.50

7.13

ug/l

0.93

161

633

Diseases of peritoneum

526

3178

1.75

28.56

3.0

2.4

6.93

7.02

ug/l

0.03

460

2759

Abnormalities of gait and mobility

644

4098

1.66

28.50

2.5

2.3

6.14

7.08

ug/l

1.00

561

3534

Use of pramipexole

1111

7884

1.46

28.44

2.6

2.4

5.46

6.99

ug/l

2.23

920

6779

Trigger finger

625

3928

1.65

28.42

2.5

2.1

6.18

8.12

ug/l

2.17

552

3438

Dermatophytosis

2699

21617

1.27

28.38

2.5

2.3

7.21

7.58

ug/l

0.30

2320

18972

Other and unspecified local infections of skin and subcutaneous tissue

467

2737

1.80

28.22

2.8

2.3

6.54

7.29

ug/l

0.37

413

2408

Other benign neoplasms of skin

1783

13613

1.34

28.21

2.5

2.3

6.80

6.92

ug/l

0.06

1497

11713

ILD, hospital admission 2, with pulmonary infections

527

3198

1.74

28.20

2.8

2.3

10.91

7.47

ug/l

2.64

457

2766

Dislocation, sprain and strain of joints and ligaments at neck level

550

3352

1.69

28.03

2.3

5.18

6.95

ug/l

2.01

483

2980

Conjunctivitis (acute, non atopic)

1117

7894

1.44

27.91

2.5

2.3

5.59

7.26

ug/l

1.95

969

6916

Disorders resulting from impaired renal tubular function

222

1027

2.39

27.91

2.2

2.5

5.80

7.17

ug/l

0.98

200

917

Other diseases of pancreas

441

2564

1.83

27.83

2.3

5.29

7.89

ug/l

4.47

391

2261

Rheumatism, unspecified

563

3471

1.68

27.67

2.3

2.2

4.45

6.93

ug/l

3.38

468

2981

2242

16221

1.30

27.59

2.5

2.4

5.72

6.87

ug/l

2.76

1910

13755

Chondrocostal junction syndrome [Tietze]

204

911

2.44

27.55

3.1

2.4

5.67

7.06

ug/l

0.53

177

806

Other and unspecified tonsillitis

1084

6398

1.45

27.53

2.1

2.0

7.70

8.65

ug/l

0.45

954

5770

Pneumonitis due to solids and liquids

482

2883

1.78

27.44

2.8

2.4

8.67

7.13

ug/l

0.35

382

2461

Cerebral cysts

260

1274

2.17

27.32

2.7

2.3

12.89

7.17

ug/l

1.43

234

1128

Varicose veins

3028

18594

1.25

27.20

2.5

2.3

5.51

7.04

ug/l

4.73

2573

16058

Phobic anxiety disorders

398

2228

1.83

27.14

2.4

2.0

5.45

7.26

ug/l

1.04

346

1978

Chronic rhinitis, nasopharyngitis and pharyngitis

1276

9301

1.40

27.10

2.2

5.85

7.63

ug/l

3.44

1091

8175

Mental and behavioural disorders due to opioids

152

592

2.73

27.07

5.3

2.2

11.90

9.25

ug/l

0.31

136

537

Use of other anti-dementia drugs

1623

10201

1.36

26.99

2.4

2.5

4.88

6.06

ug/l

3.25

1150

8521

Use of memantine

1623

10201

1.36

26.99

2.4

2.5

4.88

6.06

ug/l

3.25

1150

8521

Adverse effects, not elsewhere classified

745

4923

1.56

26.90

2.6

2.3

4.69

7.19

ug/l

5.73

642

4281

Disorders of calcium metabolism

318

1687

2.01

26.89

2.6

2.1

4.96

7.15

ug/l

2.84

270

1468

Other pulmonary heart/vessel disease

290

1505

2.10

26.82

2.7

2.6

17.93

6.87

ug/l

2.93

254

1288

Retinal vascular occlusion

681

4456

1.61

26.81

2.8

2.4

6.66

6.97

ug/l

0.13

583

3791

Transient global amnesia

502

3061

1.74

26.67

2.4

5.90

6.94

ug/l

0.84

444

2684

Unspecific neurodegenerative disorder

2391

13000

1.29

26.51

2.4

2.5

5.41

6.54

ug/l

2.88

1782

11124

Retinal vascular disorders

690

4539

1.60

26.48

2.7

2.4

6.64

6.94

ug/l

0.12

592

3860

Other ill-defined and unspecified causes of mortality

476

2874

1.77

26.46

3.2

2.4

5.75

7.12

ug/l

0.84

406

2442

COPD, hospital admissions 1, only main diagnosis

1885

12516

1.33

26.38

2.8

2.4

7.04

7.43

ug/l

0.33

1578

10782

Primary gonarthrosis, bilateral

2578

17762

1.27

26.32

2.4

5.86

7.58

ug/l

3.48

2150

15378

Anti-inflammatory and antirheumatic products, non-steroids

1321

4798

1.41

26.26

2.5

2.3

5.96

9.64

ug/l

12.29

1144

4157

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

285

1463

2.05

26.20

2.6

2.2

4.40

7.19

ug/l

3.67

242

1304

Moderate visual impairment, binocular

205

945

2.41

26.12

2.4

2.6

7.24

5.73

ug/l

0.22

115

780

Other specified/unspecified arthritis

1135

8174

1.42

26.09

2.4

2.3

8.75

8.07

ug/l

0.28

983

7173

Amputation of ankle bones

162

678

2.72

26.09

3.1

2.6

5.70

7.32

ug/l

0.96

148

593

Disorders of mineral metabolism

396

2271

1.84

25.88

2.5

2.1

5.02

7.30

ug/l

3.04

331

1993

Vitreous haemorrhage

519

3208

1.70

25.87

2.6

2.3

6.39

7.73

ug/l

1.40

461

2805

Atrial septal defect, secundum type

135

509

2.87

25.79

1.8

2.4

15.29

6.53

ug/l

2.56

116

447

Postmenopausal bleeding

1167

4449

1.44

25.54

2.6

2.2

5.10

6.40

ug/l

1.70

956

3790

Transport accidents

1875

12501

1.31

25.41

2.4

2.2

7.37

7.67

ug/l

0.17

1620

11157

Coagulation defects, purpura and other haemorrhagic conditions

872

6035

1.49

25.39

2.6

2.3

8.29

7.15

ug/l

0.88

764

5225

Noninfectious colitis NAS

608

3911

1.61

25.18

2.7

2.3

4.96

7.06

ug/l

4.01

512

3405

Any dementia

2217

12223

1.29

25.16

2.5

5.57

6.41

ug/l

1.73

1633

10462

Focal brain injury

302

1605

1.98

25.09

2.6

2.2

7.06

8.75

ug/l

0.92

256

1431

Injuries to the wrist and hand

4423

25961

1.19

25.04

2.3

7.47

7.36

ug/l

0.09

3846

22684

Skin changes due to chronic exposure to nonionizing radiation

2128

15582

1.29

25.03

2.5

2.4

5.55

6.69

ug/l

2.75

1816

13205

Normal-pressure hydrocephalus

323

1787

1.98

24.88

2.6

2.5

4.55

6.22

ug/l

1.80

274

1508

Diseases of liver

1584

12109

1.34

24.88

2.6

2.3

7.79

ug/l

0.00

1378

10620

Contact with and exposure to communicable diseases

370

6338

0.57

24.81

1.9

2.1

12.94

7.17

ug/l

1.55

311

5616

Elevated blood glucose level

409

2400

1.80

24.78

2.7

2.3

8.46

7.26

ug/l

0.35

356

2120

Other and unspecified disorders of vitreous body

1945

15072

1.30

24.77

2.5

2.3

6.07

7.17

ug/l

1.13

1720

13125

Liquid cancers, helper endpoint

1949

13348

1.30

24.63

2.4

6.46

7.93

ug/l

1.95

1664

11584

Open wound of lower leg

700

4672

1.55

24.55

2.8

2.3

6.85

7.40

ug/l

0.31

590

4050

Actinic keratosis

2082

15310

1.29

24.48

2.6

2.4

5.63

6.68

ug/l

2.33

1775

12963

Early lumbar disc prolapse, operated

298

1579

1.95

24.47

1.9

5.77

10.75

ug/l

2.99

274

1435

Appendectomy

2595

20111

1.25

24.44

2.3

2.2

5.89

7.62

ug/l

3.34

2300

17621

Keratitis

1534

11700

1.34

24.31

2.5

2.3

6.88

7.51

ug/l

0.39

1333

10188

Osteoporosis with pathological fracture (FG)

398

2341

1.81

24.27

2.9

2.5

5.59

6.20

ug/l

0.26

303

1923

Lateral epicondylitis

529

3320

1.65

24.18

2.2

2.1

7.23

8.58

ug/l

0.35

468

2952

Other disorders of glucose regulation and pancreatic internal secretion

405

2386

1.78

24.09

2.6

2.4

5.53

7.06

ug/l

1.32

354

2066

Seborrhoeic dermatitis

470

2885

1.71

24.01

2.6

2.3

6.07

8.01

ug/l

1.56

415

2561

Chronic periodontitis, complicated

2536

20416

1.25

24.00

2.4

2.3

8.38

7.57

ug/l

0.83

2225

18012

Ascites

371

2139

1.83

23.98

2.7

2.2

7.78

8.63

ug/l

0.33

335

1875

Behavioural syndromes associated with physiological disturbances and physical factors

3912

23352

1.20

23.97

2.5

2.2

5.92

7.43

ug/l

5.07

3364

20379

Visual field defects

430

2586

1.75

23.90

2.5

2.3

5.71

6.77

ug/l

0.90

367

2256

Hallux rigidus

658

4379

1.56

23.52

2.5

2.3

5.36

7.89

ug/l

5.02

544

3811

Arterial embolism and thrombosis of lower extremity artery

226

1125

2.20

23.50

3.2

2.4

10.43

6.44

ug/l

1.29

195

956

Cerebral palsy and other paralytic syndromes

511

3214

1.66

23.44

2.6

2.3

6.66

7.25

ug/l

0.34

427

2804

Superficial injury of thorax

692

4657

1.54

23.36

2.7

2.3

6.87

7.63

ug/l

0.35

598

4040

Injuries to the ankle and foot

2748

19993

1.24

23.31

2.5

2.2

7.15

7.61

ug/l

0.47

2372

17589

Other diseases of oesophagus

491

3074

1.68

23.20

2.6

2.3

8.21

7.70

ug/l

0.15

404

2658

Combinations of oral blood glucose lowering drugs

1379

10463

1.36

23.16

2.5

2.3

6.06

8.54

ug/l

6.36

1232

9225

Other necrotizing vasculopathies (FG)

319

1783

1.91

23.11

2.8

2.4

4.97

7.63

ug/l

3.80

265

1556

Anaemia in chronic diseases classified elsewhere

161

710

2.55

23.00

2.6

2.4

9.56

7.17

ug/l

0.43

146

618

Fracture of shoulder and upper arm

1646

12765

1.32

22.94

2.4

2.3

8.66

7.19

ug/l

0.95

1342

10917

Hypotension due to drugs

115

437

3.09

22.87

3.7

2.8

8.75

7.19

ug/l

0.26

383

Other/unspecified cytomegaloviral diseases

117

443

2.97

22.87

2.6

2.3

16.63

6.89

ug/l

1.38

106

397

Certain disorders involving the immune mechanism

825

5767

1.48

22.84

2.5

2.3

9.01

7.53

ug/l

0.61

736

5073

Other bursopathies

612

4039

1.57

22.73

2.5

2.2

7.67

8.11

ug/l

0.11

520

3493

Amenorrhoea

177

795

2.30

22.68

2.0

2.5

5.01

5.68

ug/l

0.29

153

692

Tobacco use

252

1313

2.04

22.55

2.6

2.3

6.95

8.00

ug/l

0.14

224

1185

Fissure and fistula of anal and rectal regions

1013

7342

1.41

22.55

2.3

2.2

6.94

8.29

ug/l

0.80

838

6483

Eating disorders

306

1677

1.87

22.53

2.4

2.3

7.29

6.03

ug/l

0.20

267

1459

Disorders of parathyroid gland

1041

7515

1.41

22.45

2.7

2.4

5.97

6.23

ug/l

0.16

849

6300

Coxarthrosis, primary, with hip surgery

2434

18578

1.25

22.36

2.5

2.4

6.34

7.06

ug/l

1.17

2098

15966

Secondary right heart disease

257

1364

2.05

22.34

2.8

2.6

18.57

6.99

ug/l

2.78

226

1163

COPD-related respiratory insufficiency

654

4414

1.55

22.31

2.6

2.4

9.94

7.13

ug/l

1.56

528

3797

Cardiomyopathy in other diseases

112

5.62

22.27

3.1

2.0

5.02

4.78

ug/l

0.08

Polyuria

1113

8237

1.39

22.19

2.6

2.3

6.17

7.46

ug/l

1.57

921

7229

Benign neoplasm: Descending colon

388

2327

1.78

22.19

3.0

2.4

6.50

7.39

ug/l

0.29

342

2047

Erythema intertrigo

149

644

2.58

22.16

3.0

2.5

5.39

6.94

ug/l

0.50

126

566

Stomatitis and related lesions

793

5529

1.48

22.12

2.4

2.3

5.10

7.27

ug/l

4.27

669

4822

Covid-19 suspected case

778

5394

1.48

22.10

3.2

2.1

5.31

7.25

ug/l

3.17

668

4753

Tubulo-interstitial nephritis, not specified as acute or chronic

343

1982

1.82

21.96

2.9

2.4

6.09

6.50

ug/l

0.17

291

1685

Other diseases of lip and oral mucosa

1685

13194

1.30

21.95

2.4

2.3

6.67

7.28

ug/l

0.38

1456

11515

Other congenital malformations of the digestive system

193

914

2.23

21.90

2.8

2.4

6.29

7.39

ug/l

0.34

172

805

Shock, not elsewhere classified

248

3.78

21.88

2.8

2.2

17.36

7.83

ug/l

1.41

216

Seropositive rheumatoid arthritis

1121

8273

1.38

21.86

2.3

6.39

7.11

ug/l

0.40

963

7134

Ill-defined and unknown causes of mortality

501

3213

1.65

21.80

3.3

2.4

5.91

7.21

ug/l

0.79

429

2735

Other abnormal uterine and vaginal bleeding

884

4470

1.45

21.76

2.3

2.2

6.11

ug/l

0.00

628

3798

Disorders of ocular muscles, binocular movement, accommodation and refraction

1785

13948

1.29

21.71

2.3

7.03

7.23

ug/l

0.12

1540

12188

Somnolence, stupor and coma

224

1137

2.11

21.71

2.9

2.3

9.58

7.60

ug/l

0.32

203

990

Sequelae of other external causes

274

1487

1.96

21.71

2.5

2.4

7.95

7.08

ug/l

0.22

256

1313

Other disorders of eye and adnexa

566

3705

1.58

21.66

2.6

2.3

5.74

6.74

ug/l

0.48

467

3246

Acute suppurative otitis media

755

4859

1.47

21.56

2.2

2.1

7.91

7.40

ug/l

0.15

649

4300

Unspecified privation

496

3165

1.63

21.53

2.4

2.3

9.68

7.25

ug/l

1.29

442

2779

Hypoglycaemia, other or unspecified

324

1854

1.84

21.46

2.6

2.4

5.21

6.86

ug/l

2.09

284

1622

Sulfasalazine

1161

8670

1.37

21.31

2.3

2.2

6.81

7.12

ug/l

0.15

1037

7569

Diabetic retinopathy, strict definition

881

5584

1.45

21.26

2.8

2.5

6.27

7.78

ug/l

2.19

753

4865

Wet age-related macular degeneration

1018

7274

1.41

21.25

2.6

2.5

5.40

6.02

ug/l

0.77

807

6015

Congenital malformations of pulmonary and tricuspid valves

5.52

21.19

2.0

2.6

32.21

7.28

ug/l

2.10

Other disorders of bone

776

5432

1.47

21.14

2.5

2.2

8.69

7.46

ug/l

0.43

648

4812

Respiratory insufficiency

408

2496

1.71

20.90

2.8

2.2

9.32

7.23

ug/l

1.33

334

2158

Other embolism and thrombosis

627

4241

1.54

20.86

2.5

2.3

10.37

7.55

ug/l

0.79

539

3670

Embolic stroke

284

1585

1.92

20.86

2.5

6.64

7.12

ug/l

0.19

244

1353

Assault

454

2853

1.64

20.56

2.4

2.2

6.83

8.81

ug/l

0.75

391

2580

Cytomegalovirus infection, IBD co-morbidity

129

539

2.65

20.56

2.5

2.4

16.09

7.50

ug/l

1.29

117

482

Central retinal artery occlusion

154

702

2.47

20.49

2.5

2.7

4.41

6.58

ug/l

1.65

135

601

Use of disulfiram, acamprosate or naltrexone

386

2346

1.72

20.46

2.8

2.3

10.47

9.42

ug/l

0.15

341

2143

Polymyalgia rheumatica

731

5129

1.49

20.45

2.6

2.4

5.88

6.58

ug/l

0.54

597

4304

Disorders of psychological development

326

1735

1.78

20.41

2.3

6.49

ug/l

0.00

277

1510

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1238

9408

1.34

20.29

2.3

7.37

7.97

ug/l

0.29

1089

8258

Strabismus

1020

7510

1.38

20.24

2.4

2.3

6.67

7.25

ug/l

0.29

868

6523

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1307

8653

1.33

20.24

2.1

4.93

6.10

ug/l

1.79

1161

7487

Open wound of wrist and hand

1825

14229

1.27

20.15

2.3

7.94

8.20

ug/l

0.15

1604

12652

Sleep disorders

3683

22641

1.19

20.09

2.4

2.2

5.78

7.44

ug/l

5.91

3156

19770

Hyperkinetic disorders

269

1435

1.87

20.08

1.8

2.0

3.91

6.73

ug/l

3.63

234

1244

Peritonsillar abscess

741

5191

1.46

19.93

2.2

5.48

8.13

ug/l

6.60

658

4646

Superficial injury of forearm

387

2366

1.70

19.84

2.8

2.3

8.23

7.06

ug/l

0.21

325

2099

Open wound of ankle and foot

452

2876

1.63

19.81

2.4

2.3

7.35

8.25

ug/l

0.42

406

2555

DVT of lower extremities

926

6786

1.41

19.70

2.5

2.4

6.64

7.37

ug/l

0.29

780

5840

Foreign body in alimentary tract

267

1486

1.91

19.61

3.1

2.4

4.62

7.32

ug/l

4.53

231

1329

ILD, hospital admissions 3, with pneumonia sepsis

450

2882

1.64

19.59

2.9

2.3

11.20

7.27

ug/l

2.68

385

2480

Disease of hard tissues of teeth, NOS

2603

11217

1.23

19.48

2.5

2.2

6.93

7.53

ug/l

0.79

2255

9725

Schizoaffective disorder

296

1693

1.82

19.45

2.9

2.2

4.86

7.58

ug/l

2.31

251

1527

Sulfonylureas

1904

12209

1.27

19.42

2.8

2.4

5.63

7.33

ug/l

5.03

1603

10314

Superficial injury of wrist and hand

721

5057

1.46

19.35

2.4

2.3

5.83

7.34

ug/l

1.70

613

4442

Duodenal ulcer

577

3906

1.54

19.28

2.7

2.3

6.29

7.45

ug/l

1.32

492

3359

Other necrotizing vasculopathies

373

2294

1.72

19.28

2.9

2.4

5.48

6.96

ug/l

1.30

315

2001

Abnormal results of function studies

385

2375

1.69

19.27

2.7

2.3

8.61

7.20

ug/l

0.42

334

2111

Monoamine oxidase A inhibitors

502

3292

1.58

19.22

2.5

2.2

5.57

8.24

ug/l

3.78

423

2952

Eating disorder

209

1065

2.01

19.19

2.1

2.2

5.20

5.46

ug/l

0.07

177

928

Inflammatory bowel disease

1239

9484

1.33

19.18

2.5

2.3

6.12

7.96

ug/l

3.02

1093

8318

Hallux valgus (acquired)

1406

7828

1.32

19.14

2.4

2.2

5.52

7.27

ug/l

3.91

1180

6769

Other hammer toe(s) (acquired)

807

5349

1.44

19.10

2.3

5.84

6.94

ug/l

0.93

631

4567

Preterm labour and delivery

736

5187

1.45

19.07

2.4

2.1

4.66

6.15

ug/l

1.64

660

4507

Injury of muscle and tendon at shoulder and upper arm level

1662

13245

1.28

19.05

2.4

2.3

6.59

8.21

ug/l

2.00

1505

11729

Disturbance of activity and attention

249

1320

1.89

19.05

1.8

2.0

3.54

6.82

ug/l

4.70

216

1150

Discitis, unspecified

109

439

2.80

19.02

3.0

2.2

8.57

7.57

ug/l

0.21

384

127

543

2.53

19.01

2.4

2.1

5.27

7.53

ug/l

0.68

121

496

Injuries to unspecified part of trunk, limb or body region

464

3003

1.61

19.00

2.9

2.4

9.25

7.09

ug/l

0.49

397

2633

Other congenital malformations of the digestive system

212

1095

2.02

18.93

2.7

2.4

6.77

7.19

ug/l

0.12

188

958

Oesophagitis

281

1608

1.85

18.88

3.1

2.3

6.45

7.81

ug/l

0.52

250

1418

Calcific tendinitis of shoulder

249

1368

1.91

18.87

2.4

2.2

5.38

8.18

ug/l

1.98

231

1220

Cytomegaloviral disease

130

568

2.51

18.76

2.5

2.4

15.97

7.48

ug/l

1.29

118

508

Rheumatoid arthritis, including avohilmo

1700

13599

1.27

18.71

2.4

2.3

6.20

6.93

ug/l

0.63

1458

11685

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2510

14122

1.23

18.68

2.4

6.65

7.67

ug/l

1.46

2136

12249

Traumatic subarachnoid haemorrhage

187

941

2.12

18.65

2.3

2.2

8.23

7.65

ug/l

0.13

158

841

Obsessive-compulsive disorder

187

929

2.08

18.65

1.9

2.0

4.76

7.15

ug/l

2.01

159

821

Otitis externa, unspecified

441

2828

1.61

18.62

2.4

2.3

6.37

7.38

ug/l

0.44

383

2521

Benign neoplasm: Skin of eyelid, including canthus

731

5210

1.45

18.50

2.5

2.4

7.01

7.17

ug/l

0.04

622

4489

Glucosamine medication

2441

16178

1.23

18.45

2.4

5.77

6.66

ug/l

1.83

2008

13859

Mixed connective tissue disease

273

1557

1.84

18.36

2.4

2.3

10.39

6.64

ug/l

0.59

227

1364

Inflammatory disease of uterus

402

2520

1.63

18.35

2.2

3.78

5.31

ug/l

1.89

341

2181

Olecranon bursitis

320

1916

1.77

18.29

2.5

2.2

8.68

9.90

ug/l

0.18

275

1715

Arthropod-borne viral fevers and viral haemorrhagic fevers

774

5570

1.43

18.26

2.4

2.3

6.92

7.57

ug/l

0.36

710

4899

Pneumonia due to other infectious organisms, not elsewhere classified

174

863

2.17

18.18

2.4

2.2

7.06

7.72

ug/l

0.20

154

762

Malignant neoplasm, wide definition for exclusion

3868

19493

1.18

18.15

2.2

2.3

6.75

7.90

ug/l

2.34

3326

17099

Otitis externa

894

6587

1.39

18.14

2.3

5.96

7.22

ug/l

1.27

739

5798

Degenerative macular diseases

634

4431

1.49

18.13

2.6

2.4

5.61

6.71

ug/l

1.44

534

3745

Other specified/unspecified systemic involvement of connective tissue

253

1419

1.88

18.03

2.5

2.3

10.82

6.56

ug/l

0.65

215

1242

Pregnancy hypertension

1123

7629

1.34

18.01

2.1

2.0

5.06

5.90

ug/l

0.92

997

6623

Attention to artificial openings

218

1174

1.99

18.00

2.9

2.4

5.11

6.87

ug/l

1.16

184

1036

Hyperparathyroidism

911

6683

1.39

17.98

2.7

2.4

5.72

6.19

ug/l

0.29

746

5578

conjunctival haemorrhage

385

2428

1.67

17.97

3.0

2.4

8.87

7.26

ug/l

0.48

329

2123

Pain associated with micturition

513

3434

1.55

17.95

2.7

2.2

4.02

6.75

ug/l

7.70

404

2996

Speech disturbances, not elsewhere classified

456

2989

1.60

17.91

2.9

2.4

7.25

7.00

ug/l

0.07

365

2572

Lesion of lateral popliteal nerve

246

1375

1.90

17.91

2.7

2.4

7.73

7.83

ug/l

0.02

224

1237

Other disorders of kidney and ureter

634

4438

1.48

17.86

2.4

6.50

7.60

ug/l

0.98

558

3888

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1210

9263

1.32

17.86

2.6

2.1

7.38

7.68

ug/l

0.14

1032

8153

Special screening examination for neoplasms

234

1282

1.91

17.81

2.2

2.1

5.95

8.87

ug/l

2.44

194

1140

Recurrent aphthous stomatitis , including avohilmo

578

3964

1.50

17.80

2.6

2.3

4.83

6.89

ug/l

3.78

496

3453

Ocular pain

333

2019

1.72

17.79

2.8

2.3

3.37

6.80

ug/l

11.06

275

1786

Alcohol-induced chronic pancreatitis

327

1986

1.74

17.78

3.2

2.3

4.79

9.57

ug/l

8.40

296

1812

Diseases of tongue

283

1646

1.80

17.78

2.8

2.3

4.66

6.72

ug/l

1.94

235

1417

Other specified/unspecified dorsopathies

164

800

2.18

17.75

2.5

2.2

4.33

7.79

ug/l

4.48

142

696

Unspecified visual impairment (binocular)

357

2.91

17.75

2.3

5.34

6.63

ug/l

0.36

311

Specific development disorders of scholastic skills

114

466

2.50

17.69

1.9

8.26

7.37

ug/l

0.15

408

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

408

2618

1.64

17.67

3.0

2.4

6.54

6.42

ug/l

0.04

350

2218

Glaucoma

2805

20380

1.20

17.66

2.5

2.4

6.10

7.01

ug/l

1.39

2382

17483

Disorders of continuity of bone

386

2432

1.65

17.64

2.3

8.86

7.22

ug/l

0.26

327

2159

Alzheimer disease, including avohilmo

2037

11752

1.25

17.59

2.5

5.33

6.35

ug/l

2.33

1538

9917

Injury of unspecified body region

356

2209

1.69

17.56

3.0

2.4

9.82

6.96

ug/l

0.52

302

1936

Alcohol withdrawal state with delirium

355

2209

1.70

17.54

3.0

2.4

6.61

9.30

ug/l

1.82

307

2005

Postprocedural disorders of nervous system

229

1251

1.89

17.40

2.3

2.0

3.76

6.68

ug/l

3.39

197

1119

Other and unspecified epidermal thickening

138

637

2.35

17.40

3.0

2.4

5.01

7.44

ug/l

1.61

126

564

Atrophic disorders of skin

578

3982

1.50

17.38

2.1

2.2

5.26

6.34

ug/l

0.83

504

3423

Car occupant injured in other and unspecified transport accidents

678

4800

1.45

17.38

2.6

2.2

6.18

7.30

ug/l

0.65

591

4221

Benign neoplasm: Colon, unspecified

1255

9795

1.32

17.35

2.5

2.4

6.35

7.21

ug/l

1.10

1058

8505

Childhood asthma (age<16), excluding more controls

243

1045

1.86

17.33

1.8

1.5

8.41

5.29

ug/l

1.19

207

912

Acquired absence of limb

224

3.50

17.32

2.9

2.4

5.51

6.44

ug/l

0.28

188

Speech and linguistic disorders

254

1372

1.83

17.27

2.3

2.5

6.93

6.78

ug/l

0.04

219

1187

Pruritus

456

3000

1.57

17.26

2.8

2.3

5.12

6.53

ug/l

0.81

384

2591

Mixed and other personality disorders

274

1585

1.79

17.25

2.4

2.1

4.28

7.96

ug/l

4.54

229

1431

Other obstructive and reflux uropathy

188

971

2.04

17.24

2.7

2.3

4.86

6.89

ug/l

2.11

158

835

Excessive attrition of teeth

2094

17246

1.23

17.24

2.2

6.11

7.79

ug/l

3.65

1841

15244

Other eating disorders

122

528

2.38

17.17

2.3

1.9

6.80

5.88

ug/l

0.16

100

463

Insomnia

3519

22021

1.18

17.14

2.4

2.2

5.76

7.41

ug/l

5.45

3021

19231

Other follicular disorders

279

1631

1.78

17.05

2.3

6.98

7.18

ug/l

0.06

240

1466

Other metabolic disorders

466

3080

1.55

17.05

2.3

2.0

8.05

6.57

ug/l

0.61

401

2682

Myositis

145

690

2.29

17.04

2.9

2.3

16.63

7.43

ug/l

3.47

134

613

Haemorrhage in early pregnancy

740

5180

1.41

17.01

2.1

5.23

6.09

ug/l

0.50

655

4481

Paralytic ileus

205

1103

1.99

16.97

3.0

2.4

5.07

7.51

ug/l

2.68

178

974

Methotrexate

581

4029

1.48

16.87

2.3

2.2

5.27

6.98

ug/l

2.41

509

3498

Degenerative diseases of the nervous system

1964

11835

1.25

16.86

2.5

5.65

6.36

ug/l

1.13

1457

10009

Restless leg syndrome

574

3981

1.49

16.84

2.6

2.3

5.13

6.91

ug/l

2.71

484

3472

Endometriosis

1114

4957

1.34

16.81

2.1

2.2

5.43

6.14

ug/l

0.50

930

4248

Outcome of delivery

1344

0.40

16.71

1.3

1.8

6.99

5.98

ug/l

0.26

1165

Hypertrophic disorders of skin

208

1121

1.94

16.66

2.5

2.2

11.69

7.13

ug/l

0.58

185

1001

Need for immunization against other single viral diseases

114

498

2.53

16.60

2.6

2.4

10.28

7.72

ug/l

0.29

452

Exclusions for E4_PCOS_CONSORTIUM

2631

13825

1.20

16.60

2.4

2.2

5.76

6.53

ug/l

1.31

2181

11935

Bruxism

297

2.94

16.56

2.5

2.2

3.18

6.35

ug/l

2.46

270

Exclusion endpoint for clefts

279

2.99

16.55

2.2

2.4

14.03

8.23

ug/l

1.28

248

Herpesviral [herpes simplex] infections

852

6313

1.38

16.54

2.3

2.2

5.44

6.84

ug/l

0.98

722

5520

Ganglion

741

5370

1.41

16.53

2.1

5.38

7.90

ug/l

4.30

646

4704

Small fibre neuropathy

165

837

2.15

16.49

2.8

2.4

10.34

7.35

ug/l

0.36

134

748

Thyrotoxicosis, other and/or unspecified

766

5593

1.40

16.47

2.5

2.2

9.88

6.68

ug/l

1.83

644

4818

Retinal detachments and breaks

1692

13741

1.26

16.45

2.5

2.4

7.07

7.50

ug/l

0.37

1459

11928

Malignant neoplasm of skin

2522

14523

1.21

16.38

2.4

6.27

7.73

ug/l

3.71

2133

12621

Budesonide

527

3605

1.50

16.37

2.4

2.1

5.98

7.22

ug/l

0.85

447

3160

Tinnitus

996

7583

1.34

16.36

2.4

2.3

5.50

7.67

ug/l

5.05

845

6666

Corneal ulcer

730

5298

1.41

16.34

2.6

2.3

5.76

7.88

ug/l

2.26

646

4660

Other and unspecified nonorganic psychotic disorders

622

4381

1.45

16.34

2.5

2.2

5.92

7.80

ug/l

1.23

516

3881

Acute appendicitis, no complications

2112

17424

1.22

16.28

2.3

2.2

6.44

7.93

ug/l

1.93

1908

15396

Invasive ventilation

346

2183

1.66

16.08

2.2

2.4

11.94

7.54

ug/l

1.18

305

1920

Infarction of spleen

169

3.99

16.06

2.5

2.6

9.35

9.52

ug/l

0.02

154

Otalgia

304

1850

1.71

16.05

2.4

2.3

4.40

6.82

ug/l

2.87

260

1635

Complications of other internal prosthetic devices, implants and grafts

208

1145

1.94

16.03

2.8

2.3

5.08

6.81

ug/l

1.19

177

978

Other and unspecified urticaria

692

4989

1.42

16.02

2.7

2.2

5.18

7.22

ug/l

2.22

576

4365

Cramp and spasm

210

1157

1.92

15.98

2.9

2.4

4.99

6.87

ug/l

0.93

173

1042

Other arterial embolism and thrombosis

162

824

2.13

15.97

3.9

2.4

7.95

6.58

ug/l

0.34

141

703

Other disorders of patella

585

4095

1.46

15.96

2.4

2.2

7.08

8.48

ug/l

0.60

495

3659

Other sleep disorders

447

2978

1.55

15.93

2.7

2.2

5.83

8.32

ug/l

2.82

371

2639

Viral haemorrhagic fevers, not elsewhere classified/unspecified

672

4840

1.43

15.86

2.4

2.3

6.77

7.43

ug/l

0.36

614

4259

Basal cell carcinoma, including avohilmo

2347

13547

1.21

15.84

2.4

6.36

7.55

ug/l

2.25

1983

11721

Collagenous colitis

391

2542

1.60

15.81

2.6

2.3

5.33

6.75

ug/l

1.43

335

2232

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1327

10527

1.28

15.69

2.5

2.3

8.32

6.88

ug/l

1.01

1127

9095

Malignant neoplasm

3748

19233

1.16

15.68

2.2

2.3

6.37

7.86

ug/l

4.07

3217

16864

Acute appendicitis

2804

22333

1.19

15.68

2.3

2.2

6.58

7.77

ug/l

1.92

2518

19600

Mixed disorders of conduct and emotions, excluding more controls

135

3.76

15.67

1.9

1.5

3.86

7.81

ug/l

1.39

111

Alzheimer disease

1780

10667

1.25

15.61

2.5

5.51

6.13

ug/l

0.90

1308

8946

Other disorders starting during childhood or adolecense, excluding more controls

100

395

2.49

15.52

2.5

1.8

4.04

7.51

ug/l

1.94

337

Pre-eclampsia or eclampsia

588

4137

1.45

15.50

2.2

2.1

4.85

5.89

ug/l

0.91

517

3580

Viral warts

753

5535

1.39

15.48

2.3

6.32

7.25

ug/l

0.59

673

4865

Scoliosis

285

1717

1.71

15.47

2.1

12.41

7.15

ug/l

0.81

236

1475

Hyperhidrosis

109

474

2.41

15.47

2.4

1.9

4.32

7.01

ug/l

1.32

416

Appendicitis, broad definition

3006

23319

1.18

15.45

2.3

2.2

6.71

7.71

ug/l

1.45

2697

20437

Diseases of appendix

3035

23491

1.18

15.35

2.3

2.2

6.75

7.69

ug/l

1.31

2720

20582

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2345

13514

1.21

15.28

2.4

6.07

7.56

ug/l

3.87

1970

11694

Purpura and other haemorrhagic conditions

586

4157

1.45

15.24

2.7

2.3

7.87

7.44

ug/l

0.22

519

3627

Pre-eclampsia

534

3704

1.47

15.21

2.1

4.52

5.92

ug/l

1.68

469

3199

Burns and corrosions

532

3704

1.48

15.17

2.4

2.3

5.46

8.14

ug/l

4.32

472

3315

Excessive earwax

2522

20893

1.19

15.15

2.4

5.47

7.43

ug/l

10.74

2098

18203

Childhood asthma (age<16)

243

1091

1.78

15.15

1.8

1.6

8.41

6.09

ug/l

0.77

207

958

Crohn disease

471

3202

1.51

15.14

2.4

2.2

6.49

7.87

ug/l

0.77

416

2869

Exclusions for E4_PCOS_BROAD

644

4636

1.42

15.10

3.2

2.3

5.87

7.56

ug/l

1.52

549

4070

Other specified disorders of muscle

147

737

2.14

14.96

2.8

2.3

11.70

8.12

ug/l

0.52

127

644

Other specified/unspecified soft tissue disorders

233

1353

1.81

14.88

2.9

2.3

4.64

6.66

ug/l

1.82

202

1142

Noninflammatory disorders of female genital tract

1327

5239

1.29

14.85

2.2

4.89

6.14

ug/l

2.06

1105

4460

Fracture of neck

307

1925

1.68

14.81

2.4

8.26

6.82

ug/l

0.46

263

1675

Spinal instabilities

129

617

2.23

14.80

2.3

2.1

3.58

7.83

ug/l

6.77

114

548

Labour and delivery complicated by umbilical cord complications

148

739

2.08

14.79

2.0

1.8

3.95

5.48

ug/l

1.16

135

649

Unspecified urinary incontinence

399

2647

1.57

14.79

2.2

2.3

3.68

6.07

ug/l

5.76

249

2267

Fall involving bed

191

1058

1.95

14.74

2.9

2.7

5.14

6.20

ug/l

0.57

152

887

Ventricular septal defect, a heart condition

308

2.75

14.71

2.3

2.4

17.99

6.53

ug/l

2.78

270

Behavioural disorders, excluding more controls

213

3.09

14.63

2.6

1.8

6.59

9.69

ug/l

0.86

193

Basal cell carcinoma

2256

13141

1.21

14.53

2.4

6.15

7.53

ug/l

3.16

1891

11352

Thyroiditis, ILD-related definition

410

2734

1.54

14.53

2.5

2.2

5.70

6.18

ug/l

0.18

364

2385

Dentofacial anomalies [including malocclusion]

2430

16507

1.19

14.53

2.3

2.2

5.53

7.53

ug/l

4.03

2116

14532

Extreme obesity with alveolar hypoventilation

198

1108

1.90

14.51

3.0

2.4

4.61

7.51

ug/l

2.67

159

992

Giant cell arteritis

236

1398

1.81

14.45

3.2

2.6

5.62

6.58

ug/l

0.47

199

1213

Hypocalcemia

121

574

2.30

14.44

2.8

2.3

5.61

6.92

ug/l

0.50

108

511

Other/unspecified rheumatoid arthritis

581

4164

1.44

14.40

2.6

2.4

5.96

6.52

ug/l

0.35

480

3526

Hypertrophic scar

186

1015

1.91

14.40

2.5

2.2

11.87

7.40

ug/l

0.49

166

902

Other diseases of biliary tract

417

2815

1.54

14.29

2.3

4.54

7.31

ug/l

4.86

354

2425

Temporal arteritis

211

1217

1.87

14.25

3.2

2.5

5.04

6.43

ug/l

1.07

175

1054

Diseases of male genital organs

2472

10539

1.20

14.23

2.4

2.3

8.87

9.25

ug/l

0.23

2189

9488

Thyrotoxicosis

985

7630

1.32

14.21

2.5

2.3

9.46

6.63

ug/l

1.96

839

6549

Maltreatment syndromes

162

847

1.98

14.20

2.5

2.1

6.38

7.83

ug/l

0.38

144

764

Sequelae of injuries, of poisoning and of other consequences of external causes

923

7092

1.33

14.16

2.1

2.3

8.73

7.86

ug/l

0.38

792

6287

Gout due to impairment of renal function

318

2.88

14.15

3.7

2.9

7.50

7.60

ug/l

0.01

281

Acute and transient psychotic disorders

428

2897

1.52

14.14

2.5

2.3

6.87

8.07

ug/l

0.37

356

2585

Explicit fungal Sepsis

151

3.80

14.03

3.3

2.3

7.69

7.63

ug/l

0.01

134

Acquired haemolytic anaemia

131

648

2.19

14.03

2.4

2.6

12.59

7.21

ug/l

0.70

119

572

Nail disorders

332

2137

1.61

14.01

2.6

2.3

6.32

7.00

ug/l

0.28

291

1894

Phlebitis and thrombophlebitis (not including DVT)

975

7568

1.32

13.97

2.5

2.3

7.63

7.37

ug/l

0.09

827

6574

Postprocedural endocrine and metabolic disorders, not elsewhere classified

417

2813

1.52

13.94

2.3

2.1

7.20

6.28

ug/l

0.31

359

2450

Vasomotor and allergic rhinitis

1247

9758

1.27

13.91

2.2

6.17

7.67

ug/l

2.03

1084

8592

Anorexia (incl.atypical)

179

972

1.90

13.91

2.5

2.1

7.53

6.87

ug/l

0.06

159

846

Superficial injury of shoulder and upper arm

466

3223

1.49

13.90

2.5

2.3

5.17

7.77

ug/l

2.91

393

2817

Neuralgia and neuritis, unspecified

215

1243

1.81

13.89

2.4

2.2

5.19

8.06

ug/l

1.56

182

1099

SLE (Finngen)

147

755

2.06

13.87

2.4

2.2

6.38

5.86

ug/l

0.17

124

661

Haemolytic anaemias

168

906

1.98

13.86

2.3

2.5

11.06

6.95

ug/l

0.66

149

795

Other respiratory diseases principally affecting the interstitium

908

7009

1.33

13.85

2.8

2.4

10.12

6.95

ug/l

3.49

793

5990

Diseases of spleen

103

467

2.43

13.83

2.8

2.4

9.23

6.69

ug/l

0.56

420

Other disorders of conjunctiva

651

4786

1.40

13.83

3.0

2.3

8.70

7.27

ug/l

0.57

560

4167

Superficial injuries involving multiple body regions

124

601

2.20

13.80

2.7

2.3

6.41

7.37

ug/l

0.20

109

534

Injuries involving multiple body regions

167

899

1.96

13.72

2.7

2.4

6.15

6.94

ug/l

0.22

148

794

Other enthesopathy of foot (+metatarsalgia)

369

2438

1.56

13.71

2.4

2.2

4.90

7.84

ug/l

3.86

326

2130

Hydronephrosis

510

3601

1.46

13.70

2.5

2.3

5.64

6.95

ug/l

1.42

442

3132

Vitamin D deficiency

384

2.54

13.69

2.7

2.4

6.11

7.08

ug/l

0.25

340

Other (seronegative) rheumatoid arthritis, wide

831

6338

1.34

13.67

2.5

2.4

5.91

6.88

ug/l

0.94

691

5438

Giant cell arteritis with polymyalgia rheumatica

211

1233

1.84

13.64

3.2

2.5

5.04

6.59

ug/l

1.24

175

1068

Herpesviral [herpes simplex] infections

448

3085

1.50

13.64

2.3

6.60

6.69

ug/l

0.02

379

2710

Secondary parkinsonism+Parkinsonism in other disease

155

823

2.03

13.60

3.1

2.5

4.88

6.96

ug/l

1.16

124

715

Pre-eclampsia or poor fetal growth

732

5437

1.36

13.55

2.1

2.0

4.77

5.78

ug/l

1.02

651

4724

Secondary parkinsonism

153

811

2.04

13.52

3.2

2.5

4.83

6.84

ug/l

1.09

123

703

Achilles tendinitis

395

2658

1.53

13.51

2.3

2.1

6.22

9.39

ug/l

2.62

349

2376

Endometriosis of rectovaginal septum and vagina

281

1752

1.66

13.50

2.4

2.3

6.88

6.29

ug/l

0.11

239

1507

D07AA Corticosteroids, weak (group I)

509

3585

1.45

13.42

2.4

2.3

5.78

6.72

ug/l

0.91

449

3116

Communicating hydrocephalus

121

592

2.23

13.41

2.8

2.4

5.19

6.41

ug/l

0.28

107

515

Agoraphobia

389

2.43

13.39

2.4

1.9

6.17

7.47

ug/l

0.17

349

Use of anticholinesterases

1871

12343

1.22

13.37

2.4

2.5

5.76

6.29

ug/l

0.64

1389

10402

N06DA Anticholinesterases

1871

12343

1.22

13.37

2.4

2.5

5.76

6.29

ug/l

0.64

1389

10402

Effects of foreign body entering through natural orifice

962

7495

1.31

13.32

2.8

2.3

6.46

8.39

ug/l

2.06

862

6669

Pulmonary oedema

113

541

2.29

13.30

3.9

2.6

6.57

5.78

ug/l

0.31

103

458

Faecal incontinence

371

2477

1.55

13.27

2.1

2.2

5.98

6.82

ug/l

0.28

293

2107

Metatarsalgia

349

2298

1.56

13.22

2.5

2.2

4.97

7.71

ug/l

3.23

307

2006

Cluster headache, strict

133

669

2.08

13.20

2.4

2.2

5.17

8.35

ug/l

0.98

113

610

Other/unspecified enthesopathies of lower limb, excluding foot

249

1515

1.70

13.17

2.3

2.1

7.78

7.83

ug/l

0.01

206

1341

Intestinal malabsorption

201

1161

1.82

13.13

2.6

2.3

5.72

7.18

ug/l

0.89

173

1036

Arthropathies in other diseases classified elsewhere

165

899

1.94

13.13

2.4

6.29

7.75

ug/l

0.77

140

794

Diabetic maculopathy

606

4190

1.41

13.12

3.0

2.5

7.27

7.63

ug/l

0.19

540

3650

Ulcerative colitis, NAS

517

3681

1.44

13.07

2.8

2.2

5.48

7.76

ug/l

2.50

463

3277

Injury of other and unspecified intrathoracic organs

302

1941

1.63

13.07

2.4

9.14

7.78

ug/l

0.44

264

1728

Cluster headache, wide

143

741

2.02

13.04

2.4

2.2

5.08

8.63

ug/l

1.25

121

673

Spondyloarthritis

724

5444

1.36

13.00

2.7

2.3

6.59

7.51

ug/l

0.33

622

4721

Toxic effect of ethanol

160

866

1.94

12.87

3.0

2.2

5.82

8.45

ug/l

1.82

141

775

Assault by bodily force

251

1538

1.68

12.86

2.4

2.2

6.11

8.32

ug/l

0.95

209

1398

Infective dermatitis

484

3425

1.46

12.85

2.6

2.3

6.12

7.85

ug/l

1.21

432

3013

Abnormal blood-pressure reading, without diagnosis

152

807

1.96

12.84

2.7

1.8

4.06

7.43

ug/l

4.15

130

693

Urolithiasis

1497

12329

1.24

12.83

2.4

6.55

7.82

ug/l

1.83

1256

10819

236

2.84

12.81

2.3

2.0

9.07

6.00

ug/l

0.23

211

Dependence on enabling machines and devices, not elsewhere classified

211

3.06

12.75

3.5

2.3

13.34

6.30

ug/l

1.28

180

Blood alcohol or alcohol intoxication level

105

492

2.27

12.73

3.5

2.2

4.85

9.05

ug/l

3.98

449

Background retinopathy and retinal vascular changes

116

570

2.21

12.71

2.4

2.5

5.59

7.13

ug/l

0.78

103

497

Benign neoplasm: Duodenum

149

802

2.02

12.71

3.2

2.6

5.26

7.10

ug/l

1.12

135

705

Glaucoma secondary to other eye disorders

208

1233

1.79

12.56

2.6

7.03

6.91

ug/l

0.02

182

1077

Alcohol-induced acute pancreatitis

184

1056

1.86

12.53

2.6

2.4

5.03

8.56

ug/l

3.31

164

967

Dermatographic urticaria

229

1383

1.71

12.51

2.3

2.2

2.96

6.80

ug/l

11.55

197

1237

Neovascular glaucoma

207

1227

1.79

12.51

2.6

7.03

6.79

ug/l

0.03

182

1054

Early lumbar disc prolapse operation

305

1969

1.58

12.49

1.9

2.1

5.70

8.82

ug/l

1.67

281

1779

Poisoning by narcotics and psychodysleptics [hallucinogens]

241

2.83

12.48

2.6

2.2

6.91

8.25

ug/l

0.34

221

Other and unspecified vascular occlusions

478

3408

1.46

12.44

2.7

2.4

7.45

7.00

ug/l

0.13

409

2884

Other and unspecified mood [affective] disorders

199

1155

1.77

12.42

2.7

2.1

5.88

7.76

ug/l

0.74

161

1019

Female genital prolapse

1058

4703

1.29

12.41

2.3

2.2

4.78

6.36

ug/l

3.09

900

4004

Complications following infusion, transfusion and therapeutic injection

360

2.53

12.35

2.6

2.3

4.89

6.74

ug/l

0.80

314

Bronchitis, not specified as acute or chronic

373

2533

1.52

12.33

2.6

2.3

7.82

8.16

ug/l

0.07

307

2206

Arthropod-borne viral fevers and viral haemorrhagic fevers

413

2865

1.49

12.33

2.6

2.3

5.68

8.25

ug/l

1.74

384

2569

Lesion of radial nerve

178

1016

1.85

12.24

3.0

2.3

9.55

7.34

ug/l

0.50

148

898

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

179

1012

1.81

12.21

2.2

1.8

3.49

5.64

ug/l

2.13

152

890

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

274

1740

1.62

12.19

2.3

2.1

5.07

5.92

ug/l

0.40

248

1501

Other disorders of nervous system

293

1901

1.61

12.16

2.3

7.98

7.51

ug/l

0.11

246

1685

Other strabismus

737

5584

1.34

12.16

2.3

6.89

7.38

ug/l

0.21

620

4877

Cystic kidney disease

147

793

1.97

12.16

2.3

4.60

7.46

ug/l

3.14

134

703

Bell's palsy

479

3417

1.44

12.14

2.3

7.63

7.87

ug/l

0.06

410

2993

Hemiplegia

224

1362

1.72

12.13

2.3

2.4

6.60

6.91

ug/l

0.09

187

1189

Injury of intra-abdominal organs

113

556

2.16

12.13

2.6

2.3

16.95

8.31

ug/l

0.91

101

499

Trigeminal neuralgia

248

1547

1.67

12.11

2.5

2.3

5.91

6.67

ug/l

0.28

204

1363

Problems related to social environment

133

694

2.03

12.09

3.3

2.5

4.99

6.70

ug/l

0.69

114

599

Open wound of forearm

396

2732

1.50

12.08

2.5

2.3

5.74

7.24

ug/l

1.36

326

2398

Paralytic strabismus

330

2204

1.56

12.05

2.6

2.4

7.43

7.20

ug/l

0.04

283

1939

Viral warts

358

2422

1.52

11.97

2.4

2.3

6.58

7.41

ug/l

0.25

326

2157

Ulcerative colitis

918

7207

1.30

11.96

2.6

2.2

6.13

7.87

ug/l

2.11

813

6340

Atypical facial pain

210

1260

1.74

11.95

2.3

4.13

6.92

ug/l

4.36

176

1110

Acute laryngitis and tracheitis

310

1992

1.56

11.94

2.3

1.9

4.15

6.99

ug/l

4.22

266

1748

Any event in cancer register

3911

20416

1.14

11.91

2.2

2.3

6.67

7.85

ug/l

2.19

3359

17905

Mental and behavioural disorders due to use of other stimulants, including caffeine

386

2.35

11.86

2.2

2.0

6.61

9.65

ug/l

0.79

352

Early complications of trauma

197

1169

1.77

11.78

3.0

2.4

10.49

7.49

ug/l

0.83

169

1038

!Aliquae complicationes praecoces traumatis

197

1169

1.77

11.78

3.0

2.4

10.49

7.49

ug/l

0.83

169

1038

Fibroblastic disorders

1013

8078

1.28

11.72

2.5

2.2

6.23

8.11

ug/l

2.66

858

6999

Postmenopausal osteoporosis with pathological fracture

326

2192

1.56

11.72

2.9

2.4

4.70

5.43

ug/l

0.41

243

1798

Other disorders of optic [2nd] nerve and visual pathways

262

1670

1.63

11.71

2.4

5.06

7.04

ug/l

2.12

229

1482

Ingrowing nail

213

1290

1.72

11.67

2.7

2.3

6.54

7.70

ug/l

0.35

184

1146

Anankastic personality disorder

132

692

1.99

11.66

2.1

6.52

7.62

ug/l

0.26

117

625

Synovial cyst of popliteal space [Baker]

323

2159

1.55

11.65

2.5

2.2

6.28

8.00

ug/l

0.89

277

1863

Other and unspecified follicular disorders

169

963

1.84

11.63

2.4

2.3

7.38

7.62

ug/l

0.05

145

866

Other congenital malformations

265

1687

1.61

11.62

2.1

2.2

10.05

6.82

ug/l

1.67

247

1495

Sarcoidosis

552

4066

1.40

11.60

2.6

2.3

11.18

7.73

ug/l

1.22

502

3602

Female infertility, associated with anovulation

134

702

1.94

11.55

1.4

2.2

3.08

6.45

ug/l

2.69

114

609

Male infertility

166

940

1.83

11.49

2.2

2.1

7.87

9.63

ug/l

0.40

149

850

Periapical abscess

1781

15042

1.20

11.48

2.3

7.01

7.88

ug/l

0.93

1568

13309

Postmenopausal atrophic vaginitis

982

4268

1.29

11.45

2.1

2.2

4.01

6.45

ug/l

7.59

855

3685

Dermatopolymyositis (FG)

309

2.58

11.45

2.8

2.4

18.27

6.84

ug/l

2.46

271

Pyogenic arthritis

298

1967

1.57

11.41

2.8

2.3

4.83

8.38

ug/l

3.73

255

1731

Hepatic failure, not elsewhere classified

187

1108

1.79

11.40

2.5

9.67

7.20

ug/l

0.83

158

976

Systemic lupus erythematosus

147

809

1.91

11.36

2.4

2.2

6.38

ug/l

0.00

124

713

Calculus of kidney and ureter

1363

11267

1.23

11.33

2.4

6.54

7.83

ug/l

1.73

1157

9900

Fracture of forearm

2244

17686

1.17

11.33

2.4

2.3

6.97

6.70

ug/l

0.21

1872

15251

Lung cancer and mesothelioma

853

5720

1.30

11.32

2.3

2.2

5.93

8.11

ug/l

2.55

745

5012

Blindness, monocular

241

2.87

11.28

2.4

2.5

4.63

6.98

ug/l

0.62

212

Impacted cerumen

469

3389

1.43

11.26

2.1

2.4

5.82

6.93

ug/l

0.92

253

2960

Acne

229

1412

1.65

11.26

2.2

7.41

6.80

ug/l

0.17

204

1226

Papulosquamous disorders

1621

13617

1.21

11.21

2.3

5.99

7.64

ug/l

3.97

1396

11950

Systemic lupus erythematosus, unspecified

123

642

2.03

11.20

2.2

6.94

6.36

ug/l

0.16

106

572

Allergic urticaria

282

1841

1.58

11.18

2.1

2.2

6.86

6.80

ug/l

0.02

237

1627

Nummular dermatitis

365

2524

1.50

11.18

2.4

2.3

5.71

7.57

ug/l

1.50

325

2231

Carcinoma in situ of other and unspecified genital organs

408

2.33

11.15

2.7

2.3

2.76

5.53

ug/l

3.66

353

Other orthopaedic follow-up care

234

1470

1.66

11.14

2.2

2.3

4.56

6.68

ug/l

3.26

200

1301

Other specified and unspecified retinal disorders

174

1018

1.81

11.11

2.7

2.4

5.33

6.85

ug/l

0.73

154

886

Solid cancers, helper endpoint

3646

19098

1.14

11.05

2.2

2.3

6.46

7.85

ug/l

3.26

3130

16746

Amyloidosis

115

594

2.09

11.00

2.5

2.3

5.14

7.18

ug/l

1.40

518

Cystic kidney disease

155

878

1.87

10.99

2.2

2.4

4.46

7.34

ug/l

3.50

142

781

Disorders of magnesium metabolism

175

3.20

10.98

2.1

2.6

6.92

9.11

ug/l

0.50

158

Sacroiliitis, not elsewhere classified

137

740

1.91

10.97

2.4

2.0

4.26

7.81

ug/l

2.13

120

653

Acute pharyngitis

426

2994

1.43

10.94

2.3

2.0

8.07

8.29

ug/l

0.05

361

2690

Other coagulation defects

285

1878

1.57

10.94

2.2

2.3

9.14

6.68

ug/l

0.94

247

1643

SLE, ICD10

140

769

1.92

10.91

2.2

6.51

6.22

ug/l

0.08

118

678

SLE, strict definition

140

769

1.92

10.91

2.2

6.51

6.22

ug/l

0.08

118

678

Glomerulonephritis

416

2959

1.45

10.86

2.6

2.4

6.68

7.62

ug/l

0.34

374

2615

Mental and behavioural disorders due to tobacco

340

2328

1.51

10.86

2.5

2.3

6.49

8.14

ug/l

0.70

279

2107

Monoarthritis, not elsewhere classified

173

1012

1.79

10.83

2.8

2.4

5.16

7.51

ug/l

1.88

160

888

Polycystic kidney disease

125

667

2.00

10.79

2.4

2.3

5.12

7.66

ug/l

1.60

114

596

False labour

597

2759

1.36

10.77

1.7

2.0

2.91

6.00

ug/l

7.08

533

2416

Acne vulgaris

174

1012

1.75

10.76

2.3

2.2

7.78

7.28

ug/l

0.10

154

878

Alzheimer’s disease (Late onset)

1265

8779

1.24

10.72

2.5

2.6

5.82

5.96

ug/l

0.10

916

7272

Event of undetermined intent

232

1465

1.64

10.72

2.8

2.3

8.06

7.33

ug/l

0.16

201

1321

Burns and corrosions of external body surface, specified by site

401

2835

1.45

10.70

2.5

2.3

5.44

8.32

ug/l

3.62

354

2543

Flat foot [pes planus] (acquired)

353

2440

1.49

10.66

2.4

2.3

5.01

7.79

ug/l

1.89

298

2122

Weight loss

426

3055

1.44

10.65

2.3

2.4

6.49

7.09

ug/l

0.16

343

2661

Crohn's disease NAS

235

1493

1.63

10.59

2.2

5.06

7.39

ug/l

1.23

200

1341

Lichen simplex chronicus and prurigo

273

1801

1.58

10.57

2.5

2.3

6.70

7.29

ug/l

0.15

243

1593

Vitamin deficiency

206

1273

1.69

10.55

4.3

2.4

4.89

7.31

ug/l

2.37

171

1114

Vitamin deficiency, wide

206

1273

1.69

10.55

4.3

2.4

4.89

7.31

ug/l

2.37

171

1114

5-aminosalicylic acid

722

5588

1.31

10.53

2.5

2.1

6.25

7.15

ug/l

0.68

636

4911

Superficial injury of ankle and foot

376

2632

1.46

10.49

2.3

2.2

5.49

7.20

ug/l

1.39

339

2329

Smoking dependency

340

2345

1.50

10.48

2.5

2.3

6.49

8.13

ug/l

0.70

279

2118

Dislocation of lens

427

2.27

10.48

2.6

2.4

6.65

6.70

ug/l

0.01

360

Infection of intervertebral disc (pyogenic)

356

2.42

10.48

2.3

7.33

8.75

ug/l

0.28

315

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

669

5152

1.34

10.43

2.6

2.5

5.30

6.98

ug/l

3.75

550

4338

Other noninfective disorders of lymphatic vessels and lymph nodes

162

944

1.81

10.41

2.7

2.3

7.89

7.26

ug/l

0.15

144

836

Other specified/unspecified spondylopathies

126

683

1.97

10.41

3.1

2.3

6.50

7.01

ug/l

0.07

102

593

Suppurative and unspecified otitis media

1078

7741

1.25

10.39

2.2

7.59

7.37

ug/l

0.08

925

6776

Hypothermia

103

524

2.13

10.37

3.3

2.7

7.19

7.96

ug/l

0.21

471

Retinal haemorrhage

133

737

1.94

10.33

2.8

2.5

6.14

6.57

ug/l

0.14

119

632

Cardiomyopathies, Secondary/extrinsic

115

3.60

10.33

3.7

2.1

7.92

5.76

ug/l

0.27

105

Maternal care for other conditions predominantly related to pregnancy

411

2863

1.42

10.32

1.9

5.44

5.54

ug/l

0.03

371

2507

Spondylopathies (FG)

468

3414

1.40

10.31

2.6

2.2

6.52

8.08

ug/l

0.38

406

3047

Pneumocystosis

105

541

2.12

10.28

2.4

2.5

7.36

6.24

ug/l

0.29

483

Hypersomnia

299

2.50

10.28

2.6

2.3

4.03

8.04

ug/l

2.34

267

Schizophrenia

563

4230

1.36

10.27

2.5

2.3

6.00

8.31

ug/l

1.56

492

3788

Pure hyperglyceridaemia

108

558

2.07

10.27

2.8

2.3

4.42

7.95

ug/l

3.05

494

Social phobias

206

1271

1.65

10.24

2.1

1.9

5.95

7.70

ug/l

0.68

172

1120

Chondropathies

547

4098

1.36

10.21

2.7

2.3

8.42

7.85

ug/l

0.14

466

3647

278

1849

1.55

10.17

3.1

2.4

5.00

6.45

ug/l

1.21

223

1482

Late syphilis

405

2.28

10.17

3.3

2.5

4.57

7.91

ug/l

2.69

369

Benign neoplasm: Small intestine

201

1254

1.70

10.16

2.8

2.5

5.13

7.13

ug/l

1.82

181

1098

Follow-up examination after treatment for malignant neoplasms

369

2595

1.46

10.14

2.3

2.1

6.29

7.83

ug/l

1.23

306

2208

Disorders of purine and pyrimidine metabolism

145

3.39

10.12

2.8

2.5

3.05

7.25

ug/l

1.66

131

Other/unspecified synovitis and tenosynovitis

426

3074

1.42

10.11

2.5

2.2

5.97

8.21

ug/l

1.93

374

2675

Other noninflammatory disorders of uterus, except cervix

823

4365

1.29

10.07

2.5

2.3

5.61

6.40

ug/l

0.46

694

3714

Disorders of conjunctiva

3261

23260

1.13

10.06

2.4

2.2

7.24

7.08

ug/l

0.11

2773

20266

Complications peculiar to reattachment and amputation

179

3.08

10.02

2.8

2.5

4.50

8.33

ug/l

1.25

156

Disorder of external ear, unspecified

149

859

1.83

10.01

2.2

2.4

8.14

7.39

ug/l

0.15

134

776

Sacrococcygeal disorders, not elsewhere classified

108

559

2.02

10.00

2.2

2.1

3.87

7.19

ug/l

3.38

496

Disorders of breast

1606

12333

1.19

10.00

2.1

2.2

4.06

5.75

ug/l

8.31

1347

10506

Conduct disorder

268

2.49

10.00

2.7

1.9

6.52

9.14

ug/l

0.76

241

Colonic or urogenital fistula

1088

8904

1.24

9.99

2.4

2.3

6.86

7.48

ug/l

0.31

895

7799

Viral haemorrhagic fevers, not elsewhere classified/unspecified

326

2256

1.50

9.97

2.6

2.3

4.98

7.93

ug/l

2.67

302

2029

Cholangitis (primary sclerosing, PSC)

272

1817

1.56

9.95

2.5

2.3

4.82

7.48

ug/l

2.71

228

1574

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1090

8935

1.24

9.91

2.3

6.40

6.81

ug/l

0.20

937

7666

Lichen sclerosus et atrophicus

393

2814

1.44

9.87

2.1

2.3

3.93

6.35

ug/l

5.04

340

2405

Hypermobility syndrome

137

766

1.84

9.85

2.1

2.0

4.50

5.18

ug/l

0.16

119

690

Lichen planus

539

4064

1.36

9.84

2.2

2.3

5.90

6.89

ug/l

0.68

454

3534

Other and unspecified mononeuropathies, also in other diseases

141

805

1.86

9.83

2.5

2.4

4.75

7.51

ug/l

2.38

116

707

Spontaneous rupture of synovium and tendon

346

2427

1.47

9.81

2.4

2.2

6.22

8.70

ug/l

1.90

293

2115

Persistent delusional disorders

320

2213

1.50

9.81

2.7

2.4

5.86

7.58

ug/l

0.76

260

1935

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

464

2.10

9.80

2.2

2.3

12.75

8.21

ug/l

1.17

412

Primary coxarthrosis, bilateral

1374

11542

1.21

9.79

2.5

2.4

5.77

7.01

ug/l

2.83

1146

9870

Hyperosmolality and hypernatraemia

366

2.33

9.75

3.6

2.3

8.10

7.63

ug/l

0.08

315

Suppurative and necrotic conditions of lower respiratory tract

265

1774

1.56

9.72

2.7

2.4

7.84

7.29

ug/l

0.20

234

1569

Dependent personality disorder

451

2.15

9.72

3.0

2.3

4.42

7.81

ug/l

2.15

405

Amyloidosis, other/unspecified

488

2.13

9.70

2.6

2.3

5.58

7.27

ug/l

0.87

433

Other inflammatory liver diseases

272

1826

1.54

9.70

2.7

2.4

6.95

7.23

ug/l

0.11

237

1627

Emotional disorders starting during childhood or adolecense, excluding more controls

336

2.25

9.70

1.5

1.7

5.36

7.23

ug/l

0.48

283

Unspecified/other endometriosis

203

1266

1.63

9.68

1.9

2.3

2.18

6.41

ug/l

9.88

162

1096

Use of galantamine

432

3172

1.42

9.67

2.5

4.57

6.14

ug/l

2.20

336

2589

Other diseases of blood and blood-forming organs, wide

898

7232

1.27

9.66

2.4

8.68

7.25

ug/l

0.67

758

6312

Abnormal spermatozoa

352

4905

0.70

9.64

2.2

2.4

6.41

8.61

ug/l

0.78

306

4372

Personal history of other diseases and conditions

264

1743

1.53

9.62

2.1

1.9

11.31

4.93

ug/l

3.55

210

1507

Dislocation, sprain and strain of joints and ligaments of thorax

145

838

1.82

9.61

3.0

2.3

4.64

7.10

ug/l

1.63

133

746

Other disorders starting during childhood or adolescence

100

502

2.02

9.60

2.5

1.9

4.04

7.11

ug/l

2.09

433

Alzheimer’s disease, strict definition

1340

9254

1.22

9.59

2.5

5.58

6.06

ug/l

0.52

971

7684

Traumatic ischaemia of muscle

316

2.41

9.57

2.9

2.4

11.86

7.86

ug/l

0.56

286

Sequelae of injuries of neck and trunk

135

767

1.86

9.54

2.1

2.3

6.24

7.14

ug/l

0.37

119

694

Inflammatory diseases of prostate (prostatitis)

613

4732

1.33

9.53

2.8

2.3

7.23

9.13

ug/l

1.17

518

4257

Manic episode

114

612

1.95

9.52

2.4

2.2

10.84

8.06

ug/l

0.29

538

Effects of other external causes

103

534

2.01

9.52

2.2

2.3

4.05

8.83

ug/l

3.07

487

Other viral hepatitis

201

1263

1.64

9.49

2.4

2.2

10.62

8.06

ug/l

0.49

180

1142

Thiazolidinediones

540

4103

1.36

9.47

2.5

2.3

6.99

7.89

ug/l

0.44

467

3578

Acute bronchiolitis

145

747

1.79

9.47

3.0

1.9

6.08

5.88

ug/l

0.05

121

636

ILD, hospital admissions

725

5725

1.30

9.46

2.6

2.4

10.76

7.02

ug/l

3.54

630

4924

Other/unspecified seropositive rheumatoid arthritis

1108

9148

1.23

9.40

2.3

2.4

6.38

6.82

ug/l

0.22

952

7844

Chalazion

420

3065

1.40

9.38

3.1

2.2

5.58

7.93

ug/l

2.37

359

2716

Behavioural disorders

270

2.43

9.38

2.6

2.0

6.59

8.12

ug/l

0.37

242

Late syphilis

333

2.36

9.34

3.3

2.4

4.36

8.37

ug/l

3.03

301

Other interstitial pulmonary diseases

737

5841

1.30

9.34

2.6

2.4

11.04

6.96

ug/l

3.94

642

5025

Seropositive rheumatoid arthritis, wide

1121

9274

1.23

9.32

2.3

2.4

6.39

6.85

ug/l

0.23

963

7950

Ectropion of eyelid

224

1464

1.61

9.32

2.4

4.69

6.38

ug/l

1.97

191

1216

Anoxic brain damage

367

2.29

9.30

3.3

2.6

24.91

7.52

ug/l

2.11

323

Interstitial lung disease

737

5847

1.29

9.26

2.6

2.4

11.04

6.98

ug/l

3.90

642

5029

Interstitial lung disease endpoints

737

5847

1.29

9.26

2.6

2.4

11.04

6.98

ug/l

3.90

642

5029

Evidence of alcohol involvement determined by blood alcohol level

326

2.34

9.25

3.7

2.3

5.12

8.88

ug/l

2.12

298

Squamous cell neoplasms and carcinomas of the skin

447

3318

1.40

9.25

2.4

2.5

5.40

6.80

ug/l

2.10

360

2761

Rheumatic fever incl heart disease

157

941

1.76

9.24

2.4

2.5

11.73

6.45

ug/l

1.03

138

797

Severe visual impairment, binocular

142

3.30

9.23

2.6

2.9

5.16

6.98

ug/l

0.40

128

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

113

612

1.94

9.23

2.5

2.4

3.92

7.55

ug/l

3.51

555

Endometriosis of pelvic peritoneum

401

2762

1.40

9.21

2.0

2.2

3.78

6.73

ug/l

4.43

341

2421

Gestational [pregnancy-induced] hypertension

576

4389

1.32

9.21

2.0

5.24

5.78

ug/l

0.32

527

3787

Benign neoplasm: Skin of ear and external auricular canal

188

1181

1.67

9.20

2.5

5.63

6.66

ug/l

0.58

155

1023

Other disorders of the musculoskeletal system and connective tissue

620

4811

1.32

9.20

2.5

2.3

7.38

7.49

ug/l

0.03

541

4200

Nontoxic multinodular goitre

798

6381

1.28

9.19

2.2

2.3

5.30

5.97

ug/l

0.56

687

5385

Sequelae of injuries of head

210

1349

1.62

9.19

1.9

2.4

7.87

7.25

ug/l

0.24

178

1217

Inflammatory diseases of the central nervous system

321

2249

1.47

9.15

2.4

2.3

5.77

7.19

ug/l

1.09

275

2001

Colectomy operation

769

6136

1.28

9.14

2.3

2.4

6.01

7.26

ug/l

0.96

669

5277

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

663

5199

1.31

9.13

2.6

2.4

8.57

8.21

ug/l

0.12

581

4603

Pneumothorax

315

2206

1.48

9.13

2.6

2.4

7.68

7.57

ug/l

0.04

274

1937

Tongue abnormality

261

1765

1.54

9.09

2.8

2.4

4.63

6.85

ug/l

2.06

214

1551

Bulimia nervosa (incl. atypical)

311

2.28

9.06

1.6

1.8

3.10

4.71

ug/l

0.57

274

Fall on and from stairs and steps

1038

8545

1.23

9.05

2.3

7.04

7.21

ug/l

0.06

854

7386

Intentional self-harm by unspecified means

168

2.84

8.99

2.1

8.17

7.78

ug/l

0.04

153

Dermatopolymyositis

344

2.29

8.99

2.8

2.3

18.27

6.55

ug/l

2.58

301

Diabetes mellitus in pregnancy

585

2849

1.32

8.96

1.9

4.58

5.61

ug/l

0.75

522

2475

Paranoid personality disorder

383

2.19

8.94

2.2

2.4

3.51

7.88

ug/l

3.85

346

Other and unspecified abdominal hernia

186

1173

1.66

8.94

2.4

6.34

7.32

ug/l

0.37

159

1028

Meralgia paraesthetica

143

843

1.78

8.88

2.6

2.4

4.54

7.57

ug/l

2.79

125

753

Recurrent dislocation of patella

119

658

1.85

8.87

2.2

2.0

6.95

6.74

ug/l

0.03

101

580

Bullous disorders

266

1819

1.52

8.82

2.4

2.5

6.38

6.71

ug/l

0.14

220

1575

Sicca syndrome [Sjögren]

325

2300

1.46

8.81

2.1

2.3

5.58

6.20

ug/l

0.25

266

1988

Other inflammation of eyelid

523

3987

1.34

8.80

2.8

2.3

5.97

7.40

ug/l

1.29

435

3476

Scar conditions and fibrosis of skin

138

804

1.78

8.80

2.1

2.2

8.80

7.25

ug/l

0.27

124

718

Symptoms and signs involving emotional state

104

556

1.95

8.80

2.2

9.49

7.99

ug/l

0.14

498

Burn and corrosion of trunk

129

741

1.83

8.80

2.4

5.54

7.90

ug/l

1.50

112

661

Other and unspecified paralytic syndromes

335

2.29

8.73

2.3

7.03

6.79

ug/l

0.06

303

Leisure time condition

707

5607

1.28

8.72

2.4

2.3

6.40

7.27

ug/l

0.69

538

4884

Postzoster neuralgia

474

2.09

8.71

3.2

2.5

5.06

6.36

ug/l

0.30

406

Medial epicondylitis

139

816

1.77

8.67

2.2

2.1

5.16

8.21

ug/l

2.27

126

724

malignant neoplasm of female genital organs

626

4880

1.30

8.57

2.4

3.92

5.81

ug/l

5.50

530

4058

Unspecified jaundice

221

1461

1.57

8.57

2.6

2.2

4.78

8.25

ug/l

2.92

193

1273

Disorders in reading

166

2.77

8.56

1.7

1.9

7.15

6.76

ug/l

0.04

150

Postprocedural disorders of digestive system, not elsewhere classified

151

915

1.74

8.54

2.4

7.31

7.15

ug/l

0.03

127

795

Algoneurodystrophy

115

642

1.87

8.53

2.0

2.2

12.29

6.37

ug/l

0.68

583

Pyoderma

453

2.07

8.52

2.6

2.3

4.06

8.36

ug/l

2.61

394

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

112

604

1.86

8.51

2.4

1.9

4.53

7.43

ug/l

2.07

103

526

Pneumonia due to Streptococcus pneumoniae

176

1106

1.66

8.51

3.3

2.2

5.38

7.45

ug/l

1.65

148

970

Mixed disorders of conduct and emotions

195

2.59

8.50

1.9

3.86

6.84

ug/l

1.05

166

Other general symptoms and signs

153

914

1.70

8.50

2.2

2.0

5.52

7.45

ug/l

1.15

130

808

Hyperplasia of prostate

1837

9017

1.17

8.49

2.5

2.3

7.70

9.31

ug/l

2.38

1579

8119

Vascular dementia

479

3506

1.36

8.46

2.5

2.6

4.51

5.94

ug/l

2.53

341

2906

Abnormal findings on diagnostic imaging of other body structures

552

4267

1.32

8.45

2.3

6.34

6.68

ug/l

0.20

472

3721

Fracture of foot, except ankle

825

6677

1.25

8.41

2.4

2.2

6.52

7.70

ug/l

1.10

708

5852

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1126

9314

1.22

8.36

2.3

2.4

4.49

7.95

ug/l

12.13

994

8131

Salpingitis and oophoritis

547

4219

1.32

8.36

2.5

2.1

5.72

6.17

ug/l

0.23

467

3667

Anorexia

287

2.34

8.35

2.2

2.4

2.68

5.17

ug/l

2.70

247

Drug-induced osteoporosis with pathological fracture

474

2.07

8.35

2.9

2.4

8.89

6.15

ug/l

0.44

408

Asthma and opportunity respiratory infection

215

1427

1.58

8.32

3.2

2.4

6.36

7.14

ug/l

0.33

177

1240

Postprocedural musculoskeletal disorders, not elsewhere classified

315

2248

1.45

8.31

2.7

2.4

4.76

7.06

ug/l

4.20

282

1977

Polyp of the female genital tract

1014

4783

1.23

8.29

2.3

2.2

4.82

6.28

ug/l

2.00

834

4084

Fenamates

561

2928

1.32

8.28

2.1

2.3

7.40

9.27

ug/l

1.10

462

2552

129

2.96

8.27

2.3

1.8

3.68

7.00

ug/l

0.91

110

Other diseases of stomach and duodenum

273

1898

1.49

8.25

2.3

2.2

6.04

7.80

ug/l

0.98

241

1679

Other retinal artery occlusion

124

723

1.83

8.23

3.3

2.6

4.59

7.10

ug/l

2.20

106

617

Intentional self-harm by sharp object

366

2.13

8.20

2.6

2.0

3.03

9.22

ug/l

4.64

330

Excessive vomiting in pregnancy

185

1178

1.60

8.20

2.2

2.3

5.78

5.09

ug/l

0.20

157

1030

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

933

7670

1.23

8.17

2.5

2.2

7.84

7.71

ug/l

0.04

820

6783

Benign neoplasm: Skin of other and unspecified parts of face

457

3465

1.35

8.13

2.6

2.4

5.94

6.86

ug/l

0.34

367

2992

Artificial joint re-operation

320

2302

1.44

8.13

2.3

2.4

5.48

6.83

ug/l

0.51

270

1998

Other noninflammatory disorders of vulva and perineum

268

1854

1.47

8.08

2.2

6.01

6.59

ug/l

0.11

217

1602

Orchitis and epididymitis

426

3204

1.37

8.03

2.6

2.3

10.55

8.89

ug/l

0.36

374

2858

Total colectomy operation

166

1045

1.65

8.01

2.5

2.3

4.79

7.46

ug/l

1.63

146

938

Total colectomy

166

1045

1.65

8.01

2.5

2.3

4.79

7.46

ug/l

1.63

146

938

Other and unspecified nail disorders

520

1.96

8.00

2.5

2.4

5.12

7.39

ug/l

0.98

461

Fibrosis and cirrhosis of liver

338

2457

1.42

8.00

2.5

2.3

10.13

7.51

ug/l

0.70

299

2177

Other noninflammatory disorders of vagina

244

1664

1.50

7.97

2.2

4.29

6.59

ug/l

2.76

185

1429

Vestibular neuronitis

361

2650

1.40

7.97

2.3

2.4

4.94

7.41

ug/l

2.99

318

2361

Cluster headache, strict, including avohilmo

163

1020

1.65

7.94

2.4

2.1

4.77

7.65

ug/l

1.14

138

922

Psoriatic and enteropathic arthropathies

412

3081

1.37

7.92

2.3

2.2

4.82

8.18

ug/l

6.63

360

2747

Oligomenorrhoea

481

1.95

7.91

2.6

2.2

6.53

6.20

ug/l

0.07

418

Pyothorax

204

1355

1.58

7.90

2.7

2.5

7.56

7.54

ug/l

0.01

180

1208

Prurigo nodularis

118

686

1.83

7.87

3.0

2.5

8.53

7.34

ug/l

0.14

109

608

Other keratitis

394

2931

1.37

7.86

2.5

2.3

7.84

7.51

ug/l

0.06

359

2609

Fracture at wrist and hand level

1266

10726

1.19

7.84

2.4

2.3

7.47

7.99

ug/l

0.29

1097

9448

Disturbances of smell and taste

164

1035

1.65

7.83

2.5

2.2

5.85

7.47

ug/l

0.86

143

924

Other female pelvic inflammatory diseases

495

3803

1.32

7.83

2.1

2.2

4.59

6.02

ug/l

1.14

387

3261

Polyarthritis, unspecified

149

919

1.69

7.82

2.5

2.4

4.60

6.93

ug/l

1.86

132

803

Diabetic neuropathy

550

4290

1.32

7.80

2.9

2.5

5.41

7.79

ug/l

4.75

489

3738

Deep endometriosis

302

2154

1.43

7.79

2.3

2.2

6.49

5.47

ug/l

0.23

258

1835

Other disorders of adrenal gland

166

1051

1.64

7.78

3.0

2.3

5.76

6.67

ug/l

0.33

148

933

Follicular cysts of skin and subcutaneous tissue

695

5580

1.27

7.77

2.3

5.29

7.52

ug/l

4.73

619

4908

Exposure to other and unspecified inanimate mechanical forces

260

1809

1.48

7.75

2.4

2.3

6.12

7.90

ug/l

1.23

211

1631

Blepharochalasis

1270

10819

1.19

7.74

2.4

2.3

5.52

6.89

ug/l

1.90

1080

9338

Bronchiectasis

359

2651

1.40

7.74

3.0

2.3

6.58

7.36

ug/l

0.37

291

2268

Other diseases of liver

682

5468

1.27

7.73

2.4

2.3

7.55

7.50

ug/l

0.02

598

4802

Abnormal weight loss

381

2836

1.38

7.73

2.3

2.4

6.97

7.11

ug/l

0.03

303

2472

Heterophoria

254

1758

1.48

7.72

2.4

2.2

6.08

6.95

ug/l

0.27

212

1563

Other and unspecified injuries of abdomen, lower back and pelvis

324

2.21

7.72

2.7

2.3

7.06

8.13

ug/l

0.19

289

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

128

3.18

7.69

3.0

2.6

3.10

7.46

ug/l

1.47

116

Infections of genitourinary tract in pregnancy

241

1651

1.49

7.65

2.1

2.3

4.48

5.42

ug/l

0.42

225

1418

Other and unspecified coagulation defects

166

1054

1.63

7.65

1.8

2.3

10.48

6.73

ug/l

0.89

145

936

Non-allergic asthma

338

2468

1.41

7.65

2.6

2.4

5.04

6.96

ug/l

2.70

308

2180

Disorders of optic nerve and visual pathways

327

2375

1.41

7.62

2.3

5.37

6.91

ug/l

1.54

281

2101

Other juvenile arthritis

530

1.88

7.61

2.0

2.2

5.19

6.88

ug/l

0.71

460

Complications following myocardial infarction

155

2.80

7.61

3.6

1.9

6.98

3.95

ug/l

0.90

117

Drug-induced cataract

104

588

1.87

7.60

2.8

2.4

10.95

7.59

ug/l

0.65

525

Mixed specific developmental disorders

167

2.57

7.58

1.6

2.0

12.87

6.68

ug/l

0.63

140

Other blood glucose lowering drugs, excl. Insulins

737

5985

1.26

7.57

2.7

2.3

5.83

7.51

ug/l

2.00

643

5131

Schizoid personality disorder

395

2.07

7.56

3.3

2.2

11.70

8.93

ug/l

0.17

356

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

158

994

1.64

7.56

2.2

4.44

7.79

ug/l

3.40

145

890

Exposure to other and unspecified man-made environmental factors

347

2.15

7.55

2.4

2.3

5.61

7.29

ug/l

0.60

310

Other disorders involving the immune mechanism, not elsewhere classified

126

752

1.76

7.55

2.3

2.4

6.63

7.92

ug/l

0.24

109

683

Protozoal diseases

134

816

1.73

7.53

2.4

2.5

8.04

7.50

ug/l

0.12

121

729

ILD, hospital admissions 1, main diag only

638

5112

1.28

7.49

2.7

2.4

11.50

6.80

ug/l

4.39

559

4414

Burns and corrosions of multiple and unspecified body regions

524

1.91

7.47

2.8

2.4

6.70

8.27

ug/l

0.54

470

Other disorders of the genitourinary system

503

3911

1.32

7.46

2.5

2.4

6.50

6.11

ug/l

0.18

417

3332

Lesion of sciatic nerve

216

1470

1.53

7.46

3.0

2.5

8.53

6.79

ug/l

0.30

194

1243

Optic atrophy

426

2.03

7.45

2.3

2.4

4.02

6.86

ug/l

2.22

374

Iridocyclitis

865

7139

1.23

7.45

2.5

2.3

5.20

7.41

ug/l

4.81

761

6206

Nontoxic goitre/thyroid nodule

1184

10060

1.19

7.42

2.3

5.33

6.16

ug/l

1.09

1027

8524

Alzheimer’s disease (Early onset), excluding more controls

167

1006

1.61

7.42

2.6

2.3

6.82

6.81

ug/l

0.00

112

852

Chronic viral hepatitis

156

982

1.63

7.41

2.5

2.2

11.65

8.66

ug/l

0.44

141

892

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

507

2469

1.31

7.41

1.7

1.8

4.95

5.28

ug/l

0.14

433

2147

Plantar fascial fibromatosis

328

2394

1.40

7.41

2.6

2.1

5.48

8.16

ug/l

1.92

286

2107

Seronegative rheumatoid arthritis

452

3465

1.33

7.40

2.3

5.75

7.57

ug/l

1.32

372

3017

Rheumatic valve diseases

114

668

1.81

7.40

2.3

2.6

14.60

6.28

ug/l

1.22

560

Psoriatic arthropathies

359

2660

1.38

7.39

2.2

5.00

8.56

ug/l

6.17

310

2365

Dermatitis due to substances taken internally

205

1377

1.54

7.37

2.3

2.4

5.87

7.38

ug/l

0.84

176

1205

Cluster headache, wide,, including avohilmo

173

1119

1.59

7.36

2.4

2.2

4.72

7.94

ug/l

1.43

146

1010

Dislocation, sprain and strain of joints and ligaments of head

127

761

1.72

7.35

2.2

4.37

7.64

ug/l

3.06

113

677

Congenital malformations and deformations of the musculoskeletal system

229

1558

1.49

7.34

2.0

2.1

9.13

6.80

ug/l

0.59

203

1368

Viral hepatitis

235

1621

1.49

7.32

2.4

2.3

9.89

7.71

ug/l

0.47

204

1465

Haemorrhagic disorder due to circulating anticoagulants

425

2.05

7.32

3.1

2.5

6.83

6.10

ug/l

0.21

363

Other obstetric conditions, not elsewhere classified

526

2585

1.30

7.28

1.7

1.8

4.99

5.30

ug/l

0.13

451

2256

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

116

684

1.78

7.28

2.4

4.04

8.06

ug/l

4.29

100

624

Chronic conjunctivitis

120

714

1.76

7.27

2.8

2.3

3.96

7.27

ug/l

3.59

102

633

Hidradenitis suppurativa

110

636

1.79

7.25

2.2

2.1

6.24

7.91

ug/l

0.46

577

Prepatellar bursitis

193

1288

1.56

7.25

2.2

7.23

10.46

ug/l

1.32

169

1164

Dissocial personality disorder

346

2.12

7.23

3.0

2.1

6.73

11.16

ug/l

0.99

323

Ptosis of eyelid

481

3740

1.32

7.21

2.5

2.4

5.38

7.14

ug/l

2.26

407

3253

Primary_lymphoid and hematopoietic malignant neoplasms

1082

9159

1.20

7.19

2.4

7.19

7.17

ug/l

0.01

920

7890

Lichen planus, including avohilmo

745

6086

1.25

7.19

2.2

2.3

5.81

7.31

ug/l

1.71

635

5294

Assault by sharp object

333

2.12

7.15

2.4

2.1

6.79

9.84

ug/l

0.44

308

Ehlers-Danlos syndrome

130

2.83

7.09

1.5

2.0

10.29

3.92

ug/l

0.59

115

Persons encountering health services in circumstances related to reproduction

1473

11465

0.86

7.09

2.0

2.1

9.18

8.31

ug/l

0.44

1335

10236

Other diseases of gallbladder

196

1320

1.54

7.08

2.5

2.4

6.78

7.02

ug/l

0.07

164

1138

Anomalies of dental arch relationship, including avohilmo

547

3881

1.29

7.06

2.1

2.2

6.49

7.25

ug/l

0.28

477

3443

Kyphosis

303

2.19

7.02

2.7

2.3

4.73

7.06

ug/l

1.19

258

Other maternal disorders predominantly related to pregnancy

1484

8025

1.17

7.01

2.1

5.68

6.12

ug/l

0.34

1326

6938

Iliotibial band syndrome

192

2.50

6.98

2.1

2.3

5.56

7.77

ug/l

0.37

175

Persons with potential health hazards related to communicable diseases

727

8810

0.81

6.98

2.2

2.1

11.38

7.38

ug/l

1.93

619

7790

Radial styloid tenosynovitis [de Quervain]

170

1109

1.57

6.94

2.3

2.1

5.77

7.14

ug/l

0.60

146

972

Personal history of risk-factors, not elsewhere classified

211

2.40

6.92

2.7

2.3

4.27

6.07

ug/l

0.68

189

Cirrhosis of liver, NAS

245

1735

1.47

6.89

2.7

2.4

11.18

7.56

ug/l

0.76

223

1551

Sequelae of injuries of lower limb

332

2464

1.38

6.83

2.3

8.17

7.64

ug/l

0.12

297

2206

Congenital malformations of the urinary system

211

1449

1.50

6.81

2.1

2.3

6.41

7.37

ug/l

0.40

190

1289

Optic atrophy

454

1.94

6.81

2.3

2.4

3.98

7.20

ug/l

2.82

399

Other superficial mycoses

445

1.93

6.80

2.3

5.59

8.16

ug/l

0.96

400

Abnormal findings in nipple discharge synovial fluid wound secretions

341

2.09

6.79

2.2

2.3

13.00

7.79

ug/l

0.97

301

Necrosis of pulp, including avohilmo

2058

18232

1.13

6.77

2.3

2.2

7.04

7.81

ug/l

0.90

1810

16157

Melanocytic naevi, other sites/unspecified

284

2060

1.41

6.76

2.5

2.3

8.87

7.25

ug/l

0.34

260

1849

Injury of eye and orbit

477

3726

1.30

6.73

2.4

2.2

6.72

8.62

ug/l

1.36

420

3341

Entropion and trichiasis of eyelid

405

3112

1.34

6.72

2.6

2.4

5.26

7.10

ug/l

2.45

336

2648

Mental and behavioural disorders due to cannabinoids

387

1.97

6.70

2.1

2.0

3.05

10.35

ug/l

6.82

350

Congenital malformations of the urinary system

199

1356

1.51

6.70

2.2

2.3

6.23

7.56

ug/l

0.59

178

1203

Respiratory disorders in diseases classified elsewhere

344

2.09

6.69

2.9

2.3

13.40

6.61

ug/l

0.94

302

Contusion of other and unspecified parts of foot

151

968

1.60

6.68

2.5

2.2

5.25

7.15

ug/l

1.03

138

865

Dementia due to Parkinsons disease, excluding more controls

103

604

1.80

6.68

2.5

2.3

5.87

7.05

ug/l

0.41

540

Crystal arthropathies, rheuma endpoint

101

593

1.82

6.64

2.9

2.6

4.16

6.37

ug/l

1.54

516

Other crystal arthropathies

101

593

1.82

6.64

2.9

2.6

4.16

6.70

ug/l

1.86

517

Open wound of hip and thigh

122

747

1.70

6.63

2.3

7.04

8.29

ug/l

0.25

104

671

L02BG Aromatase inhibitors

803

9630

0.82

6.63

2.0

2.3

3.90

5.75

ug/l

7.19

661

8211

Other congenital malformations

365

2756

1.35

6.57

2.1

2.2

9.34

6.34

ug/l

2.16

328

2430

Emphysema

336

2522

1.37

6.57

3.1

2.3

9.75

8.06

ug/l

0.72

287

2169

Polymyositis

200

2.47

6.55

3.2

2.2

18.28

7.24

ug/l

2.02

177

Car occupant injured in noncollision transport accident

124

765

1.68

6.52

2.4

2.3

7.07

8.00

ug/l

0.23

113

690

Other drug-induced secondary parkinsonism

260

2.28

6.51

3.1

2.5

4.89

7.58

ug/l

0.88

237

Lichen ruber planus, wide definition including periferal and oral lichen planus

849

7096

1.22

6.51

2.2

2.3

6.00

7.23

ug/l

1.38

724

6175

Other peripheral vascular diseases

290

2125

1.40

6.51

2.3

6.07

6.34

ug/l

0.14

245

1857

Ankylosing spondylitis

292

2139

1.39

6.51

2.7

2.2

5.24

9.66

ug/l

3.76

250

1921

Other and/or unspecified nontoxic goitre

306

2264

1.39

6.49

2.4

2.3

6.29

ug/l

0.00

276

1947

Volvulus

120

739

1.70

6.47

2.8

2.3

5.93

7.40

ug/l

0.44

106

651

Acute and subacute iridocyclitis

713

5862

1.24

6.46

2.5

2.3

5.45

7.61

ug/l

3.55

636

5138

Congenital malformations and deformations of the musculoskeletal system

290

2108

1.39

6.46

3.2

2.2

8.93

6.85

ug/l

0.64

250

1856

Fourth [trochlear] nerve palsy

106

635

1.77

6.43

2.7

2.4

10.18

6.94

ug/l

0.27

562

Pemphigoid

137

877

1.65

6.43

2.3

2.5

5.37

6.28

ug/l

0.36

109

750

Benign neoplasm of meninges

415

3217

1.32

6.40

2.5

2.4

6.56

6.43

ug/l

0.05

343

2759

Stenosis and insufficiency of lacrimal passages

367

2797

1.34

6.38

2.4

2.3

5.38

6.69

ug/l

0.71

312

2421

Varicose veins of other sites

258

1864

1.42

6.37

2.6

2.3

6.84

8.54

ug/l

0.80

218

1668

Hypopituitarism

242

1726

1.44

6.37

2.5

2.3

6.50

8.43

ug/l

0.64

207

1559

Rosacea

388

2976

1.33

6.37

2.5

2.3

8.09

6.82

ug/l

0.23

336

2626

Immunodeficiencies

170

1136

1.55

6.35

2.6

2.3

5.16

7.23

ug/l

1.65

146

1015

Other and unspecified injuries of lower leg

243

1734

1.43

6.35

2.5

2.2

7.19

6.96

ug/l

0.06

205

1539

Other intracranial haemorrhages

155

1022

1.59

6.33

2.8

2.6

4.05

6.16

ug/l

3.34

136

883

ILD-related respiratory insufficiency

166

1113

1.57

6.33

2.8

2.5

14.53

6.79

ug/l

3.34

150

966

Open wound of shoulder and upper arm

449

1.89

6.33

2.9

2.3

6.18

7.66

ug/l

0.38

395

Reactive arthropathies

304

2253

1.38

6.33

2.5

2.3

5.38

8.18

ug/l

3.82

256

1996

Toxic effect of other and unspecified substances

207

2.34

6.32

3.5

2.2

13.87

9.06

ug/l

0.53

191

Other abnormalities of plasma proteins

438

1.93

6.31

2.5

6.67

7.25

ug/l

0.11

387

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

241

2.26

6.30

2.9

2.4

5.45

5.60

ug/l

0.02

216

Chronic tubulo-interstitial nephritis

152

996

1.58

6.25

2.4

2.3

5.41

6.60

ug/l

0.48

126

840

Atopic dermatitis, strict definition with reimbursement

781

6256

1.22

6.25

2.1

2.0

6.74

7.60

ug/l

0.53

682

5499

Idiopathic pulmonary fibrosis

375

2886

1.34

6.24

2.6

2.5

13.39

7.11

ug/l

5.00

329

2450

Carcinoma in situ of skin of ear and external auricular canal

486

1.89

6.24

2.3

2.8

5.37

6.34

ug/l

0.33

423

Emotional disorders and disorders of social functioning with onset specific to childhood

459

1.83

6.23

1.6

2.5

4.15

6.84

ug/l

1.18

384

Burn and corrosion of hip and lower limb, except ankle and foot

517

1.82

6.23

2.0

2.4

4.38

8.64

ug/l

3.55

466

Scabies

390

2997

1.32

6.23

2.6

2.2

7.37

7.34

ug/l

0.01

345

2667

Other salmonella infections

144

934

1.60

6.21

2.7

2.2

6.58

7.81

ug/l

0.33

118

821

Obstructive hydrocephalus

374

1.99

6.21

2.2

2.4

7.70

7.06

ug/l

0.07

329

Complications of genitourinary prosthetic devices, implants and grafts

100

593

1.76

6.21

2.6

2.4

4.78

6.64

ug/l

0.80

510

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1547

13945

0.87

6.21

2.0

2.2

6.05

6.93

ug/l

0.67

1347

12170

Divergent concomitant strabismus

254

1836

1.42

6.19

2.2

2.3

7.47

7.12

ug/l

0.07

217

1640

Anxious personality disorder

274

2.12

6.19

2.7

2.2

4.18

8.40

ug/l

1.62

246

Generalized skin eruption due to drugs and medicaments

149

975

1.58

6.18

2.4

2.5

6.12

6.98

ug/l

0.29

124

851

Toxic effect of alcohol

512

1.83

6.18

3.1

2.3

4.96

8.89

ug/l

2.95

464

Assault by unspecified means

365

1.97

6.17

1.8

2.1

6.95

9.70

ug/l

0.38

333

Thyrotoxicosis with diffuse goitre

441

3453

1.30

6.15

2.2

8.41

6.19

ug/l

0.74

373

2985

Oesophageal obstruction

161

1076

1.56

6.15

2.4

5.01

7.40

ug/l

2.10

140

948

Ankylosing hyperostosis [Forestier]

348

2.03

6.14

3.1

2.3

4.98

7.24

ug/l

0.94

306

Other and unspecified disorders of skin and subcutaneous tissue

242

1742

1.43

6.13

2.3

2.4

6.48

6.93

ug/l

0.19

166

1534

Other renal tubulo-interstitial diseases

535

1.80

6.11

2.4

2.3

7.94

6.68

ug/l

0.26

462

Crohn's disease of small intestine

220

1555

1.45

6.10

2.4

2.2

7.40

7.38

ug/l

0.00

197

1408

Chronic laryngitis and laryngotracheitis

527

4226

1.27

6.10

2.3

6.61

7.43

ug/l

0.50

411

3673

Campylobacter enteritis

110

673

1.71

6.09

2.6

2.3

5.08

7.77

ug/l

1.20

602

Other disorders of veins

1565

13699

1.15

6.09

2.3

8.11

6.83

ug/l

0.71

1265

11906

Glaucoma suspect

1583

13964

1.15

6.07

2.5

2.4

6.18

6.96

ug/l

0.60

1382

11978

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

235

1694

1.44

6.07

2.4

2.5

5.97

7.48

ug/l

0.82

206

1461

Other disorders of breast

373

2864

1.32

6.05

2.1

2.2

3.77

5.78

ug/l

4.48

309

2435

Open wound of abdomen, lower back and pelvis

112

688

1.69

6.04

2.3

2.4

6.02

8.16

ug/l

0.94

623

Inflammatory disease of cervix uteri

223

1586

1.45

6.04

2.0

2.3

4.21

5.54

ug/l

1.12

176

1356

Dislocation, sprain and strain of joint and ligaments of hip

163

1098

1.55

5.99

2.7

2.5

5.82

6.80

ug/l

0.37

144

941

Neuromuscular dysfunction of bladder

358

2747

1.33

5.97

2.3

2.2

5.36

7.75

ug/l

2.23

291

2448

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

670

5534

1.23

5.96

2.2

2.5

7.51

8.13

ug/l

0.22

597

4844

Diffuse brain injury

122

768

1.64

5.92

2.4

2.2

8.03

8.64

ug/l

0.14

703

Erectile dysfunction

391

3052

1.32

5.90

2.7

2.4

20.74

7.85

ug/l

4.70

355

2684

Abnormal findings on diagnostic imaging of central nervous system

167

1130

1.52

5.89

2.0

2.4

4.23

6.73

ug/l

3.36

146

999

Nasal polyp

764

6388

1.21

5.88

2.2

2.3

7.18

7.99

ug/l

0.41

682

5628

Scabies

157

1049

1.54

5.87

2.3

6.59

8.45

ug/l

0.78

138

945

Deviated nasal septum

1306

11380

1.16

5.87

2.3

9.36

8.66

ug/l

0.28

1140

10151

Malignant neoplasm of vulva, including Hilmo

384

1.96

5.84

2.6

2.3

3.21

4.90

ug/l

1.42

325

Acute generalized exanthematous pustulosis

166

1126

1.52

5.83

2.3

2.5

6.44

7.07

ug/l

0.21

139

979

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

355

2733

1.33

5.82

2.1

2.4

11.59

7.22

ug/l

0.76

305

2415

Viral infections of the central nervous system

266

1960

1.39

5.81

2.6

2.3

5.44

6.90

ug/l

1.02

223

1743

Disorders of speech understanding and production

127

795

1.61

5.80

2.8

2.5

5.43

6.88

ug/l

0.49

111

692

Drug-induced hypoglycaemia without coma

435

1.88

5.77

2.1

2.5

7.73

7.71

ug/l

0.00

385

Evidence of alcohol involvement determined by level of intoxication

177

2.39

5.76

2.9

2.3

4.77

7.01

ug/l

1.02

159

Chronic nephritic syndrome

161

1091

1.53

5.74

2.6

2.4

5.25

7.78

ug/l

1.41

144

974

Nonspecific lymphadenitis

192

1341

1.47

5.72

1.9

2.2

5.46

8.24

ug/l

1.55

169

1203

122

783

1.65

5.71

3.4

2.6

5.81

6.58

ug/l

0.28

678

Colitis due to radiation

302

2.09

5.70

2.9

2.6

5.49

8.55

ug/l

1.06

264

Inguinal hernia, bilateral

482

3868

1.28

5.70

2.3

2.4

8.24

8.51

ug/l

0.07

430

3427

Other and unspecified injuries of wrist and hand

125

800

1.61

5.69

2.2

6.85

6.75

ug/l

0.03

109

702

Anterior Iridocyclitis

752

6298

1.21

5.68

2.5

2.3

5.46

7.57

ug/l

3.64

665

5497

Adrenocortical insufficiency

134

874

1.59

5.68

3.1

2.4

5.12

6.95

ug/l

0.78

119

777

Bursitis of shoulder

593

1.72

5.68

2.4

2.3

6.01

7.28

ug/l

0.42

519

Melanocytic naevi

1013

8693

1.18

5.67

2.4

2.3

9.08

7.21

ug/l

0.94

891

7575

Specific development disorders of speech and language

154

991

1.53

5.65

2.6

2.4

5.52

6.87

ug/l

0.54

133

858

Other specified/unspecified inflammatory spondylopathies

131

847

1.58

5.64

2.2

2.0

10.55

7.93

ug/l

0.17

115

752

Inguinal or femoral hernia, bilateral

488

3926

1.27

5.64

2.4

8.25

8.44

ug/l

0.05

435

3478

Other and unspecified intracranial injuries

124

797

1.62

5.63

2.6

2.3

6.60

7.46

ug/l

0.29

109

703

Acute nasopharyngitis (common cold)

384

2970

1.30

5.63

2.4

2.1

6.85

9.50

ug/l

2.38

345

2697

Hypercalcemia

188

1320

1.48

5.63

2.5

4.87

7.07

ug/l

2.41

154

1139

Pleural plaque

478

3844

1.28

5.62

3.0

2.4

5.89

6.94

ug/l

0.98

402

3328

Hordeolum and other deep inflammation of eyelid

198

1397

1.45

5.62

2.7

2.2

8.45

7.41

ug/l

0.25

172

1257

Other nonscarring hair loss

154

2.48

5.61

2.1

2.0

13.05

3.58

ug/l

0.65

131

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

160

1062

1.51

5.61

1.9

2.1

9.15

7.03

ug/l

0.36

133

930

Other and unspecified rosacea

301

2275

1.35

5.59

2.5

2.3

9.24

6.95

ug/l

0.36

260

2016

Systemic sclerosis (FG)

543

1.75

5.57

2.5

2.4

16.96

6.99

ug/l

0.52

487

Unspecified nephritic syndrome

568

1.74

5.53

3.1

2.4

7.06

7.49

ug/l

0.07

505

Contusion of toe(s) without damage to nail

415

1.84

5.53

2.2

2.1

7.53

6.61

ug/l

0.14

373

Scleritis

268

2.10

5.52

2.6

2.4

3.98

6.27

ug/l

1.58

242

Perforation of tympanic membrane

362

2812

1.31

5.51

2.3

2.4

5.71

7.07

ug/l

1.05

296

2471

Thyroiditis

236

1722

1.40

5.51

2.5

2.2

6.88

6.53

ug/l

0.07

206

1504

Molar incisor enamel hypoplasia, with caries

3.36

5.49

3.0

1.6

10.89

5.75

ug/l

0.64

Fall on same level involving ice and snow

2280

20642

1.11

5.48

2.4

2.3

7.49

7.10

ug/l

0.27

1902

17983

Other fall from one level to another

796

6718

1.20

5.47

2.4

2.3

8.35

7.75

ug/l

0.26

708

5888

Sudden idiopathic hearing loss

402

3172

1.30

5.46

2.3

6.46

7.54

ug/l

0.66

330

2788

Injury of muscle and tendon at wrist and hand level

497

4013

1.26

5.45

2.2

2.3

6.55

8.52

ug/l

1.61

452

3606

Coeliac disease

404

3183

1.29

5.45

2.1

2.3

5.90

6.76

ug/l

0.57

349

2790

Superficial injury of neck

345

1.93

5.45

2.3

15.28

8.16

ug/l

0.28

314

Later onset COPD

1458

10266

1.15

5.43

2.8

2.4

5.56

6.94

ug/l

3.96

1179

8706

Herpesviral keratitis and keratoconjunctivitis

176

1227

1.48

5.43

2.2

2.4

6.58

7.20

ug/l

0.16

148

1089

Isolated proteinuria

110

694

1.65

5.43

2.8

2.4

6.63

7.46

ug/l

0.11

622

Benign neoplasm: Cerebral meninges

371

2902

1.31

5.42

2.4

6.95

6.31

ug/l

0.27

302

2503

Congenital iodine-deficiency syndrome/hypothyroidism

118

759

1.62

5.37

2.7

2.4

5.06

5.94

ug/l

0.40

643

Pneumonia derived septicemia

134

886

1.57

5.37

2.9

2.3

5.74

7.15

ug/l

0.80

110

777

Suggestive for eosinophilic asthma

350

2719

1.32

5.36

2.4

2.2

6.29

8.06

ug/l

1.37

313

2413

Hydrocele

538

4396

1.25

5.36

2.6

2.3

9.20

8.35

ug/l

0.27

477

3891

Residual foreign body in soft tissue

177

1235

1.47

5.36

2.3

2.2

4.15

9.58

ug/l

6.17

155

1113

Hypertrophy of breast in women and men

565

4628

1.24

5.33

2.2

4.40

6.70

ug/l

2.92

490

4047

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

148

1002

1.53

5.33

2.6

2.4

5.03

6.97

ug/l

1.65

121

882

Crohn's disease of large intestine

162

1112

1.49

5.33

2.2

6.12

7.70

ug/l

0.57

140

1009

Personal history of certain other diseases

195

2.22

5.32

1.9

2.2

4.31

5.48

ug/l

0.45

172

Viral infections of the central nervous system

247

1827

1.38

5.31

2.6

2.3

5.51

6.84

ug/l

0.82

207

1619

Superficial frostbite

153

2.49

5.31

2.1

5.46

11.49

ug/l

1.42

137

Frostbite

252

2.12

5.30

2.2

5.44

9.42

ug/l

1.28

226

Hypoparathyroidism

148

1004

1.53

5.30

2.5

2.4

7.75

6.18

ug/l

0.38

119

862

Perineal laceration during delivery

141

1750

0.67

5.29

1.6

1.9

4.46

5.43

ug/l

0.39

117

1516

Thyrotropin deficiency

211

2.22

5.29

2.3

2.1

3.31

8.06

ug/l

2.26

190

Burns and corrosions confined to eye and internal organs

589

1.69

5.27

2.1

2.2

5.07

8.48

ug/l

2.27

533

Benign neoplasm of other and unspecified endocrine glands

500

4060

1.25

5.27

2.5

2.3

5.85

7.86

ug/l

1.40

442

3577

Unspecified event, undetermined intent

551

1.72

5.26

2.4

2.3

9.92

7.45

ug/l

0.24

497

Nonalcoholic fatty liver disease

328

2533

1.32

5.23

2.2

6.66

7.95

ug/l

0.54

293

2267

Implicit parasitic Sepsis

124

2.71

5.23

2.7

2.2

9.09

6.79

ug/l

0.34

106

Other bursitis of hip

531

1.74

5.22

2.6

2.3

4.83

7.32

ug/l

0.83

454

Adhesive middle ear disease

337

1.93

5.22

2.8

2.3

5.11

7.63

ug/l

0.77

301

Carbimazole or st.post thyroidectomy, condition for graves disease

683

5717

1.21

5.20

2.3

2.2

9.81

6.93

ug/l

1.29

582

4974

Malignant neoplasm of vulva

270

2.10

5.19

2.9

2.3

3.33

4.29

ug/l

0.51

223

Benign neoplasm of mouth and pharynx

421

3361

1.28

5.19

2.4

2.3

6.54

7.77

ug/l

0.68

353

2962

Type 1 diabetes, definitions combined

230

1678

1.39

5.18

2.0

7.50

7.86

ug/l

0.11

194

1494

Collapsed vertebra, not elsewhere classified

222

2.21

5.16

2.3

5.46

6.33

ug/l

0.18

187

Impacted teeth

378

2632

1.29

5.16

2.1

6.91

6.60

ug/l

0.08

339

2293

Conjunctivitis

2737

20908

1.10

5.14

2.3

2.2

6.83

7.01

ug/l

0.13

2325

18201

Implicit parasitic Sepsis

137

2.58

5.14

2.6

2.2

9.94

6.47

ug/l

0.62

115

Benign neoplasm: Other and unspecified parts of mouth

137

921

1.55

5.14

2.5

5.27

7.20

ug/l

1.39

114

827

Thrombocytopenia, unspecified

283

2152

1.35

5.14

2.3

2.4

8.64

7.38

ug/l

0.53

248

1890

Dislocation, sprain and strain of joints and ligaments of knee

2082

17332

1.11

5.13

2.1

2.2

7.29

7.95

ug/l

0.48

1818

15403

Convalescence

184

1305

1.45

5.12

2.3

2.2

8.27

6.21

ug/l

0.33

149

1158

Previous suicide attempt

167

2.34

5.12

2.4

2.2

3.24

8.63

ug/l

2.31

158

231

3093

0.73

5.08

2.7

2.4

8.41

8.50

ug/l

0.02

205

2728

Type 1 diabetes, strict (exclude DM2)

229

1676

1.38

5.07

2.0

7.53

7.63

ug/l

0.03

193

1494

Inflammatory disorders of male genital organs, not elsewhere classified

364

1.90

5.07

2.2

2.3

7.06

10.21

ug/l

0.77

323

Muscle strain

111

712

1.61

5.07

2.1

2.2

5.39

7.81

ug/l

1.19

100

626

Disorders of refraction and accommodation

807

6837

1.19

5.06

2.1

2.2

7.92

7.50

ug/l

0.17

704

5993

IBD patients in KELA-register

729

6152

1.20

5.04

2.4

2.2

6.26

7.97

ug/l

1.70

645

5469

Speech therapy

1063

9254

1.16

5.04

2.1

2.4

7.72

7.06

ug/l

0.30

987

7952

Oesophageal varices

179

1273

1.46

5.03

2.2

2.4

5.24

8.01

ug/l

1.66

156

1144

Other Crohn's disease

210

1526

1.40

5.03

2.2

6.79

7.14

ug/l

0.09

187

1383

Papilloedema, unspecified

467

1.76

5.01

2.0

2.5

3.52

6.93

ug/l

3.22

418

Agranulocytosis

406

3241

1.28

5.00

2.2

2.3

7.41

7.02

ug/l

0.17

345

2852

Intermittent heterotropia

153

1049

1.49

5.00

2.2

2.3

8.85

6.65

ug/l

0.31

123

928

Schizotypal disorder

422

1.79

4.98

2.3

2.2

5.01

8.57

ug/l

2.39

389

Other misadventures during surgical and medical care

609

1.67

4.96

2.2

2.4

7.64

7.59

ug/l

0.01

539

Epidural haemorrhage

183

2.26

4.95

2.7

2.3

5.03

8.09

ug/l

0.89

164

Benign neoplasm: Liver

484

1.74

4.95

2.1

2.3

7.40

6.03

ug/l

0.24

431

Other and unspecified trigeminal disorders

351

1.89

4.95

2.6

2.4

6.54

7.44

ug/l

0.15

313

Seropositive rheumatoid arthritis, strict definition

551

4550

1.23

4.94

2.3

5.80

7.05

ug/l

1.52

494

3963

Idiopathic thrombocytopenic purpura

114

744

1.59

4.90

2.6

2.4

4.61

6.57

ug/l

1.54

104

657

Crohn disease (strict definition, all UC cases excluded)

157

1091

1.47

4.88

2.1

2.3

4.82

7.31

ug/l

1.73

136

983

Nonsuppurative otitis media

610

4386

1.21

4.87

2.2

6.18

6.67

ug/l

0.27

511

3835

Other facial nerve disorders

105

673

1.62

4.87

2.6

2.4

4.88

7.30

ug/l

1.10

592

Abnormal findings on examination of urine, without diagnosis

167

1178

1.46

4.87

2.6

2.4

5.83

7.19

ug/l

0.30

141

1036

Progressive vascular leukoencephalopathy

188

1361

1.44

4.86

1.8

2.5

4.61

5.36

ug/l

0.61

153

1125

Malignant neoplasm of ovary, including Hilmo

237

1771

1.37

4.86

2.4

3.46

6.17

ug/l

5.13

206

1501

Habit and impulse disorders

287

1.96

4.85

2.4

2.2

6.04

9.50

ug/l

0.91

265

Primary open-angle glaucoma, strict

1235

10877

1.15

4.84

2.5

2.4

6.77

6.60

ug/l

0.08

1034

9173

Malignant neoplasm of prostate, including Hilmo

1193

8063

0.87

4.84

2.4

2.5

7.23

9.40

ug/l

2.88

1017

7202

Ehlers-Danlos syndrome

114

2.57

4.83

1.5

2.1

12.28

3.93

ug/l

0.63

101

Psoriasis vulgaris

689

5818

1.20

4.83

2.5

2.3

6.55

7.94

ug/l

1.39

597

5149

Abscess of anal and rectal regions

285

2185

1.33

4.81

2.2

9.65

8.96

ug/l

0.11

245

1984

Autoimmune hyperthyroidism

193

1395

1.41

4.80

2.2

10.19

6.18

ug/l

0.65

155

1226

Bacterial, viral and other infectious agents

296

2283

1.32

4.79

2.3

9.92

8.74

ug/l

0.28

260

2056

Abscess of external ear

297

1.95

4.77

3.6

2.3

4.75

7.39

ug/l

0.73

270

Supervision of high-risk pregnancy

386

1830

1.28

4.76

1.8

4.00

6.11

ug/l

2.29

339

1608

Use of rivastigmine

758

6461

1.19

4.75

2.4

2.5

5.49

5.93

ug/l

0.34

575

5302

Other superficial mycoses

295

2275

1.32

4.74

2.3

2.2

8.23

7.06

ug/l

0.31

245

2025

Allergic rhinitis

831

7041

1.18

4.73

2.1

2.2

6.55

7.41

ug/l

0.55

716

6216

Medicines for HER+ breast cancer

1022

11089

0.87

4.73

2.0

2.3

3.72

5.78

ug/l

11.60

838

9427

Crohn disease (strict definition, require KELA, min 2 HDR)

185

1332

1.42

4.71

2.2

5.70

7.23

ug/l

0.47

158

1201

Hyphaema and other vascular disorders of iris and ciliary body

571

1.67

4.71

2.7

2.5

5.28

7.27

ug/l

1.14

504

Crohn disease (strict definition, require KELA)

187

1349

1.41

4.71

2.2

5.72

7.20

ug/l

0.45

160

1218

Pregnancy examination and test

265

1236

1.34

4.69

3.2

1.7

4.09

6.06

ug/l

1.19

235

1073

Achalasia of cardia

463

1.75

4.68

2.5

2.3

3.77

7.63

ug/l

3.11

403

Dental pulpitis, including avohilmo

3331

20000

1.09

4.68

2.2

6.14

7.99

ug/l

5.52

2934

17744

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

414

1.76

4.67

2.3

2.2

4.57

6.78

ug/l

1.04

363

Adenocarcinoma of pancreas

902

0.53

4.66

2.0

2.5

2.40

7.35

ug/l

13.02

779

Histrionic personality disorder

112

2.66

4.65

3.4

2.4

7.24

4.83

ug/l

0.20

Brain meningioma, including Hilmo

203

1494

1.40

4.65

2.0

2.4

5.32

6.99

ug/l

1.35

178

1299

Other acute viral hepatitis

257

2.01

4.64

1.9

2.3

5.79

9.26

ug/l

1.11

234

Cutaneous lupus erythematosus

572

1.66

4.62

2.6

2.4

4.99

7.48

ug/l

1.41

502

Severe visual impairment, monocular

238

2.07

4.62

2.9

2.7

4.65

7.76

ug/l

0.94

210

Third [oculomotor] nerve palsy

536

1.69

4.61

2.4

4.57

6.91

ug/l

1.42

467

Caries of enamel

3313

22134

1.08

4.61

2.2

7.44

7.58

ug/l

0.12

2901

19529

Scleritis and episcleritis

196

1433

1.40

4.60

2.1

2.2

4.72

6.92

ug/l

1.70

180

1273

Additional codes for the location of defect, injury or illness

208

1538

1.39

4.59

2.5

2.4

3.98

7.02

ug/l

6.58

195

1369

Congenital deformities of feet

418

1.75

4.55

2.2

2.3

12.45

7.77

ug/l

0.37

378

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

211

1568

1.38

4.54

2.3

5.09

6.28

ug/l

0.54

176

1358

Other/unspecified enthesopathies, not elsewhere classified

316

2479

1.30

4.54

2.4

2.2

5.28

8.34

ug/l

3.91

269

2159

Post-traumatic wound infection, not elsewhere classified

106

694

1.59

4.53

3.2

2.4

9.32

7.88

ug/l

0.23

623

Memory loss

391

3155

1.27

4.51

2.2

2.5

5.15

7.04

ug/l

2.97

322

2747

Dementia in other diseases classified elsewhere

200

1478

1.40

4.51

2.6

2.4

5.70

6.99

ug/l

0.64

107

1292

Emotional disorders starting during childhood or adolescence

458

1.69

4.50

1.6

1.8

5.29

7.00

ug/l

0.49

398

ILD and respiratory illness in diseases classified elsewhere

140

2.45

4.48

3.1

2.4

9.08

9.17

ug/l

0.01

128

Other congenital malformations of skin

122

822

1.52

4.48

2.4

2.3

6.99

7.20

ug/l

0.05

112

732

Other diseases of peritoneum

164

1172

1.44

4.47

2.4

5.14

6.80

ug/l

0.67

134

1026

Other and unspecified injuries of ankle and foot

123

831

1.52

4.44

2.4

2.2

6.26

6.92

ug/l

0.19

108

733

Eosinophilic disease (BM)

327

1.86

4.41

2.6

2.2

20.34

7.42

ug/l

0.47

294

Drug-induced osteoporosis

329

1.87

4.40

2.2

2.5

9.73

6.37

ug/l

0.47

285

Blindness or visual impairment, binocular

109

2.63

4.39

2.8

2.7

9.59

6.33

ug/l

0.32

Other forms of systemic lupus erythematosus

166

2.25

4.39

1.7

2.4

8.47

5.47

ug/l

0.45

147

Other and specified injuries of hip and thigh

637

1.61

4.38

2.7

2.6

4.68

6.59

ug/l

0.90

539

Intracranial and intraspinal abscess and granuloma

308

1.90

4.36

2.7

2.5

6.91

7.29

ug/l

0.06

273

Bacterial, viral and other infectious agents

276

2139

1.31

4.35

2.4

2.3

9.71

8.46

ug/l

0.29

242

1932

Recurrent dislocation and subluxation of joint

184

1341

1.39

4.35

2.0

2.1

5.89

7.97

ug/l

0.79

155

1198

Tonsillectomy and adenotomy

1529

9526

1.12

4.35

2.2

2.1

6.47

7.69

ug/l

1.06

1342

8469

Chronic diseases of tonsils and adenoids

2835

16521

1.09

4.35

2.3

2.2

6.39

7.91

ug/l

2.87

2492

14624

Injury of urinary and pelvic organs

511

1.67

4.35

2.5

2.4

10.25

8.33

ug/l

0.23

456

Benign neoplasm of urinary organs

189

1392

1.40

4.34

2.3

2.5

4.44

7.00

ug/l

3.30

154

1225

Juvenile arthritis (FINNGEN)

104

680

1.56

4.34

2.1

5.04

6.83

ug/l

0.89

599

Benign neoplasm: Skin of lip

368

1.82

4.33

2.0

2.5

5.09

7.34

ug/l

0.80

325

Erythema multiforme

535

1.65

4.31

2.9

2.5

6.70

7.09

ug/l

0.08

474

Other otitis externa (chronic)

232

1761

1.35

4.31

2.4

2.3

5.97

7.27

ug/l

0.82

166

1583

Congenital malformations of the respiratory system

404

1.75

4.30

2.7

2.3

5.08

6.31

ug/l

0.50

357

Other/unspecified disorders of vestibular function

165

1192

1.43

4.29

2.5

2.4

6.56

7.11

ug/l

0.10

135

1042

Other meningitis

337

1.83

4.29

2.3

4.60

6.65

ug/l

0.84

301

Bicipital tendinitis

173

1257

1.41

4.28

2.0

2.2

9.00

9.28

ug/l

0.05

144

1133

Brain meningioma

194

1438

1.39

4.28

2.0

2.4

5.46

7.08

ug/l

1.21

170

1254

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

197

1458

1.38

4.28

2.2

5.58

7.37

ug/l

0.61

167

1317

Infective bursitis

119

810

1.52

4.27

2.6

2.3

11.97

8.61

ug/l

0.21

102

728

Psoriasis

1055

9291

1.15

4.27

2.3

5.93

8.03

ug/l

4.68

921

8194

Pleural plaque with presence of asbestos

362

2923

1.27

4.26

3.0

2.5

5.66

7.29

ug/l

1.62

301

2537

Type 1 diabetes, strict definition, subgroup 1

141

981

1.45

4.25

1.8

1.9

6.65

7.47

ug/l

0.21

122

872

Contact with hot air and gases

149

2.32

4.25

1.7

2.8

11.55

9.04

ug/l

0.27

133

Systemic sclerosis, icd10

585

1.62

4.25

2.5

2.4

16.96

6.50

ug/l

0.56

516

Dystonia

184

1352

1.39

4.24

2.7

2.3

3.70

6.99

ug/l

7.66

159

1204

Beningn neoplasm: Meninges, unspecified

431

1.74

4.24

2.4

2.6

4.47

6.14

ug/l

0.67

374

Amblyopia ex anopsia

118

799

1.51

4.24

2.3

6.72

6.85

ug/l

0.04

699

Other congenital malformations of circulatory system

633

1.59

4.23

1.8

2.4

5.08

7.64

ug/l

1.27

572

Lichen simplex chronicus

129

893

1.49

4.23

2.3

2.4

4.57

7.39

ug/l

2.66

113

795

Benign neoplasm: Kidney

141

994

1.47

4.23

2.3

2.5

4.76

6.89

ug/l

1.70

118

877

Other disorders of iris and ciliary body

114

772

1.53

4.21

2.8

2.4

5.90

6.69

ug/l

0.33

675

Cholesteatoma of external ear

212

2.10

4.20

2.2

2.7

6.73

7.62

ug/l

0.10

189

Endometriosis ASRM stages 1,2

413

3364

1.24

4.19

2.0

3.75

5.70

ug/l

2.84

351

2903

Other specified disorders of kidney and ureter

131

912

1.49

4.19

2.9

2.4

7.35

7.70

ug/l

0.08

119

799

Ulcer of vagina/vulva

483

1.67

4.19

2.1

2.3

5.51

5.77

ug/l

0.07

420

Exposure to smoke, fire and flames

619

1.59

4.18

2.5

2.4

5.06

8.44

ug/l

2.62

556

Encephalitis

105

699

1.55

4.16

2.3

2.4

4.32

7.64

ug/l

2.92

615

Rash and other nonspecific skin eruption

328

2614

1.28

4.16

2.2

2.3

6.70

6.77

ug/l

0.03

295

2273

Other encephalitis

100

659

1.57

4.16

2.3

2.4

4.44

7.73

ug/l

2.68

582

Paraplegia, diplegia of upper limbs

573

1.62

4.15

3.5

2.3

6.38

7.96

ug/l

0.50

504

Inflammatory bowel disease, strict (require KELA)

729

6263

1.17

4.15

2.4

2.2

6.26

7.75

ug/l

1.39

645

5561

Complications predominantly related to the puerperium

580

4885

1.20

4.14

2.0

5.33

5.70

ug/l

0.15

513

4250

Syphilis

102

677

1.56

4.14

2.9

2.4

5.19

8.22

ug/l

2.61

610

Syphilis

102

677

1.56

4.14

2.9

2.4

5.19

8.22

ug/l

2.61

610

Urethritis and urethral syndrome

509

1.65

4.14

3.1

2.2

5.47

7.65

ug/l

0.44

452

Malignant neoplasm of oesophagus, including Hilmo

170

1245

1.42

4.14

1.9

2.4

4.68

7.94

ug/l

3.51

138

1094

Pneumococcal septicemia

128

889

1.49

4.13

2.9

2.5

5.79

7.09

ug/l

0.68

104

784

Other autoimmune haemolytic anaemias

359

1.81

4.13

2.3

2.6

5.26

6.58

ug/l

0.46

319

Pediculosis, acariasis and other infestations

197

1469

1.37

4.13

2.2

2.3

6.92

8.65

ug/l

0.74

174

1329

Other salmonella infections

151

1079

1.44

4.13

2.7

2.2

6.42

7.71

ug/l

0.38

124

955

Enteropathic arthropathies

455

1.68

4.10

2.6

2.3

3.35

8.56

ug/l

4.26

404

Disorders of optic nerve, not elsewhere classified

584

1.61

4.10

2.9

2.5

5.06

6.96

ug/l

1.09

520

Other and unspecified injuries of shoulder and upper arm

113

767

1.52

4.09

3.7

2.3

9.47

7.17

ug/l

0.30

677

Other and unspecified mononeuropathies of upper limb

105

702

1.54

4.08

2.7

2.4

12.56

7.45

ug/l

0.47

631

Drug-induced adrenocortical insufficiency

419

1.72

4.08

3.0

2.4

6.84

7.85

ug/l

0.16

376

malignant neoplasm of male genital organs

1180

8084

0.88

4.08

2.4

2.5

7.32

9.41

ug/l

2.65

1010

7221

Type1 diabetes, definitions combined, early onset

117

791

1.49

4.07

2.2

1.9

5.97

7.98

ug/l

0.75

700

Hyperfunction of pituitary gland

136

954

1.46

4.07

5.8

2.2

6.19

6.49

ug/l

0.07

117

849

Malignant neoplasm of corpus uteri

338

2719

1.27

4.06

2.4

2.5

4.20

5.89

ug/l

2.22

282

2241

Other specified and unspecified disorders of eye and adnexa

142

1009

1.45

4.05

2.1

2.4

11.13

6.98

ug/l

0.55

115

879

Calcification and ossification of muscle

3.25

4.05

2.5

2.1

2.29

8.66

ug/l

1.60

Benign neoplasm: Liver/bile ducts

567

1.61

4.05

2.0

2.3

6.88

6.52

ug/l

0.06

499

IgA nephropathy (IgA glomerulonephritis)

576

1.61

4.05

2.4

3.88

8.64

ug/l

4.24

527

Disorders of globe

107

722

1.54

4.04

2.5

2.4

6.29

6.59

ug/l

0.09

617

Congenital malformations of the respiratory system

366

1.77

4.04

2.6

2.3

4.65

6.71

ug/l

1.12

322

Vascular dementia (multiple infarctions)

404

1.73

4.04

2.9

2.6

4.16

6.41

ug/l

1.57

347

Other bullous disorders

107

722

1.54

4.03

2.4

2.5

7.05

7.01

ug/l

0.01

640

Sleep disorders, other/unspecified

622

1.56

4.01

2.5

2.2

4.87

6.66

ug/l

0.71

559

Pediculosis, acariasis and other infestations

468

3883

1.22

4.00

2.5

2.2

7.33

7.53

ug/l

0.05

412

3449

L04AC Interleukin inhibitors

171

1253

1.39

4.00

2.2

5.13

7.69

ug/l

1.94

145

1139

Systemic sclerosis

594

1.59

3.99

2.5

2.3

16.96

6.41

ug/l

0.56

521

Right hemicolectomy

254

1981

1.32

3.98

2.4

2.5

7.16

6.84

ug/l

0.07

222

1708

135

2.38

3.95

3.0

2.3

9.70

8.40

ug/l

0.13

124

Long labour

305

3281

0.79

3.95

1.8

1.9

4.74

5.50

ug/l

0.30

263

2865

Other bacterial agents as the cause of diseases classified to other chapters

259

1.93

3.95

2.3

18.30

7.35

ug/l

0.61

226

Malignant neoplasm of prostate

1172

7868

0.88

3.93

2.4

2.5

7.32

9.42

ug/l

2.65

1001

7021

Osteonecrosis

236

1825

1.32

3.91

2.5

2.3

9.15

6.95

ug/l

0.44

198

1629

Malignant neoplasm of bronchus and lung

666

6422

0.85

3.91

2.2

2.5

6.13

7.56

ug/l

0.99

574

5513

Benign neoplasm: Larynx

130

918

1.47

3.89

2.9

2.5

5.08

7.18

ug/l

1.44

119

810

Malignant neoplasm of corpus uteri, including Hilmo

378

3092

1.25

3.89

2.4

2.5

4.48

5.98

ug/l

1.83

317

2561

Acute alcohol intoxication ICD-9

141

1010

1.44

3.89

3.3

2.5

6.09

7.75

ug/l

0.47

126

898

Myelodysplastic syndrome, including Hilmo

139

997

1.45

3.86

2.9

2.6

5.01

6.86

ug/l

1.42

111

857

Disorders of myoneural junction and muscle in diseases classified elsewhere

204

2.05

3.86

2.1

2.4

3.89

6.14

ug/l

0.71

181

Bullous pemphigoid

104

708

1.54

3.86

2.5

2.6

5.54

6.05

ug/l

0.14

611

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

214

1629

1.33

3.85

2.0

2.1

6.47

8.16

ug/l

0.62

181

1459

Other vitreous opacities

155

1131

1.41

3.83

2.4

4.71

7.27

ug/l

2.93

135

988

Congenital mitral valve regurgitation

5.07

3.83

1.6

2.7

9.78

4.89

ug/l

0.79

Redundant prepuce, phimosis and paraphimosis

780

6718

1.16

3.82

2.3

2.2

9.03

9.29

ug/l

0.07

695

6061

Nephrotic syndrome

113

779

1.50

3.82

2.3

2.4

4.66

7.36

ug/l

1.68

691

Hypertrophy of breast

438

3631

1.22

3.79

2.0

2.1

3.49

6.17

ug/l

8.43

371

3145

Effects of heat and light

191

2.08

3.79

2.2

2.5

7.43

6.16

ug/l

0.19

174

Subacute thyroiditis

118

820

1.48

3.79

2.0

2.2

4.49

6.48

ug/l

1.29

104

722

Drug-induced neutropenia

251

1965

1.30

3.77

2.2

2.4

7.18

7.14

ug/l

0.01

219

1753

Contact with heat and hot substances

176

1310

1.37

3.77

2.3

6.70

7.77

ug/l

0.49

158

1177

Type 1 diabetes, strict definition

149

1072

1.40

3.77

2.0

1.9

6.88

7.47

ug/l

0.15

129

951

Other peripheral vertigo

346

2813

1.25

3.76

2.6

2.4

6.58

6.91

ug/l

0.12

288

2463

Other abnormal immunological findings in serum

389

1.70

3.75

2.7

2.3

5.27

7.77

ug/l

0.88

347

Primary open-angle glaucoma

1494

13094

1.11

3.74

2.4

6.61

6.56

ug/l

0.03

1230

11053

Viral encephalitis, not elsewhere classified/unspecified

516

1.61

3.74

2.7

2.5

4.62

7.25

ug/l

1.46

457

Other symptoms and signs involving the urinary system

417

3459

1.23

3.72

2.4

2.3

7.86

7.85

ug/l

0.00

376

3059

Congenital deformities of feet

103

699

1.51

3.70

5.5

2.2

11.28

7.57

ug/l

0.40

632

Combined immunodeficiencies

257

1.89

3.70

3.2

2.3

3.26

6.64

ug/l

2.33

228

Vulvovaginal ulceration/inflammation in other diseases

130

921

1.43

3.69

2.5

2.0

3.17

5.71

ug/l

2.91

108

817

Lactose intolerance, other/unspecified

524

1.59

3.66

2.1

2.3

3.76

6.68

ug/l

2.47

458

Portal vein thrombosis

425

1.68

3.66

2.4

3.96

7.48

ug/l

3.23

374

Osteonecrosis due to drugs

419

1.69

3.65

2.2

2.6

7.54

6.02

ug/l

0.22

373

Aphakia

354

1.73

3.64

2.7

2.3

5.50

7.39

ug/l

0.67

308

Chronic hepatitis, not elsewhere classified

119

837

1.46

3.63

2.0

2.3

5.63

7.49

ug/l

0.91

106

739

Benign neoplasm of middle ear and respiratory system

307

2477

1.26

3.61

2.4

8.73

7.78

ug/l

0.15

275

2186

Cachexia

133

2.29

3.61

2.1

2.2

4.32

8.05

ug/l

1.89

113

Sixth [abducent] nerve palsy

140

1017

1.42

3.61

2.6

2.5

6.89

7.18

ug/l

0.04

122

903

Biological medication for rheuma

475

3990

1.20

3.60

2.1

2.2

5.99

7.65

ug/l

1.38

415

3558

Atopic dermatitis, strict definition

718

6100

1.16

3.59

2.1

7.02

7.33

ug/l

0.14

633

5364

Melanocytic naevi of trunk

390

3224

1.23

3.57

2.6

2.3

11.94

7.40

ug/l

1.21

355

2869

Benign neoplasm of major salivary glands

375

3094

1.23

3.56

2.5

2.4

5.96

7.41

ug/l

1.22

332

2705

Ménière disease

360

2960

1.24

3.54

2.5

2.3

6.75

ug/l

0.00

308

2580

Hyperkinetic disorders (excl. ADHD)

184

1.98

3.53

2.1

1.8

7.62

9.77

ug/l

0.32

166

Wide developmental disorders, excluding more controls

260

1.81

3.53

1.7

1.8

3.54

7.76

ug/l

2.42

222

Foreign body in respiratory tract

162

1204

1.37

3.53

2.7

2.5

5.46

7.17

ug/l

0.62

143

1065

Tuberculosis, IBD comorbidity

303

2449

1.26

3.53

2.6

2.5

5.33

6.75

ug/l

1.46

248

2067

Use of levodopa decarboxylase inhibitor

622

5373

1.18

3.52

2.4

5.83

6.81

ug/l

1.09

466

4607

Acquired absence of organs, not elsewhere classified

276

1.83

3.51

2.4

2.5

4.93

5.93

ug/l

0.32

243

Hodgkin lymphoma, hilmo

101

694

1.50

3.50

2.2

2.4

6.63

7.82

ug/l

0.38

624

Other/unspecified soft tissue disorders related to use, overuse and pressure

636

1.52

3.49

1.6

2.2

7.32

7.26

ug/l

0.01

566

Abnormal serum enzyme levels

1362

12026

1.11

3.49

2.5

2.4

7.29

8.25

ug/l

1.17

1250

10635

Intentional self-harm by crashing of motor vehicle

5.82

3.49

1.8

2.5

3.46

5.34

ug/l

—

Carcinoma in situ of oral cavity, oesophagus and stomach

163

2.14

3.48

2.3

2.7

3.93

5.40

ug/l

0.69

144

Other and unspecified bullous disorders

255

1.87

3.48

2.2

2.5

8.14

4.88

ug/l

0.47

225

Drug-induced obesity

168

2.07

3.48

2.1

2.6

3.87

5.31

ug/l

0.63

150

Granulomatous disorders of skin and subcutaneous tissue

532

1.57

3.46

2.4

2.3

5.45

6.87

ug/l

0.56

464

Other specified and unspecified disorders of eyelid

377

1.70

3.46

3.1

2.4

4.51

8.00

ug/l

1.46

338

Pilonidal cyst

232

1816

1.29

3.44

2.2

5.43

8.71

ug/l

2.66

201

1646

Vascular dementia (undefined)

193

1466

1.34

3.44

2.5

2.6

4.38

5.64

ug/l

0.87

129

1201

Perichondritis of external ear

504

1.60

3.44

2.8

2.5

4.60

6.35

ug/l

0.89

450

Exposure to sunlight

3.02

3.44

2.6

6.05

5.17

ug/l

0.09

Female infertility

646

3371

1.17

3.44

1.8

2.1

4.92

6.81

ug/l

2.10

559

2950

Other acute skin changes due to ultraviolet radiation

129

931

1.43

3.44

2.2

2.4

6.90

6.58

ug/l

0.08

106

815

Monoplegia

385

1.69

3.44

2.9

2.5

6.87

7.43

ug/l

0.08

345

Other lack of coordination

424

1.65

3.43

2.7

2.3

6.67

7.35

ug/l

0.08

372

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

489

1.61

3.42

2.6

2.5

7.74

6.45

ug/l

0.15

425

Secondary uncertain malignant neoplasm

567

4873

1.18

3.41

2.1

2.5

7.10

7.54

ug/l

0.14

483

4203

Procedures for purposes other than remedying health state

502

1.58

3.41

2.1

2.2

3.80

6.64

ug/l

1.88

450

Malignant neoplasm of oesophagus

122

877

1.45

3.40

1.8

2.5

4.05

7.93

ug/l

5.41

103

774

therapeutic use

126

909

1.43

3.40

2.2

2.5

6.21

6.56

ug/l

0.10

804

Lagophthalmos

364

1.71

3.40

2.8

2.5

5.45

5.90

ug/l

0.11

323

Tuberculosis, wide

314

2559

1.25

3.40

2.6

2.5

5.27

6.77

ug/l

1.64

257

2153

Other and unspecified nerve root and plexus disorders, also in other diseases

670

5821

1.16

3.40

2.3

2.2

6.26

8.14

ug/l

1.49

569

5143

Viral meningitis

100

688

1.49

3.40

2.1

2.2

5.85

7.56

ug/l

0.58

622

Chylothorax

2.96

3.40

2.3

2.4

3.82

6.16

ug/l

1.20

Senility

263

1.82

3.38

3.6

2.2

4.76

6.13

ug/l

0.46

210

Toxic liver disease

387

1.67

3.36

3.0

2.5

7.39

6.97

ug/l

0.08

344

Degenerative conditions of globe

137

2.21

3.36

3.5

2.8

4.04

6.30

ug/l

0.68

115

Vascular dementia (mixed)

605

1.54

3.36

2.0

2.7

6.27

5.82

ug/l

0.09

520

Other and unspecified mononeuropathies of lower limb

103

718

1.48

3.34

2.1

2.4

6.96

7.24

ug/l

0.03

633

Other lesions of median nerve

116

828

1.45

3.34

2.4

2.5

5.09

7.59

ug/l

1.73

708

Reactive arthropathies, FINNGEN

221

1730

1.30

3.33

2.4

2.3

5.60

8.35

ug/l

2.24

184

1547

Contracture of joint

311

1.75

3.32

2.3

2.6

7.58

8.36

ug/l

0.14

271

In situ neoplasms

1541

14078

1.10

3.32

2.3

2.4

6.45

6.43

ug/l

0.01

1333

11996

Primary biliary cholangitis (PBC)

515

1.57

3.31

2.0

2.3

5.40

5.97

ug/l

0.21

451

Maternal care for known or suspected fetal abnormality and damage

145

1683

0.74

3.31

1.6

2.0

16.63

5.58

ug/l

1.17

119

1466

Benign neoplasm of other and unspecified sites

122

879

1.43

3.30

2.2

2.5

5.65

7.25

ug/l

0.58

111

779

Secondary and unspecified malignant neoplasm of lymph nodes

332

2731

1.24

3.30

2.2

2.4

9.25

7.93

ug/l

0.28

287

2382

Mental retardation, excluding more controls

624

1.49

3.29

2.4

2.1

5.52

9.00

ug/l

1.25

556

Cerebral palsy

228

1.85

3.28

2.4

2.2

8.24

7.74

ug/l

0.07

209

Congenital malformations of trachea and bronchus

231

1.88

3.26

3.0

2.3

5.86

5.41

ug/l

0.12

205

Actinomycosis

2.54

3.25

1.6

2.3

6.82

6.91

ug/l

0.01

Inflammatory disorders of breast

140

1032

1.38

3.19

1.9

2.1

4.01

5.57

ug/l

1.18

119

901

Diseases of middle ear and mastoid

1890

14243

1.09

3.19

2.2

6.44

7.44

ug/l

0.96

1618

12423

Lactose intolerance

591

1.51

3.18

2.1

2.2

3.75

7.13

ug/l

3.30

517

Single delivery by forceps and vacuum extractor

139

1135

0.73

3.17

1.6

2.1

4.57

7.10

ug/l

1.43

118

974

Injury of nerves and spinal cord at neck level

628

1.50

3.17

2.1

2.3

10.96

7.13

ug/l

0.62

559

Abnormal findings on diagnostic imaging of breast

331

1.70

3.16

2.8

2.4

3.10

4.84

ug/l

1.43

289

Intercostal neuropathy

197

1.95

3.16

2.4

2.5

5.14

5.85

ug/l

0.15

174

Polycystic ovarian syndrome, broad definition

164

1238

1.34

3.16

1.8

3.22

4.25

ug/l

0.83

142

1080

Vascular dementia (other)

228

1.89

3.14

2.8

2.5

4.09

6.08

ug/l

0.69

200

Vasculitis limited to skin, not elsewhere classified

686

1.48

3.14

2.6

2.5

5.40

7.06

ug/l

0.88

598

Injury of blood vessels of thorax

2.50

3.12

2.8

2.6

11.88

3.61

ug/l

0.64

Primary angle-closure glaucoma

190

1479

1.32

3.12

2.9

2.5

4.77

6.80

ug/l

1.90

156

1257

Other disorders of bladder

491

4207

1.18

3.11

2.4

2.3

6.13

7.94

ug/l

1.89

401

3709

Oral lichen planus and hypothyroidism or thyroxine medication

403

1.63

3.11

2.1

2.2

7.65

5.32

ug/l

0.32

352

Palmar fascial fibromatosis [Dupuytren]

653

5713

1.16

3.10

2.6

2.3

6.52

8.24

ug/l

1.53

539

4930

Unspecified chronic bronchitis

142

1060

1.37

3.09

3.0

2.4

8.57

7.12

ug/l

0.14

118

908

Other and unspecified injuries of thorax

435

1.60

3.09

3.0

2.5

3.73

7.65

ug/l

3.59

387

Retinal detachment with retinal break

527

4547

1.18

3.06

2.4

2.3

7.36

7.78

ug/l

0.22

460

3967

Gingival hyperplasia

123

900

1.40

3.05

2.2

2.3

8.27

7.31

ug/l

0.19

102

793

Follow-up care involving plastic surgery

120

873

1.41

3.05

2.2

4.43

6.16

ug/l

0.91

776

Episcleritis

155

1173

1.35

3.04

2.0

2.2

4.94

6.86

ug/l

1.05

146

1045

Pedestrian injured in collision with car, pick-up truck or van

599

1.50

3.04

2.2

2.4

6.06

7.08

ug/l

0.28

526

Pneumoconiosis due to asbestos and other mineral fibres

103

735

1.46

3.04

3.1

2.5

6.85

6.62

ug/l

0.05

629

Nonpyogenic thrombosis of intracranial venous system

177

1.95

3.03

1.4

2.2

6.50

8.13

ug/l

0.24

158

Lesion of plantar nerve

207

1632

1.29

3.02

2.4

2.3

3.81

6.70

ug/l

7.23

175

1420

Other and unspecified myoneural disorders

2.40

3.02

2.8

2.1

4.29

4.50

ug/l

0.06

Injury of nerves at shoulder and upper arm level

259

1.78

3.02

3.0

2.2

14.71

7.28

ug/l

0.57

231

All dysplastic lesions of the vulva

121

883

1.40

3.02

2.3

2.2

3.51

5.47

ug/l

1.64

107

764

Macular pucker

654

5741

1.16

3.01

2.6

2.4

6.50

7.02

ug/l

0.37

561

4982

Supervision of normal pregnancy

263

1863

0.80

3.00

1.5

1.8

4.34

6.33

ug/l

1.76

230

1635

Benign neoplasm of bone and articular cartilage

259

2095

1.25

3.00

2.2

2.3

6.39

7.38

ug/l

0.40

223

1875

Sequelae of other and unspecified infectious and parasitic diseases

166

1272

1.33

2.99

2.2

9.54

8.08

ug/l

0.27

146

1145

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

516

1.52

2.99

1.9

2.1

9.54

8.13

ug/l

0.23

463

Atlantoaxial subluxation

143

2.08

2.99

2.1

2.2

7.34

6.96

ug/l

0.05

132

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

131

969

1.38

2.99

2.6

2.1

3.44

5.39

ug/l

2.31

121

853

Conductive hearing loss, unspecified

275

2242

1.25

2.97

2.2

2.3

5.89

7.33

ug/l

1.33

228

1980

Hyperprolactinaemia

591

1.48

2.97

7.6

2.2

5.37

6.64

ug/l

0.26

533

Other specified/unspecified bacterial intestinal infections

238

1913

1.27

2.96

2.3

2.4

6.71

7.10

ug/l

0.12

199

1680

Symptoms and signs involving appearance and behaviour

157

2.00

2.96

2.7

2.4

2.83

6.50

ug/l

2.53

134

Other maltreatment syndromes

593

1.48

2.94

2.0

2.2

7.83

8.36

ug/l

0.12

544

Impotence

230

1847

1.27

2.94

2.5

2.3

10.56

9.37

ug/l

0.16

211

1678

Corneal scars and opacities

104

746

1.44

2.94

2.4

2.5

4.83

7.19

ug/l

1.65

659

Other congenital malformations of female genitalia

2.44

2.94

3.2

1.8

2.11

5.05

ug/l

1.72

Exposure to unspecified smoke, fire and flames

231

1.82

2.94

2.9

2.3

4.90

9.64

ug/l

1.77

207

Arteriovenous malformation of cerebral vessels

269

1.76

2.94

1.7

2.5

5.23

7.35

ug/l

0.54

246

Prolapse and hernia of ovary and fallopian tube

178

1374

1.32

2.92

2.9

2.6

5.94

5.66

ug/l

0.06

147

1116

Aspergillosis

240

1.82

2.92

2.2

2.5

16.82

8.54

ug/l

1.14

211

Primary adrenocortical insufficiency

254

1.77

2.92

3.0

2.3

2.66

6.39

ug/l

2.70

227

L01XE Protein kinase inhibitors

211

1680

1.29

2.91

2.2

2.4

8.95

7.20

ug/l

0.45

186

1498

Polyhydramnios

527

1.50

2.90

2.1

2.0

2.12

5.01

ug/l

5.73

459

Other contact dermatitis

254

2059

1.25

2.89

2.3

4.67

6.79

ug/l

2.55

221

1814

Benign neoplasm: salivary glands, exclude unknown (D119)

325

2707

1.22

2.88

2.6

2.4

6.02

7.31

ug/l

0.97

291

2378

Immunodeficiency with predominantly antibody defects

564

1.49

2.88

2.5

2.2

5.39

6.75

ug/l

0.59

501

Endometriosis of ovary

426

3534

1.19

2.87

2.0

2.1

4.06

6.52

ug/l

4.71

349

3064

Hyperaldosteronism

109

793

1.42

2.86

2.4

12.18

6.74

ug/l

0.55

706

Distal bite

502

1.51

2.85

1.6

2.1

5.64

7.96

ug/l

0.80

435

Ectopic pregnancy

410

3480

1.19

2.84

1.9

2.1

4.43

5.88

ug/l

1.75

347

3057

Embedded and impacted teeth

533

3801

1.16

2.83

2.1

7.14

6.56

ug/l

0.22

480

3327

Use of ropinirole

148

1132

1.35

2.83

2.9

2.5

6.04

7.42

ug/l

0.66

117

1007

Injury of muscle and tendon at hip and thigh level

325

2710

1.22

2.83

2.5

2.2

9.33

8.40

ug/l

0.14

289

2438

Other diseases of spinal cord

102

734

1.43

2.82

2.4

5.50

7.24

ug/l

0.67

655

Contact urticaria

2.91

2.82

2.0

2.7

2.61

6.15

ug/l

1.59

Systemic sclerosis,strict definition

182

1.90

2.81

2.8

2.3

30.70

7.36

ug/l

0.41

158

Parkinson's disease, strict definition

633

5575

1.15

2.80

2.3

2.4

6.19

6.80

ug/l

0.53

479

4789

Juvenile osteochondrosis

558

1.48

2.79

2.3

2.2

5.06

8.26

ug/l

1.42

505

Delivery

1108

6459

0.90

2.78

2.3

5.02

6.06

ug/l

1.72

985

5349

Barrett oesophagus

189

1493

1.30

2.78

1.9

2.3

7.02

8.15

ug/l

0.41

156

1334

Crushing injury of head

3.40

2.78

2.1

3.1

8.85

5.56

ug/l

0.45

Congenital malformations of the nervous system

325

1.64

2.78

2.3

2.2

6.73

7.27

ug/l

0.07

290

Other and unspecified aplastic anaemias

289

1.70

2.78

2.3

2.5

7.92

7.03

ug/l

0.13

255

Mixed conductive and sensorineural hearing loss

477

4119

1.17

2.77

2.4

2.3

6.86

7.27

ug/l

0.16

374

3566

Non-follicular lymphoma

389

3310

1.20

2.75

2.3

2.4

7.26

7.18

ug/l

0.02

328

2899

Cauda equina syndrome

313

1.67

2.74

3.5

2.4

7.13

6.83

ug/l

0.04

286

Actinomycosis

2.31

2.74

1.6

2.2

6.82

6.63

ug/l

0.02

Patent foramen ovale

439

1.55

2.74

2.4

2.3

14.12

7.97

ug/l

1.15

394

Abscess of mediastinum

3.02

2.73

2.6

2.7

3.51

6.64

ug/l

1.24

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

125

937

1.37

2.73

2.7

2.6

4.11

6.14

ug/l

2.26

106

793

Oral leukoplakia, including avohilmo

104

757

1.42

2.73

2.3

2.5

5.19

7.00

ug/l

0.47

666

Other and unspecified acute skin changes due to ultraviolet radiation

102

741

1.42

2.72

2.3

2.5

6.58

7.11

ug/l

0.14

641

Benign neoplasm: other/unspecified salivary gland

107

784

1.41

2.71

2.4

2.6

5.50

6.94

ug/l

0.60

685

Unspecified dementia

511

3992

1.17

2.71

2.7

2.5

5.93

6.01

ug/l

0.03

375

3300

Female infertility, cervical, vaginal, other or unspecified origin

578

3273

1.15

2.71

1.8

2.1

4.93

6.88

ug/l

2.06

498

2866

Benign neoplasm: Adrenal gland

287

2380

1.23

2.70

2.5

2.3

6.34

7.25

ug/l

0.28

255

2116

Pedestrian injured in transport accident

231

1872

1.25

2.69

2.6

2.4

6.55

7.21

ug/l

0.22

197

1644

Morphin

549

1.49

2.69

3.1

2.2

4.43

6.81

ug/l

1.08

481

Upper arm

2.91

2.68

2.6

2.3

1.90

5.50

ug/l

2.86

HSIL lesion of the vulva

378

1.59

2.68

2.1

2.3

2.10

4.76

ug/l

4.54

330

Contusion of ankle

109

799

1.39

2.68

2.3

2.2

4.53

7.40

ug/l

1.82

102

709

Assault by blunt object

283

1.68

2.67

3.3

2.1

15.23

9.84

ug/l

0.20

259

Carcinoma in situ of breast, intraductal

173

2192

0.78

2.67

2.0

2.2

4.78

5.86

ug/l

0.44

142

1874

Nosocomial condition (hospital)

150

2.00

2.67

1.8

2.4

3.09

7.98

ug/l

1.89

134

Autonomic disorders

541

1.48

2.66

2.4

5.63

7.08

ug/l

0.38

479

Other bacterial agents as the cause of diseases classified to other chapters

300

1.67

2.66

2.3

17.84

7.00

ug/l

0.63

262

Diastasis of muscle

156

1.94

2.66

2.7

2.3

4.06

8.82

ug/l

1.49

139

Malnutrition

542

1.49

2.66

3.1

2.6

5.61

6.48

ug/l

0.30

466

Other overlap syndromes

419

1.56

2.66

2.3

7.28

7.02

ug/l

0.04

363

Other degenerative diseases of the basal ganglia

562

1.49

2.65

2.0

2.7

9.12

6.92

ug/l

0.40

497

Rheumatoid lung disease

130

2.10

2.64

4.0

2.5

3.59

5.85

ug/l

1.45

112

Polyarteritis nodosa and related conditions

324

1.63

2.64

4.2

2.2

5.63

6.83

ug/l

0.31

291

Melanocytic naevi of lower limb, including hip

133

1009

1.34

2.63

2.2

2.3

7.08

6.97

ug/l

0.02

115

897

301

1.66

2.63

3.1

2.5

5.16

8.36

ug/l

1.10

270

Other disorders of prostate

153

1188

1.32

2.63

2.2

2.3

6.12

8.89

ug/l

2.09

147

1048

Generalized epilepsy

110

811

1.38

2.61

1.9

2.2

7.34

7.58

ug/l

0.02

726

Autism spe, excluding more controls

192

1.80

2.61

1.9

1.8

3.43

8.41

ug/l

2.10

162

Premature rupture of membranes

252

2202

0.81

2.60

2.1

2.0

5.07

5.66

ug/l

0.19

217

1916

Other specified/unspecified disorders of bone/cartilage

712

1.41

2.60

2.4

2.3

5.89

7.73

ug/l

0.59

635

Dysplasia of cervi uteri

534

3363

1.16

2.60

2.0

2.1

6.65

6.59

ug/l

0.01

467

2922

Other and unspecified hydrocephalus

504

1.50

2.60

2.1

2.5

6.04

6.86

ug/l

0.10

440

Fatigue fracture of vertebra

109

2.16

2.59

2.1

2.5

4.33

5.60

ug/l

0.67

Vascular dementia (subcortical)

151

1175

1.32

2.58

2.5

2.6

4.78

6.02

ug/l

0.97

120

996

Other benign neoplasms of connective and other soft tissue

332

2801

1.20

2.58

2.2

2.3

4.93

6.99

ug/l

2.67

286

2464

Congenital heart conduction disorder

4.86

2.57

1.4

2.1

11.57

3.53

ug/l

—

Serous carcinoma of ovary, including Hilmo

120

903

1.36

2.56

2.5

2.4

3.69

6.28

ug/l

2.18

105

779

Other melanin hyperpigmentation

597

1.45

2.56

2.0

2.5

9.04

6.90

ug/l

0.38

522

Single spontaneous delivery

1106

6438

0.90

2.54

2.3

4.99

6.06

ug/l

1.82

980

5333

Other deformities of toe(s)

120

903

1.36

2.54

2.5

2.4

3.55

6.90

ug/l

4.82

786

Disorders of synovium and tendon in diseases classified elsewhere

522

1.48

2.54

2.7

2.3

8.82

7.91

ug/l

0.11

460

Other sexually transmitted chlamydial diseases

1222

0.72

2.53

1.6

2.1

11.22

6.15

ug/l

0.70

1068

Other psoriatic arthropathies

334

2824

1.20

2.53

2.2

2.3

4.96

8.17

ug/l

4.77

292

2531

L02BA Anti-estrogens

395

4597

0.85

2.52

2.1

2.3

3.25

5.97

ug/l

13.54

324

3916

Panniculitis, unspecified

242

1.73

2.52

2.8

2.2

4.36

7.32

ug/l

0.94

205

Burn and corrosion of head and neck

481

1.50

2.52

3.0

2.2

5.78

8.78

ug/l

1.22

435

Endometriosis ASRM stages 3,4

627

5548

1.14

2.52

2.2

5.47

5.68

ug/l

0.08

523

4720

Viral agents as the cause of diseases classified to other chapters

564

1.46

2.52

2.4

11.14

7.79

ug/l

0.51

503

Impacted maxillary molar

644

1.41

2.51

1.8

2.4

4.94

6.78

ug/l

0.79

565

Impetigo

112

834

1.36

2.50

2.7

2.3

6.36

8.00

ug/l

0.27

742

Spinal enthesopathy

116

869

1.36

2.49

2.9

2.3

5.11

6.30

ug/l

0.78

693

Other infective otitis externa

193

1549

1.27

2.49

2.1

2.4

6.19

7.53

ug/l

0.66

155

1396

Anogenital herpesviral [herpes simplex] infection

224

1822

1.24

2.48

2.1

2.2

6.06

6.30

ug/l

0.06

177

1618

Benign neoplasm: Brain, supratentorial

361

1.58

2.48

3.1

2.4

7.04

6.39

ug/l

0.12

323

Occlusion and stenosis of arteries, not leading to stroke

394

1.55

2.48

3.0

2.6

7.18

6.67

ug/l

0.07

336

conjunctival degenerations and deposits

593

1.45

2.47

1.9

2.4

3.38

7.28

ug/l

3.70

521

Other chondrocalcinosis

405

1.56

2.46

3.1

2.6

3.78

6.35

ug/l

1.67

358

Left hemicolectomy

722

1.40

2.45

2.3

2.5

8.60

6.52

ug/l

0.30

631

Biomechanical lesions, not elsewhere classified

174

1384

1.28

2.45

2.4

2.5

9.97

7.13

ug/l

0.48

150

1228

Other disorders of amniotic fluid and membranes

211

1665

1.24

2.45

1.7

2.0

4.21

5.80

ug/l

0.49

191

1450

Abnormal findings on antenatal screening of mother

100

732

1.38

2.44

1.5

2.2

9.80

4.52

ug/l

0.33

625

Folate deficiency anaemia

277

1.67

2.44

3.8

2.5

7.08

9.12

ug/l

0.42

244

Vitamin A deficiency

2.18

2.43

19.5

2.4

4.68

8.68

ug/l

0.55

Psoriatic arthropathies, ICD10

340

2891

1.19

2.43

2.2

2.3

5.00

8.24

ug/l

4.93

296

2594

Meningitis

159

1253

1.29

2.40

2.3

5.91

7.22

ug/l

0.53

134

1122

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

278

2333

1.21

2.38

2.4

5.82

7.65

ug/l

0.96

242

2010

Other abnormal findings of blood chemistry

156

1230

1.29

2.37

2.7

2.4

12.07

7.01

ug/l

1.25

141

1093

Adalimumab

250

2071

1.22

2.36

2.0

2.2

6.49

7.83

ug/l

0.53

216

1862

CR(E)ST syndrome

358

1.56

2.35

2.5

2.3

23.37

5.05

ug/l

0.57

314

Malignant neoplasm of bladder, including Hilmo

559

4916

1.14

2.35

2.5

5.77

7.83

ug/l

2.98

464

4241

Livedoid vasculitis

2.21

2.35

1.8

2.4

6.31

6.55

ug/l

0.03

Occupational exposure to risk-factors

125

961

1.33

2.34

3.2

2.4

8.11

8.04

ug/l

0.01

108

876

Presbyopia

204

1661

1.25

2.33

1.8

2.2

9.16

8.07

ug/l

0.20

184

1498

Other disorders of white blood cells

188

1519

1.26

2.32

2.4

11.31

6.81

ug/l

0.51

160

1347

Flatulence and related conditions

209

1.74

2.32

2.0

2.3

3.48

8.95

ug/l

2.52

186

Femoral hernia

166

1324

1.28

2.31

3.6

2.4

7.25

7.04

ug/l

0.04

141

1157

Iron deficiency

333

1.56

2.31

2.8

2.2

15.06

5.68

ug/l

0.78

298

Foreign body on external eye

490

4301

1.15

2.30

2.6

2.3

7.71

9.29

ug/l

0.69

450

3909

Spondylopathies in diseases classified elsewhere

337

1.58

2.30

3.1

2.2

6.33

7.52

ug/l

0.19

293

Torticollis

271

1.63

2.29

2.4

2.2

7.29

8.80

ug/l

0.24

245

Otitis media, unspecified

259

1985

1.21

2.29

2.0

2.3

5.76

6.53

ug/l

0.34

219

1750

Inflammation of lacrimal passages (chronic)

460

1.49

2.29

2.7

2.5

3.21

7.02

ug/l

3.69

395

Other neurotic disorders

169

1352

1.27

2.29

2.2

2.3

5.92

7.20

ug/l

0.43

150

1193

Drug-induced interstitial lung disorders, unspecified

2.68

2.28

2.2

2.7

9.45

6.14

ug/l

0.29

Dermatitis herpetiformis

468

1.48

2.28

2.5

6.19

6.86

ug/l

0.17

422

Inhalation and ingestion of other objects causing obstruction of respiratory tract

129

1.96

2.27

3.2

2.4

3.11

7.09

ug/l

2.66

116

Malignant immunoproliferative diseases

315

1.61

2.26

2.7

2.8

13.65

7.05

ug/l

0.35

277

Other disorders of cornea

329

2810

1.19

2.26

2.3

8.32

7.34

ug/l

0.24

278

2470

Renal cell carcinoma of kidney

144

1135

1.30

2.26

3.0

2.5

4.16

7.44

ug/l

5.28

125

979

Other specified/unspecified necrotizing vasculopathies

379

1.54

2.25

2.5

2.4

5.23

7.52

ug/l

0.85

336

Special screening examination for infectious and parasitic diseases

455

2916

1.15

2.25

1.6

1.9

11.84

8.99

ug/l

0.71

354

2626

Gestational diabetes (for exclusion)

615

3796

1.13

2.24

1.8

1.9

4.34

5.70

ug/l

1.01

547

3327

Alzheimer’s disease (undefined)

334

0.49

2.24

2.1

2.6

15.03

6.06

ug/l

—

263

Benign lipomatous neoplasm

1110

10201

1.10

2.24

2.3

6.69

7.41

ug/l

0.47

974

8891

Benign neoplasm of ovary

550

4874

1.14

2.23

2.4

2.3

5.18

5.81

ug/l

0.40

473

4129

Complications following abortion and ectopic and molar pregnancy

104

783

1.36

2.23

2.0

2.3

9.04

5.74

ug/l

0.39

689

Alcoholic liver disease

398

3457

1.17

2.23

2.6

2.4

6.62

8.53

ug/l

1.51

345

3101

Parkinson's disease

667

5990

1.13

2.22

2.4

6.18

6.91

ug/l

0.68

510

5154

Pollen allergy

393

3356

1.16

2.21

1.9

2.1

6.92

6.79

ug/l

0.05

330

2965

Haemangioma and lymphangioma, any site

287

2428

1.20

2.21

2.3

4.62

6.92

ug/l

2.34

244

2152

Glaucoma, exfoliation

493

4350

1.15

2.21

2.4

2.5

4.88

6.48

ug/l

2.90

397

3580

Puerperal sepsis

325

2776

1.18

2.20

2.1

5.74

6.07

ug/l

0.09

293

2418

Anogenital herpesviral [herpes simplex] infection

133

1035

1.30

2.20

1.8

2.1

4.67

6.57

ug/l

1.13

925

Other and unspecified vasculitis limited to skin

623

1.40

2.20

2.6

2.5

5.66

7.00

ug/l

0.58

544

Multifocal fibrosclerosis

176

1.81

2.19

2.2

2.6

7.71

4.89

ug/l

0.44

150

Non-Hodgkin lymphoma, all, including Hilmo

555

4935

1.14

2.19

2.3

2.4

6.86

7.70

ug/l

0.29

477

4282

HSIL lesion of the cervix uteri, vagina or vulva

381

3292

1.16

2.19

1.9

2.1

6.22

5.45

ug/l

0.14

332

2855

Allergic purpura

665

1.38

2.18

2.6

2.3

6.78

7.50

ug/l

0.12

585

Disorders of eyelid in diseases classified elsewhere

105

795

1.35

2.18

3.1

2.3

5.29

6.92

ug/l

0.58

702

Adenocarcinoma and ductal carcinoma of pancreas

1143

0.73

2.18

2.1

2.5

2.25

7.52

ug/l

20.45

990

Benign lipomatous neoplasm of other sites/unspecified

331

2841

1.18

2.18

2.2

2.4

6.23

6.97

ug/l

0.38

282

2457

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

146

1157

1.29

2.18

2.1

2.5

7.79

7.09

ug/l

0.14

130

1036

Urethral stricture

240

2008

1.22

2.15

2.3

6.72

8.23

ug/l

0.94

202

1780

Tumor necrosis factor alpha inhibitors

403

3505

1.16

2.15

2.1

2.2

6.03

7.86

ug/l

1.35

355

3126

Other specified disorders of external ear

149

1187

1.29

2.15

2.4

2.5

7.30

7.48

ug/l

0.05

116

1082

Myeloid leukaemia

101

764

1.36

2.15

2.2

2.6

4.58

7.10

ug/l

1.68

675

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

276

1.60

2.15

2.8

2.1

10.79

6.78

ug/l

0.31

238

Poisoning by medicine, drug-induced

277

1.60

2.14

2.2

4.33

7.96

ug/l

1.18

255

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

436

3826

1.16

2.14

2.6

2.5

5.16

7.59

ug/l

3.09

383

3322

Other and unspecified erythematous conditions

102

772

1.35

2.14

2.2

2.5

7.03

7.37

ug/l

0.08

675

Thyroiditis, unspecified

317

1.56

2.14

2.1

2.2

3.44

5.62

ug/l

1.86

279

Injury of muscle and tendon at lower leg level

528

4684

1.14

2.14

2.4

2.3

11.35

8.60

ug/l

0.71

462

4212

Nezelof syndrome

111

2.03

2.13

3.6

2.5

2.78

6.33

ug/l

2.41

Eosinophilia

408

1.50

2.13

2.6

2.4

20.19

6.87

ug/l

0.51

364

Ulcerative rectosigmoiditis

247

2069

1.21

2.13

2.8

2.2

5.05

7.89

ug/l

3.01

222

1860

Vitamin B12 deficiency anaemia

425

3721

1.16

2.13

2.4

5.48

6.79

ug/l

0.90

343

3155

Sequelae of infectious and parasitic diseases

256

2153

1.20

2.13

2.4

7.84

7.30

ug/l

0.13

220

1861

Female infertility, tubal origin

640

1.37

2.12

1.9

5.21

7.27

ug/l

0.46

573

Other and unspecified medical devices associated with adverse incidents

148

1.88

2.12

2.8

2.6

10.18

8.68

ug/l

0.16

133

Chronic Coagulation defects

440

1.46

2.12

2.2

2.4

6.75

6.93

ug/l

0.03

394

Guillain-Barre syndrome

401

1.49

2.10

2.2

2.4

8.28

8.21

ug/l

0.01

359

Drug-induced tremor

163

1.82

2.10

2.3

5.96

8.35

ug/l

0.36

149

Other surgical follow-up care

730

1.35

2.10

2.2

2.3

14.93

6.31

ug/l

0.79

644

Malignant neoplasm of lip, including Hilmo

345

1.54

2.10

2.6

2.7

4.90

6.07

ug/l

0.57

298

Carcinoma in situ of vagina

2.16

2.09

2.9

2.4

2.00

2.93

ug/l

0.85

Acute lymphadenitis

155

1240

1.27

2.09

2.2

7.64

7.70

ug/l

0.01

137

1096

Burn and corrosion confined to eye and adnexa

492

1.44

2.09

2.0

2.3

4.34

8.52

ug/l

3.16

448

Atopic conjunctivitis

118

913

1.31

2.08

2.4

2.2

7.03

7.09

ug/l

0.01

109

802

Malignant neoplasm of digestive organs

1745

12908

1.07

2.08

2.2

2.4

4.98

7.90

ug/l

12.34

1467

11167

Asthma mixed form (mode), excluding more controls

140

1107

1.28

2.07

2.1

2.0

4.19

6.95

ug/l

3.13

124

958

Sexual assault by bodily force

3.27

2.06

1.8

1.7

13.66

4.07

ug/l

—

Maternal care for known or suspected abnormality of pelvic organs

335

2653

0.86

2.06

1.9

2.0

4.90

5.39

ug/l

0.21

293

2310

Adenomyosis (Endometriosis of uterus)

376

3267

1.16

2.06

2.0

2.2

5.60

6.40

ug/l

0.39

313

2815

Benign neoplasm: Lip

597

1.40

2.06

2.7

2.5

5.76

6.82

ug/l

0.29

527

Non-Hodgkin lymphoma, all

184

1509

1.25

2.06

2.0

2.5

5.27

7.68

ug/l

1.32

153

1299

Hypersplenism

2.07

2.05

3.2

2.3

17.28

9.28

ug/l

0.36

All dysplastic lesions of the cervix uteri, vagina or vulva

597

5258

1.12

2.05

2.0

5.81

5.56

ug/l

0.07

526

4545

Contact with blunt object, undetermined intent

119

1.93

2.05

3.0

2.2

6.07

8.54

ug/l

0.36

106

Malignant neoplasm of respiratory system and intrathoracic organs

797

7283

0.90

2.05

2.2

2.5

6.30

7.97

ug/l

1.36

691

6270

Other factor of the environment

281

1.58

2.03

2.4

5.62

6.63

ug/l

0.18

255

Bilateral sagittal split ramus osteotomy operation

562

1.39

2.02

1.8

2.2

4.15

7.33

ug/l

2.05

513

Other and unspecified psoriasis

231

1938

1.21

2.01

2.3

2.4

5.75

7.44

ug/l

1.41

203

1739

Human immunodeficiency virus [HIV] disease

448

0.59

2.01

1.7

2.1

8.72

9.41

ug/l

0.05

416

Other/unspecified crystal arthropathies

197

1.73

2.01

3.2

2.7

4.45

8.07

ug/l

0.87

167

Dysplastic lesion of unknown severity of the cervix uteri

134

1.84

2.00

2.7

2.4

1.81

5.20

ug/l

1.83

119

Carcinoma in situ of skin of scalp and neck

115

899

1.32

2.00

2.3

2.7

6.89

6.49

ug/l

0.11

100

777

Benign neoplasm: Parotid gland

283

2418

1.19

2.00

2.6

2.4

6.25

7.24

ug/l

0.55

251

2135

Pituitary-dependent Cushing's disease

2.40

1.99

2.1

5.30

5.16

ug/l

0.02

Acute nephritic syndrome

549

1.40

1.99

2.7

2.4

3.88

7.84

ug/l

4.55

494

Inflammation of lacrimal passages (acute and unspecified)

439

1.45

1.99

2.2

2.4

6.18

6.19

ug/l

0.00

380

Malignant neoplasm of floor of mouth, including Hilmo

261

1.61

1.97

2.8

2.6

7.76

7.82

ug/l

0.01

223

Small cell lung cancer, including Hilmo

791

0.69

1.97

2.3

2.5

4.25

7.04

ug/l

2.36

671

Small cell lung cancer

791

0.69

1.97

2.3

2.5

4.25

7.04

ug/l

2.36

671

Primary hyperparathyroidism

395

3464

1.15

1.97

2.3

2.4

4.79

6.41

ug/l

1.56

319

2979

Myelodysplastic syndrome

359

1.51

1.96

3.3

2.5

2.46

5.36

ug/l

6.25

305

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

100

765

1.33

1.96

2.4

2.3

5.57

7.32

ug/l

0.80

684

Erythema nodosum

687

1.35

1.96

3.4

2.3

5.01

6.40

ug/l

0.58

608

Childhood allergy (age < 16)

177

1187

1.23

1.96

1.7

1.9

6.97

5.84

ug/l

0.32

148

1009

Malignant neoplasm of urinary organs

410

3609

1.15

1.95

2.6

2.5

5.10

7.55

ug/l

2.92

360

3135

Unspecified lump in breast

455

4024

1.14

1.95

2.2

2.3

3.72

5.99

ug/l

6.58

385

3417

Benign mammary dysplasia

458

4055

1.14

1.95

2.3

4.69

5.88

ug/l

1.26

381

3394

Rare circulating lymphoid malignancy, including Hilmo

111

864

1.31

1.95

2.0

2.5

7.42

7.62

ug/l

0.03

749

Other localized connective tissue disorders

441

1.44

1.94

2.3

2.1

24.95

6.95

ug/l

0.61

385

Infections with a predominantly sexual mode of transmission

721

6529

1.11

1.93

2.1

8.25

7.07

ug/l

0.48

600

5754

Benign neoplasm: Peripheral nerves and autonomic nervous system

417

1.46

1.93

2.2

2.5

5.34

7.49

ug/l

0.52

368

Fall on and from ladder

295

2540

1.18

1.92

2.5

2.4

6.76

8.49

ug/l

1.13

266

2278

Haemangioma, any site

266

2268

1.19

1.92

2.2

2.4

4.78

6.85

ug/l

1.79

226

2010

Parkinson's disease, including avohilmo

692

6284

1.11

1.91

2.4

6.07

6.86

ug/l

0.80

531

5407

Tuberculosis

253

2152

1.19

1.91

2.7

2.5

5.00

6.65

ug/l

1.71

204

1811

Malignant neoplasm of ovary

161

1312

1.25

1.91

2.3

2.4

3.86

6.19

ug/l

2.58

140

1116

Infection due to other mycobacteria

435

1.45

1.91

3.1

2.4

8.88

7.23

ug/l

0.33

374

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

471

4180

1.14

1.91

2.5

2.2

6.57

8.01

ug/l

0.96

422

3736

Other and unspecified disorders of adult personality and behaviour

2.10

1.90

1.4

2.3

9.38

6.61

ug/l

—

FESS (DNB20)

385

3376

1.15

1.90

2.1

2.3

7.21

7.97

ug/l

0.19

337

3038

Adult respiratory distress syndrome

369

1.49

1.90

2.9

2.5

8.18

7.73

ug/l

0.04

323

Universal erythroderma, KELA reimbursement

352

1.50

1.89

2.4

2.6

7.51

8.61

ug/l

0.17

315

Ankylosing spondylitis, ICD10

271

2318

1.18

1.88

2.7

2.3

5.31

8.09

ug/l

1.81

231

2089

Ulcerative proctitis

172

1412

1.23

1.87

2.1

2.2

4.41

7.77

ug/l

4.25

146

1274

Benign neoplasm: Spinal cord

353

1.49

1.87

2.6

2.5

4.75

7.27

ug/l

0.77

314

Other disorders of bone density and structure

555

1.38

1.85

2.5

2.3

6.61

7.45

ug/l

0.21

499

Causalgia

328

1.50

1.85

1.9

2.4

3.27

7.61

ug/l

3.50

298

Renal tubulo-interstitial disorders in diseases classified elsewhere

240

1.61

1.85

2.5

18.59

6.85

ug/l

0.44

208

Von Willebrand disease

215

1.62

1.85

2.3

2.2

4.24

5.62

ug/l

0.32

189

Ulcerative enterocolitis

694

1.34

1.84

2.5

2.3

3.91

7.99

ug/l

3.65

626

Use of biperiden

173

1426

1.23

1.84

2.7

2.4

4.46

8.07

ug/l

4.75

145

1277

Erythema elevatum diutinum

4.74

1.83

2.6

1.5

7.84

3.77

ug/l

—

Fistulae involving female genital tract

329

1.50

1.83

3.1

2.2

3.14

6.73

ug/l

3.23

287

Cyst of kidney

278

2394

1.18

1.83

2.2

2.4

6.74

7.58

ug/l

0.39

239

2105

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

533

4779

1.12

1.83

2.5

2.3

6.64

7.76

ug/l

0.78

478

4265

Torsion of ovary, ovarian pedicle and fallopian tube

295

1.52

1.83

2.5

2.3

1.28

6.61

ug/l

7.62

263

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

768

7026

1.10

1.82

2.0

2.4

4.94

8.00

ug/l

4.96

665

6125

Small cell lung cancer, helper endpoint

779

0.70

1.82

2.3

2.7

4.25

6.60

ug/l

1.69

659

Carcinoma in situ of skin of upper limb, including shoulder

109

858

1.31

1.82

2.2

2.7

6.01

6.22

ug/l

0.07

734

Atypical virus infections of central nervous system

225

1.62

1.82

2.4

2.3

5.84

7.86

ug/l

0.46

202

Endocrine disorders, other/unspecified

448

0.61

1.82

1.7

2.3

6.85

6.36

ug/l

0.08

400

Malignant neoplasm of bladder

307

2663

1.17

1.82

2.3

2.4

4.70

7.20

ug/l

3.88

254

2267

Malignant neoplasm of kidney, except renal pelvis

372

3273

1.15

1.81

2.6

2.5

5.18

7.64

ug/l

2.55

327

2862

Disorders of orbit

135

1086

1.26

1.80

2.2

2.3

5.98

7.37

ug/l

0.71

111

971

Vasomotor rhinitis (mode)

229

1941

1.19

1.80

1.9

2.4

4.82

6.83

ug/l

2.03

197

1726

Dyshidrosis [pompholyx]

281

1.53

1.79

1.7

2.2

4.01

7.78

ug/l

1.65

249

Thyrotoxicosis with toxic multinodular goitre

217

1834

1.20

1.79

2.6

2.4

5.06

6.20

ug/l

0.58

192

1559

Mental disorders, not otherwise specified

193

1609

1.21

1.79

2.1

7.41

7.19

ug/l

0.04

171

1432

Diffuse large B-cell lymphoma

182

1516

1.22

1.79

2.5

12.70

7.95

ug/l

0.61

147

1313

Diffuse large B-cell lymphoma, including Hilmo

182

1516

1.22

1.79

2.5

12.70

7.95

ug/l

0.61

147

1313

Diffuse large B-cell lymphoma, helper endpoint

182

1516

1.22

1.79

2.5

12.70

7.95

ug/l

0.61

147

1313

Multiple myeloma, including Hilmo

184

1535

1.22

1.78

2.8

2.4

6.13

7.90

ug/l

0.76

160

1326

Cholesteatoma of middle ear

192

1607

1.22

1.77

2.3

2.5

5.77

7.49

ug/l

1.26

162

1412

Lymphoid leukaemia

209

1763

1.21

1.77

2.3

2.5

7.27

7.32

ug/l

0.01

169

1538

Other and unspecified pemphigoid

293

1.54

1.77

2.1

2.8

4.74

6.07

ug/l

0.40

255

Corticotropin deficiency

195

1.66

1.77

2.7

2.4

3.35

6.29

ug/l

1.80

173

Frontotemporal dementia, wide, incl. Pick's disease

204

1.66

1.77

3.4

2.3

7.45

8.65

ug/l

0.12

180

Acute appendicitis, with complications

692

6308

1.10

1.75

2.2

2.3

6.98

7.70

ug/l

0.56

610

5536

Multiple myeloma and malignant plasma cell neoplasms

191

1602

1.22

1.75

2.8

2.5

5.99

7.29

ug/l

0.53

167

1394

Other erythematous conditions

112

886

1.29

1.75

2.1

2.4

7.02

7.44

ug/l

0.10

776

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.13

1.74

4.4

2.8

8.72

7.24

ug/l

0.10

Other benign neoplasm of uterus: Other parts/unspecified

116

1446

0.79

1.74

2.1

2.4

10.27

5.34

ug/l

1.04

1175

Purulent endophthalmitis

181

1.69

1.74

2.6

9.69

5.21

ug/l

0.85

153

Malignant neoplasm of bronchus and lung, including Hilmo

824

7494

0.91

1.74

2.3

2.5

5.93

7.94

ug/l

2.19

714

6450

Hirsutism in women

202

1.61

1.74

1.6

2.0

8.16

4.42

ug/l

0.41

179

Other mycoses, not elsewhere classified/unspecified

409

1.43

1.74

2.4

2.3

12.83

7.48

ug/l

0.70

359

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

187

1.64

1.73

3.8

2.4

2.55

5.31

ug/l

1.51

165

Tuberculosis of other organs, strict

757

1.31

1.72

2.6

5.89

5.54

ug/l

0.10

633

Malignant neoplasm of pancreas

207

2440

0.84

1.72

2.2

2.4

3.03

7.48

ug/l

16.16

173

2089

Cysts of oral region, not elsewhere classified

192

1612

1.21

1.71

2.2

2.4

7.18

7.77

ug/l

0.17

172

1454

Personal history of malignant neoplasm

114

1427

0.79

1.70

2.2

2.1

3.25

5.24

ug/l

3.20

1231

Other congenital malformations of intestine

245

1.56

1.69

2.2

7.81

6.60

ug/l

0.23

217

Other and unspecified iridocyclitis

140

1142

1.24

1.67

2.2

2.4

4.10

7.98

ug/l

6.38

124

1021

Benign neoplasm: Oesophagus

329

1.48

1.67

2.0

2.5

6.59

8.23

ug/l

0.30

290

Ovarian dysfunction

118

941

1.26

1.67

2.0

6.80

4.33

ug/l

0.52

107

814

Reduction defects of upper limb

2.52

1.67

1.8

2.3

15.63

7.30

ug/l

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.06

1.66

2.4

2.3

2.60

4.53

ug/l

0.93

Respiratory tuberculosis, confirmed and not-confirmed

211

1793

1.19

1.66

2.7

2.5

4.99

6.62

ug/l

1.58

172

1522

Periodontal disease, other/unspecified

654

1.33

1.66

1.9

2.3

4.51

6.46

ug/l

1.51

582

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

611

1.34

1.66

2.5

3.90

7.65

ug/l

2.68

539

Deficiency of other B group vitamins

559

1.36

1.65

2.8

2.4

3.75

6.81

ug/l

2.75

483

Accidental poisoning by and exposure to alcohol

353

1.45

1.65

3.4

2.5

5.39

8.35

ug/l

0.94

313

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

750

1.30

1.65

1.9

2.2

5.41

7.27

ug/l

0.91

672

Respiratory tuberculosis

211

1794

1.19

1.65

2.7

2.5

4.99

6.62

ug/l

1.58

172

1523

Lens-induced iridocyclitis

2.51

1.65

1.6

2.1

4.89

5.61

ug/l

—

Striking against or struck by other objects

1065

9901

1.08

1.65

2.6

2.2

9.24

8.03

ug/l

0.71

897

8758

Need for other prophylactic measures

188

1582

1.20

1.64

1.8

2.4

9.95

7.40

ug/l

0.71

159

1418

Medical abortion

1956

10039

1.06

1.64

2.4

2.2

5.90

5.49

ug/l

0.43

1650

8539

Other nonthrombocytopenic purpura

256

1.54

1.64

3.5

2.6

6.90

6.88

ug/l

0.00

223

Embedded teeth, including avohilmo

171

1422

1.21

1.64

2.1

2.3

7.44

6.61

ug/l

0.25

158

1248

Injury of muscle and tendon at forearm level

465

1.39

1.64

2.0

2.4

14.77

8.49

ug/l

0.35

419

Use of entacapone

259

0.52

1.63

2.3

2.6

3.79

6.90

ug/l

1.67

225

Other disorders of pigmentation

142

1165

1.24

1.62

2.0

2.3

7.38

7.12

ug/l

0.06

126

1022

Thrombotic microangiopathy

145

1.73

1.62

3.3

2.4

4.11

8.19

ug/l

1.11

127

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

448

4015

1.13

1.62

2.4

2.3

6.61

7.70

ug/l

0.38

390

3555

Poor fetal growth

174

1451

1.21

1.61

1.7

2.0

4.25

4.67

ug/l

0.17

160

1258

Ethmoidectomy

398

3543

1.13

1.61

2.1

2.3

7.38

7.96

ug/l

0.14

349

3182

Carcinoma in situ of skin, other sites/unspecified

469

1.39

1.61

2.2

2.6

5.61

6.04

ug/l

0.08

408

Overjet

286

1.48

1.60

1.8

1.9

2.91

8.41

ug/l

3.35

249

Other sexually transmitted chlamydial diseases

777

0.73

1.59

1.5

2.3

12.50

7.32

ug/l

0.45

684

Hypermetropia

195

1648

1.19

1.59

2.3

6.75

7.26

ug/l

0.10

174

1454

Cyst of Bartholin Gland

683

1.31

1.59

2.0

2.1

4.34

5.55

ug/l

0.49

606

Vitiligo

216

1.57

1.59

2.1

2.4

4.85

7.82

ug/l

0.80

194

Personality and behavioural disorders due to brain disease, damage and dysfunction

382

1.43

1.59

2.5

2.4

5.23

8.69

ug/l

1.03

340

HSIL lesion of the cervix uteri

316

2769

1.15

1.59

1.9

2.1

6.97

5.35

ug/l

0.28

278

2414

Drug phototoxic response

3.29

1.59

2.0

2.4

23.03

3.19

ug/l

—

Prolonged pregnancy

158

1665

0.83

1.59

1.4

2.0

2.39

5.61

ug/l

6.18

128

1445

Procreative management

745

6759

0.92

1.59

2.0

2.1

12.06

7.53

ug/l

2.11

649

5981

Other and unspecified injuries of neck

153

1.69

1.58

1.7

2.3

2.26

6.19

ug/l

4.09

140

Other noninflammatory disorders of cervix uteri

143

1177

1.23

1.58

1.9

2.3

5.03

6.78

ug/l

1.20

119

1011

LeFortI or BSSO operation

710

1.30

1.58

1.7

2.1

4.29

7.25

ug/l

2.38

644

Other disorders of penis

359

3183

1.14

1.57

2.8

2.3

7.55

9.14

ug/l

0.44

308

2851

Alcohol induced polyneuropathy

292

1.50

1.57

2.3

2.4

5.09

9.46

ug/l

1.35

262

Other appendicitis

258

2236

1.17

1.57

2.3

8.56

7.59

ug/l

0.20

228

1997

Certain conditions originating in the perinatal period

134

968

1.24

1.57

2.1

2.3

10.94

6.05

ug/l

0.86

117

830

Other bursitis, not elsewhere classified

242

1.54

1.57

2.2

2.5

2.85

8.78

ug/l

3.04

210

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

548

1.35

1.56

2.4

2.6

9.50

6.82

ug/l

0.36

469

Prominent ears

1.96

1.56

1.9

1.83

4.25

ug/l

—

Drug-induced dystonia

2.13

1.55

1.9

2.3

1.70

6.11

ug/l

—

Protein-energy malnutrition of moderate and mild degree

243

1.54

1.55

2.9

2.7

4.10

7.67

ug/l

1.01

217

Ulcerative colitis (strict definition, require KELA)

486

4386

1.12

1.54

2.5

2.3

6.55

7.97

ug/l

0.98

437

3917

Secondary malignant neoplasm of other and unspecified sites

577

1.34

1.53

2.2

2.5

4.41

7.81

ug/l

2.51

496

Other hearing loss

1189

10910

1.07

1.53

2.2

2.4

6.13

7.10

ug/l

0.98

968

9298

Human immunodeficiency virus [HIV] disease resulting in other conditions

391

0.63

1.52

1.8

2.1

9.12

9.77

ug/l

0.05

367

Other/unspecified reactive arthropathies

194

1651

1.19

1.51

2.5

2.3

5.53

7.16

ug/l

1.21

162

1482

Malignant neoplasm of breast, HER-positive

925

7756

0.93

1.51

2.1

2.2

3.81

5.83

ug/l

9.20

759

6616

Carcinoma in situ of skin of other and unspecified parts of face

377

3370

1.13

1.50

2.4

2.5

6.41

6.33

ug/l

0.04

319

2807

Oral lichen planus

674

1.30

1.50

1.7

2.3

7.05

7.16

ug/l

0.02

592

Benign neoplasm of brain and other parts of central nervous system

213

1829

1.18

1.50

2.6

2.4

5.51

6.91

ug/l

1.03

187

1628

Delivery, wide proxy

973

5556

0.93

1.49

2.3

2.4

5.02

5.64

ug/l

0.69

842

4553

Contact with lifting and transmission devices, not elsewhere classified

465

1.37

1.49

2.4

2.2

7.95

8.53

ug/l

0.10

422

Abrasion of teeth

1105

10347

1.07

1.48

2.1

2.2

6.00

7.28

ug/l

1.19

959

9134

Migraine, single triptan purchase ok & required. ICD-code if available is included

2423

15678

1.05

1.47

2.1

2.2

6.56

7.56

ug/l

1.12

2126

13835

Triptan medication for migraine, single purchase ok

2423

15678

1.05

1.47

2.1

2.2

6.56

7.56

ug/l

1.12

2126

13835

Motor neuron disease (with DMD)

448

1.37

1.47

2.7

2.2

12.34

7.45

ug/l

0.41

406

Injury of nerves at hip and thigh level

1.88

1.47

1.9

2.4

3.56

5.07

ug/l

0.37

Gluteal tendinitis

103

826

1.26

1.46

2.5

2.2

3.34

7.55

ug/l

7.15

723

Fluid overload

2.02

1.46

3.6

2.0

35.46

5.22

ug/l

0.45

Motorcycle rider injured in other and unspecified transport accidents

147

1224

1.21

1.45

2.1

2.2

5.62

8.39

ug/l

2.33

131

1107

Use of selegiline

177

1504

1.20

1.45

2.2

2.5

4.96

7.05

ug/l

1.93

120

1309

Cerebral arteritis

2.14

1.45

3.2

2.8

3.67

4.92

ug/l

0.41

Infectious mononucleosis

151

1259

1.21

1.45

2.0

2.2

4.26

7.03

ug/l

2.07

135

1117

Other specified/unspecified deforming dorsopathies

363

1.41

1.45

2.2

36.59

7.61

ug/l

0.88

316

Multiple myeloma

110

894

1.26

1.45

2.4

2.6

5.81

7.14

ug/l

0.33

767

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

110

894

1.26

1.45

2.4

2.6

5.81

7.14

ug/l

0.33

767

Abscess of Bartholin gland

405

1.38

1.44

2.0

3.66

5.36

ug/l

1.00

363

Other and unspecified corneal deformities and disorders

101

811

1.27

1.44

2.3

2.4

9.21

7.58

ug/l

0.18

724

Oral lichen planus, including avohilmo , including avohilmo

199

1706

1.18

1.44

2.0

2.3

7.61

6.74

ug/l

0.23

169

1502

Hypoplasia of dental enamel , including avohilmo

294

1.43

2.3

2.0

14.40

6.05

ug/l

1.00

253

Lifestyle-related condition

264

1.48

1.42

2.1

2.3

6.09

6.65

ug/l

0.08

240

Tuberculosis of other organs

654

1.30

1.42

2.6

6.34

5.95

ug/l

0.10

551

Nontoxic diffuse goitre

101

813

1.26

1.42

2.3

5.09

6.09

ug/l

0.32

693

Mental retardation

744

1.27

1.41

2.4

2.3

5.52

8.19

ug/l

0.88

657

Other benign neoplasms of uterus

148

1758

0.83

1.41

2.0

2.4

8.92

5.37

ug/l

0.96

100

1451

Nontoxic single thyroid nodule

216

1866

1.17

1.41

2.2

2.3

7.01

6.41

ug/l

0.17

180

1622

Frontotemporal dementia

176

1.62

1.41

3.2

2.4

8.18

9.09

ug/l

0.08

157

Medical treatment for female infertility

246

2804

0.87

1.40

1.6

1.9

4.17

5.41

ug/l

0.79

216

2452

Viral agents as the cause of diseases classified to other chapters

504

1.34

1.40

2.6

2.4

11.43

7.81

ug/l

0.48

451

LSIL lesion of the vulva

547

1.32

1.40

2.2

4.37

5.06

ug/l

0.23

480

Acute myeloid leukaemia and myelodysplastic syndromes

656

1.30

1.39

3.0

2.5

3.17

6.49

ug/l

4.35

553

Antepartum haemorrhage, not elsewhere classified

128

1055

1.22

1.39

1.7

1.9

4.48

6.11

ug/l

0.53

111

914

Exposure to other and unspecified forces of nature

128

1.71

1.39

1.7

2.0

3.13

6.01

ug/l

2.31

113

Orthopaedic devices associated with adverse incidents

542

1.33

1.38

2.1

2.5

5.37

6.16

ug/l

0.16

474

Other acquired deformities of musculoskeletal system and connective tissue

147

1234

1.21

1.38

2.1

2.4

10.21

7.69

ug/l

0.31

124

1089

Open bite

733

1.27

1.37

1.8

2.0

4.75

6.57

ug/l

0.79

653

Injury of nerves at ankle and foot level

144

1.65

1.37

2.3

2.1

15.15

8.42

ug/l

0.34

130

Benign neoplasm: Skin of scalp and neck

639

1.29

1.36

2.1

2.5

5.98

6.77

ug/l

0.21

573

Benign neoplasm: Appendix

301

1.44

1.36

2.2

2.7

14.64

7.71

ug/l

0.36

265

Injury of nerves at wrist and hand level

109

889

1.24

1.36

2.3

6.94

7.83

ug/l

0.25

102

804

Contact with other hot fluids

656

1.28

1.36

2.3

5.73

7.91

ug/l

1.04

588

Mental retardation, wide definition

102

820

1.25

1.36

2.3

5.85

8.29

ug/l

0.81

724

Femoral hernia, unilateral

774

1.26

1.35

2.9

2.4

9.23

6.92

ug/l

0.35

669

Inguinal of femoral hernia, unilateral

774

1.26

1.35

2.9

2.4

9.23

6.92

ug/l

0.35

669

Inguinal hernia, unilateral

774

1.26

1.35

2.9

2.4

9.23

6.92

ug/l

0.35

669

Malignant neoplasm of other and ill-defined sites, including Hilmo

491

1.34

1.35

2.2

2.4

3.50

6.79

ug/l

2.27

421

Perioral dermatitis

359

1.39

1.35

2.3

2.2

3.96

5.48

ug/l

0.68

318

Impaction of intestines

169

1.60

1.35

2.3

2.5

13.62

8.22

ug/l

0.23

147

Raynaud syndrome

242

2116

1.15

1.35

2.1

2.3

6.42

6.63

ug/l

0.07

203

1879

Other obstructed labour

153

1289

1.20

1.34

1.8

2.0

10.59

5.64

ug/l

0.44

133

1132

Retinoschisis and retinal cysts

713

1.28

1.34

2.4

2.5

6.02

6.56

ug/l

0.11

626

Triptan medication for migraine, min. 3 purchases

1456

10513

1.06

1.34

2.0

2.1

6.50

7.18

ug/l

0.40

1272

9272

Secondary polycythaemia

668

1.28

1.34

2.6

2.4

9.97

7.74

ug/l

0.23

596

Horner syndrome

293

1.44

1.34

1.8

2.3

6.01

8.25

ug/l

0.38

267

Calculus of lower urinary tract

213

1851

1.17

1.34

2.7

2.4

6.67

7.41

ug/l

0.26

165

1626

Congenital lens malformations

1.91

1.34

1.9

3.1

23.10

8.07

ug/l

—

Other congenital malformations of ear

113

1.71

1.33

1.7

1.9

11.30

5.09

ug/l

0.27

104

Benign neoplasm: Other parts of oropharynx

210

1.52

1.33

1.8

2.4

2.42

5.92

ug/l

4.72

192

Postpartum hemorraghe, parous women as controls

361

3427

0.89

1.32

1.8

7.34

5.02

ug/l

0.49

325

3018

Benign neoplasm: Floor of mouth

1.91

1.31

1.6

2.5

3.29

7.48

ug/l

2.03

Melanoma in situ

120

1440

0.82

1.31

1.9

2.5

7.28

6.80

ug/l

0.12

101

1252

Astigmatism

166

1412

1.19

1.31

2.0

2.3

8.14

7.23

ug/l

0.24

139

1256

Abscess of lung

415

1.36

1.30

2.9

2.5

9.99

8.35

ug/l

0.25

371

Juvenile rheumatoid arthirtis

310

1.41

1.30

2.1

5.50

7.15

ug/l

0.37

276

Family history of certain disabilities and chronic diseases leading to disablement

730

1.26

1.30

2.2

1.9

10.52

5.96

ug/l

0.50

644

Other injuries of upper limb, level unspecified

295

1.43

1.30

2.9

2.5

3.77

6.78

ug/l

1.77

258

Donors of organs and tissues

252

1.46

1.30

1.7

2.0

17.19

8.19

ug/l

0.49

230

Other congenital malformations of skin

206

1786

1.16

1.30

2.3

2.2

7.08

6.68

ug/l

0.15

182

1585

Melanocytic naevi of upper limb, including shoulder

546

1.31

1.29

2.7

2.4

10.57

6.19

ug/l

0.31

485

Spirochaetal infections, other/unspecified

284

2520

1.14

1.29

2.1

2.3

7.16

7.37

ug/l

0.09

232

2243

Golimumab

652

1.27

1.28

2.0

2.1

5.73

7.26

ug/l

0.44

589

Atopic dermatitis

1712

13356

1.05

1.28

2.3

2.1

6.68

7.69

ug/l

1.07

1474

11713

All dysplastic lesions of the cervix uteri

471

4253

1.10

1.28

1.9

2.0

6.18

5.46

ug/l

0.17

419

3706

Melanocytic naevi of other and unspecified parts of face

170

1456

1.18

1.27

2.0

2.3

5.11

6.76

ug/l

0.96

142

1280

Postpartum haemorrhage due to anatomy

1181

0.81

1.27

1.6

1.7

5.73

4.17

ug/l

0.34

1038

Arthropathic psoriasis

352

3165

1.12

1.27

2.3

5.30

8.00

ug/l

3.84

303

2833

Malignant neoplasm of eye, brain and central nervous system

145

1227

1.20

1.27

2.0

2.4

3.91

8.32

ug/l

8.68

124

1082

Burn and corrosion of shoulder and upper limb, except wrist and hand

504

1.31

1.27

2.9

2.2

8.29

7.79

ug/l

0.07

456

Hypertrichosis

253

1.44

1.26

1.5

2.0

7.53

4.62

ug/l

0.34

222

Macular hole

208

1814

1.16

1.26

2.4

5.48

7.28

ug/l

1.85

181

1585

Idiopathic hypoparathyroidism

1.94

1.25

3.3

2.8

5.22

4.24

ug/l

0.16

Unspecified abortion

106

870

1.23

1.25

2.0

2.1

5.23

5.78

ug/l

0.08

787

Parapsoriasis

435

1.34

1.25

2.3

2.5

6.97

7.30

ug/l

0.05

387

Hepatocellular carcinoma, including Hilmo

119

993

1.22

1.25

2.6

2.5

6.17

7.98

ug/l

0.57

867

Other disorders of Eustachian tube

674

1.27

1.24

1.8

2.4

5.95

6.94

ug/l

0.28

604

Malignant neoplasm of breast, ER-positive, including Hilmo

951

7814

0.93

1.24

2.0

2.2

3.83

5.82

ug/l

9.17

778

6666

Other puerperal infections

108

888

1.22

1.23

1.7

2.2

3.08

4.57

ug/l

1.17

774

Exposure to other and unspecified animate mechanical forces

549

1.29

1.23

2.1

2.2

5.54

7.16

ug/l

0.62

495

Malignant neoplasm of cervix uteri, including Hilmo

541

1.30

1.23

2.2

2.4

3.54

6.00

ug/l

1.94

474

Other, unspecified and serous retinal detachments

111

920

1.23

2.3

2.5

6.11

7.59

ug/l

0.63

806

Leiomyoma of uterus

2032

11011

1.05

1.23

2.1

2.2

5.58

ug/l

0.00

1658

9417

L02BB Anti-androgens

340

3769

0.89

1.23

2.5

2.4

7.18

7.15

ug/l

0.01

298

3245

Peroneal tendinitis

306

1.40

1.23

2.0

2.3

16.03

7.37

ug/l

0.35

281

Osteopathy in diseases classified elsewhere

190

1.53

1.22

2.2

4.46

7.86

ug/l

1.15

172

Hypertrophy of tongue papillae

307

1.40

1.22

2.4

2.6

3.59

7.01

ug/l

2.06

277

Malignant neoplasm of oral cavity, including Hilmo

169

1455

1.18

1.22

2.3

2.4

6.45

7.97

ug/l

0.79

152

1282

Other inflammation of vagina/vulva

523

1.29

1.22

2.0

4.61

4.90

ug/l

0.06

463

Spasmodic torticollis

739

1.25

1.22

2.5

2.4

3.47

6.53

ug/l

4.62

659

Other acquired deformities of ankle and foot

190

1.52

1.21

2.7

2.5

8.41

7.18

ug/l

0.16

169

Respiratory tuberculosis, confirmed

517

1.30

1.21

2.6

2.5

6.73

7.08

ug/l

0.07

447

Other conjunctival vascular disorders and cysts

615

1.28

1.21

2.6

2.3

13.60

7.13

ug/l

0.53

535

Molar incisor enamel hypoplasia

311

1.37

1.20

2.4

2.0

14.03

6.20

ug/l

0.95

270

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

118

1.68

1.20

1.8

2.4

5.86

6.21

ug/l

0.06

110

Simple and mucopurulent chronic bronchitis

149

1271

1.19

1.20

3.0

2.4

4.70

6.95

ug/l

1.59

121

1086

Other secondary coxarthrosis

113

941

1.22

1.20

2.4

8.50

7.55

ug/l

0.12

831

Non-small cell lung cancer

361

3951

0.90

1.18

2.1

2.5

5.20

7.35

ug/l

2.32

317

3390

Use of rotigotine

310

1.40

1.18

2.6

2.4

6.74

6.06

ug/l

0.12

275

Pregnancy with abortive outcome

2042

10199

1.05

1.17

2.3

2.2

5.61

5.49

ug/l

0.10

1722

8643

Benign neoplasm: Rectosigmoid junction

153

1313

1.18

1.17

2.4

2.5

5.99

7.16

ug/l

0.71

127

1161

150

1.57

1.17

2.1

2.2

6.11

6.80

ug/l

0.08

134

Malignant neoplasm of brain

111

925

1.22

1.17

1.8

2.3

3.60

8.29

ug/l

9.26

822

Benign neoplasm: Skin of trunk

130

1099

1.20

1.17

2.6

2.4

10.68

6.95

ug/l

0.44

103

969

Sequelae of other and unspecified effects of external causes

119

1.66

1.16

2.5

2.6

19.20

5.25

ug/l

0.41

107

Leiomyosarcoma, including Hilmo

277

1.42

1.16

1.7

2.5

10.69

7.25

ug/l

0.18

238

Separation of retinal layers (serosa)

137

1165

1.19

1.16

2.0

2.3

7.48

7.91

ug/l

0.11

114

1053

Carcinoma in situ of skin of trunk

132

1122

1.20

1.15

2.1

2.6

6.08

6.11

ug/l

0.01

111

964

Acute epiglottitis

345

1.36

1.15

4.0

2.2

3.82

8.54

ug/l

3.10

308

Other disorders affecting eyelid function

244

0.60

1.15

2.9

2.5

2.32

6.92

ug/l

3.46

224

Respiratory tuberculosis, clinically confirmed

364

0.67

1.15

2.4

2.6

4.96

7.31

ug/l

0.57

311

Retained placenta and membranes, without haemorrhage

264

2350

1.13

1.14

2.0

4.27

5.91

ug/l

1.48

233

2026

Infections with a predominantly sexual mode of transmission

912

7980

1.07

1.14

2.1

7.70

7.29

ug/l

0.17

769

7015

Atypical mycobacterium lung infection

329

1.38

1.14

2.1

2.5

8.35

7.31

ug/l

0.16

284

Injury of muscle and tendon at ankle and foot level

539

1.28

1.13

1.9

2.3

11.25

7.91

ug/l

0.31

485

Wegener granulomatosis

390

1.34

1.13

2.1

2.4

4.80

6.53

ug/l

0.49

348

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

685

1.25

1.13

2.3

2.6

5.93

7.78

ug/l

0.68

605

Toxic effect of contact with venomous animals

116

974

1.21

1.13

2.4

5.22

7.20

ug/l

1.50

104

867

Diabetes insipidus

202

1.48

1.12

2.9

2.5

3.67

5.39

ug/l

1.03

180

Glaucoma secondary to eye trauma

178

1.52

1.11

2.9

2.7

4.40

5.93

ug/l

0.60

157

Chorioretinal inflammation

712

1.24

1.11

2.6

2.4

8.95

7.46

ug/l

0.29

631

Benign neoplasm: Prostate

229

1.46

1.11

1.8

2.5

4.96

7.40

ug/l

0.72

200

Carcinoma in situ of skin

344

3123

1.11

1.10

2.5

6.70

6.82

ug/l

0.06

301

2669

Juvenile cataract

1.83

1.10

1.6

2.5

17.11

6.40

ug/l

0.31

Malignant neoplasm of breast, HER-negative

583

6161

0.92

1.10

2.2

2.4

5.26

5.74

ug/l

0.35

468

5177

Dementia due to Parkinson's disease

103

861

1.22

1.10

2.5

2.6

5.87

6.39

ug/l

0.15

740

Malignant neoplasm of breast, ER-negative, including Hilmo

645

6591

0.93

1.10

2.1

2.3

5.02

5.76

ug/l

0.69

518

5561

Other disorders of male genital organs

122

1033

1.20

1.09

2.1

2.2

12.18

9.33

ug/l

0.28

109

935

Malignant neoplasm of oral cavity

125

1062

1.20

1.09

2.2

2.5

6.57

7.59

ug/l

0.36

112

938

Acute poliomyelitis

358

1.35

1.09

3.0

2.5

5.64

7.19

ug/l

0.42

312

Noise effects on inner ear

106

1261

0.83

1.09

1.8

2.4

6.71

8.70

ug/l

0.84

1157

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

197

1734

1.15

1.08

2.2

2.4

5.22

7.68

ug/l

1.69

171

1487

Acquired pure red cell aplasia [erythroblastopenia]

114

1.65

1.08

2.1

2.3

11.55

5.16

ug/l

0.52

All dysplastic lesions of the vagina

507

1.28

1.08

2.5

2.2

4.12

6.32

ug/l

1.22

452

Malignant neoplasm of heart, mediastinum and pleura

394

1.33

1.08

2.4

2.7

6.87

7.55

ug/l

0.22

337

Deaf mutism, not elsewhere classified

130

1.60

1.08

2.4

2.5

3.80

6.31

ug/l

0.56

115

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

545

1.28

1.08

2.2

2.5

7.03

ug/l

0.00

470

Circumscribed brain atrophy

635

1.25

1.07

3.2

2.6

7.65

6.74

ug/l

0.12

553

Other and unspecified types of non-Hodgkin lymphoma, hilmo

150

1296

1.17

1.07

2.4

2.5

11.11

7.19

ug/l

0.53

131

1134

Ulcerative ileocolitis

879

0.80

1.07

2.1

2.2

9.41

8.01

ug/l

0.24

795

Mantle cell lymphoma, including Hilmo

475

1.30

1.07

1.8

2.6

6.22

7.60

ug/l

0.25

415

Respiratory tuberculosis, bacteriologically and histologically confirmed

536

1.27

1.07

2.6

2.5

6.67

6.96

ug/l

0.06

460

Pemphigus foliaceus

2.21

1.06

2.7

3.0

14.43

6.35

ug/l

—

Asthma mixed form (mode)

140

1201

1.18

1.06

2.1

4.19

7.47

ug/l

4.15

124

1043

Congenital malformations of eye, ear, face and neck

146

1257

1.17

1.05

2.1

2.3

7.27

ug/l

0.00

119

1121

Other congenital malformations of peripheral vascular system

238

1.41

1.05

1.7

2.2

2.71

6.48

ug/l

2.82

213

Malignant neoplasm of pancreas, including Hilmo

285

3157

0.89

1.05

2.3

2.5

3.80

7.14

ug/l

9.55

240

2704

Alcoholic cardiomyopathy

156

1.54

1.04

4.8

2.6

7.97

8.63

ug/l

0.05

139

Bacterial meningitis

103

864

1.21

1.04

2.3

2.4

6.48

7.82

ug/l

0.34

778

Other infiltrative disorders of skin and subcutaneous tissue

107

1.65

1.04

2.4

2.3

4.15

6.90

ug/l

1.15

Other and unspecified disorders of white blood cells

128

1095

1.18

1.04

2.3

2.4

7.00

7.02

ug/l

0.01

106

974

Rheumatic fever without mention of heart involvement

1.80

1.03

2.0

2.2

3.53

7.49

ug/l

1.64

Torsion of testis

316

1.35

1.03

1.9

2.1

6.26

10.64

ug/l

1.13

283

Wide developmental disorders

358

1.32

1.03

1.7

1.9

3.54

8.02

ug/l

2.73

311

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

657

1.24

1.03

2.0

2.6

4.00

7.21

ug/l

2.52

569

Myeloproliferative diseases

304

2755

1.11

1.02

2.3

2.4

5.23

7.17

ug/l

2.26

243

2401

Motor neuron disease

441

1.29

1.01

2.8

2.2

11.47

7.53

ug/l

0.29

400

Polyarteritis nodosa

182

1.48

1.01

6.3

2.3

7.31

5.35

ug/l

0.34

163

Malignant neoplasm of brain, including Hilmo

163

1424

1.16

1.00

2.1

2.4

4.53

7.99

ug/l

4.51

145

1257

Other predominantly sexually transmitted diseases, not elsewhere classified

409

3754

1.09

1.00

1.9

2.1

10.65

6.29

ug/l

1.49

351

3320

Other and unspecified immunodeficiencies with predominantly antibody defects

241

1.40

1.00

2.3

2.2

6.23

5.80

ug/l

0.08

212

Gastrointestinal stromal tumor and sarcoma

356

1.33

0.99

2.1

2.6

3.87

6.75

ug/l

1.92

311

Helminthiases

399

1.30

0.98

2.1

2.3

9.32

7.36

ug/l

0.25

351

Malignant neoplasm of lip

243

1.40

0.98

2.5

2.7

4.29

6.40

ug/l

1.28

206

Malignant neoplasm of mesothelium and soft tissue

146

1270

1.17

0.98

2.6

2.5

7.66

7.94

ug/l

0.05

133

1112

Other specified and unspecified strabismus

242

1.39

0.98

2.0

2.3

14.06

7.36

ug/l

0.43

217

Laparoscopic right hemicolectomy

218

1948

1.13

0.97

2.1

2.5

4.61

7.11

ug/l

1.92

186

1706

Nystagmus and other irregular eye movements

294

1.35

0.97

2.3

2.1

5.66

8.42

ug/l

0.62

262

Other bursitis of knee

347

1.32

0.97

2.1

2.3

17.10

9.46

ug/l

0.70

306

Generalized epilepsy, mode (most common among epilepsy diagnosis)

587

1.24

0.97

1.8

2.3

3.59

8.24

ug/l

4.89

522

LSIL lesion of the cervix uteri, vagina or vulva

266

2397

1.11

0.97

2.0

4.87

5.30

ug/l

0.25

235

2094

Panhypopituitarism

463

1.28

0.96

3.4

2.5

4.00

7.11

ug/l

2.25

417

Graves disease, strict definition

252

2268

1.12

0.96

2.1

2.2

5.58

6.29

ug/l

0.38

214

1996

Leiomyosarcoma

210

1.43

0.96

1.6

2.7

13.33

8.29

ug/l

0.21

180

Malignant cancer of tonsil and base of tongue

642

0.78

0.95

2.5

8.07

8.33

ug/l

0.04

575

Malignant neoplasm of anus and anal canal, including Hilmo

367

1.31

0.94

1.7

2.5

5.14

6.86

ug/l

0.59

312

Inhalation and ingestion of food causing obstruction of respiratory tract

253

1.38

0.94

2.3

2.5

5.21

7.49

ug/l

0.52

223

Myasthenia gravis

465

1.27

0.94

3.4

2.5

3.91

6.45

ug/l

1.49

419

Loose body in joint

636

1.23

0.94

2.4

5.69

8.88

ug/l

1.53

572

Use of antiglaucoma preparations and miotics

324

2962

1.10

0.94

2.3

2.5

7.91

6.68

ug/l

0.30

259

2472

Anisometropia and aniseikonia

742

0.80

0.94

2.2

2.4

6.86

6.94

ug/l

0.02

658

Other bursitis of elbow

228

1.40

0.93

2.6

2.5

36.62

10.13

ug/l

0.49

198

Ankylosing spondylitis, strict definition

110

939

1.18

0.93

3.2

2.2

7.34

8.00

ug/l

0.11

852

Carcinoma in situ, bladder

134

1166

1.17

0.92

2.8

2.5

6.46

7.33

ug/l

0.26

118

1036

Hepatocellular carcinoma

721

1.22

0.92

2.3

2.6

7.02

7.30

ug/l

0.04

626

Malignant neoplasm of colon, including Hilmo

807

7625

1.06

0.92

2.3

2.5

5.31

7.59

ug/l

3.72

674

6531

Malignant neoplasm of penis, including Hilmo

204

0.62

0.91

2.0

2.8

10.03

9.55

ug/l

—

177

Disorders of other and unspecified cranial nerves

136

1.52

0.91

3.8

2.6

4.04

7.75

ug/l

0.91

119

Malignant neoplasm of colon

626

5881

1.07

0.90

2.3

2.5

4.90

7.24

ug/l

3.55

525

5011

Use of interferon beta-1a

347

0.71

0.90

1.5

2.1

4.81

7.23

ug/l

0.50

322

Respiratory tuberculosis, not confirmed

150

1317

1.15

0.90

2.7

2.5

4.25

6.23

ug/l

2.39

125

1113

Drug-induced polyneuropathy

221

1.40

0.89

2.0

2.6

11.03

8.00

ug/l

0.22

196

Benign neoplasm: Pancreas

816

1.20

0.89

2.5

5.12

6.47

ug/l

0.64

712

Other ulcerative colitis

154

1354

1.15

0.89

2.6

2.2

5.22

7.65

ug/l

1.31

143

1226

Melanoma in situ of lip

0.00

0.88

0.0

1.9

—

3.60

—

Hereditary ataxia

335

1.31

0.88

2.7

2.4

3.79

7.62

ug/l

2.41

293

Etanercept

159

1402

1.14

0.87

2.2

2.3

6.58

7.32

ug/l

0.23

140

1260

Melanoma in situ of other and unspecified parts of face

410

0.74

0.87

2.0

2.5

7.63

7.38

ug/l

0.02

354

Other disorders of binocular movement

397

1.27

0.87

2.5

2.1

4.07

6.65

ug/l

1.69

352

Rubella [German measles]

107

920

1.18

0.86

2.2

2.3

8.78

11.82

ug/l

0.80

849

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

267

1.35

0.85

2.0

2.5

2.76

6.53

ug/l

2.84

236

Congenital deformities of hip

239

1.35

0.85

2.2

2.3

15.84

5.42

ug/l

0.62

212

Non-small cell lung cancer, including Hilmo

581

5822

0.93

0.85

2.3

2.5

5.09

7.53

ug/l

4.63

513

5003

Benign neoplasm: Pituitary gland, craniopharyngeal duct

151

1332

1.14

0.84

2.2

2.4

6.54

6.96

ug/l

0.11

126

1188

Crossbite

134

1081

1.15

0.84

2.2

2.1

13.21

7.45

ug/l

0.69

114

960

Mucosal proctocolitis

341

3139

1.09

0.84

2.6

2.2

7.83

8.31

ug/l

0.14

302

2834

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.83

0.0

2.3

—

4.22

—

Hereditary corneal dystrophies

113

980

1.17

0.83

2.0

2.5

8.77

7.46

ug/l

0.17

861

Psoriasis (vulgaris), strict definition

821

1.18

0.82

2.3

5.25

7.68

ug/l

1.57

742

Contact with other sharp object(s)

126

1441

0.87

0.82

2.4

2.3

5.42

8.13

ug/l

1.66

111

1304

Pyogenic granuloma

383

1.27

0.82

2.3

2.2

4.63

8.57

ug/l

1.34

332

Allergic contact dermatitis due to drugs in contact with skin

528

1.23

0.82

1.9

2.4

5.20

6.30

ug/l

0.33

461

Malignant neoplasm, without specification of site

123

1075

1.16

0.81

2.0

2.6

4.02

6.76

ug/l

3.44

104

913

Disorders of tooth development and eruption

413

3103

1.08

0.81

1.9

2.1

7.06

8.15

ug/l

0.45

360

2707

Hirsutism, drug-induced

0.00

0.81

0.0

3.3

—

4.63

—

Other protozoal intestinal diseases

295

1.31

0.81

2.9

2.1

4.64

7.77

ug/l

0.88

265

Anomalies of pupillary function

438

1.25

0.80

2.6

2.2

5.42

7.42

ug/l

0.73

393

Injury of blood vessels at lower leg level

132

1.49

0.80

2.9

2.1

11.64

5.76

ug/l

0.38

113

Foreign body entering into or through eye or natural orifice

235

2136

1.11

0.79

2.4

2.3

8.20

8.31

ug/l

0.02

200

1927

Benign neoplasm: Other and unspecified parts of small intestine

468

1.24

0.78

1.6

2.4

4.46

6.82

ug/l

1.25

408

Erosion of teeth , including avohilmo

654

6181

1.06

0.78

2.2

7.33

7.55

ug/l

0.10

553

5478

Melanocytic naevi of scalp and neck

549

1.22

0.78

2.7

2.5

9.55

6.96

ug/l

0.29

495

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

216

1958

1.11

0.78

2.4

2.3

9.42

7.68

ug/l

0.38

196

1752

Neurofibromatosis, type 1

107

1.53

0.78

1.9

2.7

8.69

5.63

ug/l

0.28

Shigellosis

132

1.47

0.78

3.0

2.2

10.09

7.77

ug/l

0.18

115

Exfoliative dermatitis

289

1.31

0.77

2.2

2.7

9.18

8.21

ug/l

0.12

263

Alopecia areata

504

1.22

0.77

2.4

2.2

7.38

7.64

ug/l

0.05

450

Postpartum haemorrhage

361

3279

0.92

0.77

1.8

1.9

7.34

5.51

ug/l

0.36

325

2868

Mild mental retardation

477

1.23

0.77

2.1

2.4

6.35

8.01

ug/l

0.27

420

Nutritional marasmus

1.94

0.76

1.0

2.3

2.49

4.22

ug/l

—

Alzheimer’s disease (undefined), excluding more controls

235

0.69

0.76

2.1

2.4

15.03

5.01

ug/l

—

191

Benign neoplasm: Conjunctiva

100

866

1.17

0.76

2.3

2.4

6.17

7.38

ug/l

0.45

762

Other menopausal disorders

745

3979

1.06

0.75

2.0

2.2

4.76

6.67

ug/l

2.40

656

3473

Benign neoplasm of breast

287

3116

0.92

0.75

2.0

2.3

6.48

5.54

ug/l

0.47

234

2627

Autism

271

1.30

0.75

1.9

1.8

3.62

7.82

ug/l

1.91

234

Osteomyelitis of vertebra

1.65

0.75

3.0

2.6

6.31

10.41

ug/l

0.51

Colon adenocarcinoma

489

4595

1.07

0.75

2.4

2.5

4.85

7.09

ug/l

2.66

415

3920

Benign neoplasm: Long bones of lower limb

718

1.18

0.74

2.0

2.2

5.77

7.64

ug/l

0.69

645

Other specified and unspecified disorders of lens

238

1.33

0.74

2.2

2.3

18.23

7.47

ug/l

0.45

195

Epiphora

581

1.20

0.74

2.7

2.4

7.18

7.81

ug/l

0.09

507

Colorectal cancer

996

9329

1.05

0.74

2.2

2.5

5.47

7.71

ug/l

3.96

839

8015

Myeloproliferative diseases (CML excluded)

271

2493

1.10

0.74

2.3

2.4

5.13

7.11

ug/l

2.14

211

2175

Congenital deformities of hip

272

1.30

0.73

2.1

2.3

14.80

6.50

ug/l

0.51

240

Maxillary retrognathism

246

1.31

0.73

1.5

2.3

3.00

8.99

ug/l

3.38

220

Mandibular retrognathia

102

1168

0.87

0.73

1.9

2.0

4.92

6.93

ug/l

1.37

1044

Vertigo of central origin

427

1.24

0.72

1.8

2.4

4.50

5.36

ug/l

0.33

375

Malignant neoplasm of tongue, including Hilmo

834

1.17

0.72

2.2

2.5

6.35

7.78

ug/l

0.50

741

Other infestations

464

0.78

0.71

1.7

2.4

8.28

7.16

ug/l

0.17

407

Malignant neoplasm of larynx, including Hilmo

658

1.19

0.71

2.5

2.6

7.30

7.67

ug/l

0.05

569

Personal history of allergy to drugs, medicaments and biological substances

195

1.35

0.71

2.0

2.2

4.87

7.22

ug/l

0.57

175

Gonococcal infection

722

1.17

0.71

2.2

5.91

7.84

ug/l

0.99

655

Other endocrine disorders

934

0.86

0.70

2.0

2.3

5.34

7.12

ug/l

0.93

823

Ulcerative colitis (strict definition, all Crohn cases excluded)

399

3730

1.07

0.70

2.4

2.2

6.36

7.89

ug/l

0.99

360

3336

Polycystic ovarian syndrome

545

1.20

0.70

2.3

1.9

5.33

4.10

ug/l

0.28

466

Benign leiomyoma with endometriosis

419

4467

0.93

0.69

1.9

2.3

6.88

5.67

ug/l

0.43

332

3798

Autism spe

266

1.29

0.69

1.9

3.43

7.89

ug/l

2.03

237

Postpartum care and examination

150

1063

0.89

0.69

1.8

1.7

4.75

6.10

ug/l

0.28

130

915

Otosclerosis

204

2235

0.91

0.68

2.4

2.3

8.32

7.26

ug/l

0.24

172

1979

Undescended testis, unilateral

119

1.45

0.68

3.6

2.3

12.03

8.30

ug/l

0.23

104

Syndrome of inappropriate secretion of antidiuretic hormone

163

1.39

0.68

3.0

2.6

4.80

5.17

ug/l

0.11

146

Pedal cyclist injured in noncollision transport accidents

274

2964

0.92

0.68

2.1

2.3

9.43

7.69

ug/l

0.34

237

2647

Benign neoplasm: Vagina

295

1.28

0.67

2.1

2.3

3.65

4.86

ug/l

0.56

259

Malignant neoplasm of other and unspecified parts of tongue

450

1.22

0.67

2.2

2.6

5.32

7.47

ug/l

0.77

389

Bitten or struck by other mammals

274

2531

1.09

0.67

2.2

6.24

6.64

ug/l

0.18

242

2243

Obstructed labour due to maternal pelvic abnormality

359

3351

1.08

0.67

2.2

2.1

7.19

6.34

ug/l

0.28

313

2917

Chronic suppurative otitis media, including avohilmo

233

2139

1.10

0.67

2.3

2.4

6.40

7.24

ug/l

0.29

201

1882

Ovarian dysfunction, other/unspecified

1.57

0.67

1.5

1.9

2.83

4.00

ug/l

0.49

Other abnormal products of conception

548

3425

1.06

0.67

1.7

1.9

3.93

5.39

ug/l

1.51

477

3042

Diseases caused by chlamydiae

154

1.38

0.66

2.2

2.3

2.69

4.79

ug/l

1.09

136

Malignant melanoma of skin, including Hilmo

565

5359

1.06

0.66

2.2

2.4

7.34

7.76

ug/l

0.18

486

4655

Gonococcal infection

765

1.16

0.65

2.2

6.03

7.76

ug/l

0.87

694

Deep bite

254

2053

1.09

0.65

2.1

2.2

5.12

7.23

ug/l

2.23

215

1825

Iridocyclitis in diseases classified elsewhere

488

1.20

0.65

1.9

2.4

4.30

7.52

ug/l

1.84

439

Burn and corrosion of ankle and foot

342

1.25

0.65

3.2

2.5

5.09

8.75

ug/l

1.15

309

Maternal care related to the fetus and amniotic cavity and possible delivery problems

846

5190

0.95

0.64

1.9

2.0

4.01

6.15

ug/l

3.99

755

4547

Complications of the puerperium, not elsewhere classified

496

1.20

0.64

1.7

1.9

3.52

4.89

ug/l

0.75

447

Colour vision deficiencies

1.56

0.64

2.5

1.7

3.19

7.50

ug/l

1.78

Cerebral atherosclerosis

387

1.23

0.64

2.1

2.6

4.96

6.08

ug/l

0.39

332

Benign neoplasm: Carotid body

1.65

0.64

2.2

2.1

5.03

5.55

ug/l

—

HSIL lesion of the vagina

279

1.27

0.64

2.6

2.3

2.38

4.98

ug/l

2.83

250

Congenital ichthyosis

1.64

0.64

2.6

2.1

18.81

4.58

ug/l

—

Congenital retinoschisis

1.67

0.64

2.5

5.05

7.71

ug/l

—

Disorders of male genital organs in diseases classified elsewhere

156

1.38

0.63

2.1

2.3

10.70

11.54

ug/l

0.06

144

Disease of thymus, other/unspecified

1.72

0.63

1.4

2.0

3.10

6.49

ug/l

—

Other spirochaetal diseases

953

9911

0.96

0.62

2.0

2.3

8.19

7.26

ug/l

0.50

795

8707

Crushed, pushed or stepped on by crowd or human stampede

159

1439

1.11

0.62

2.0

2.2

7.75

7.98

ug/l

0.05

139

1293

Other predominantly sexually transmitted diseases, not elsewhere classified

341

3188

1.07

0.62

1.9

2.1

11.55

6.27

ug/l

1.56

291

2810

Crowding of teeth, including avohilmo

136

1007

1.12

0.62

1.9

2.2

7.30

7.19

ug/l

0.01

123

875

Frostbite with tissue necrosis

1.58

0.61

1.5

2.2

6.68

12.54

ug/l

0.55

Other and unspecified glaucoma

272

2528

1.08

0.61

2.4

2.5

5.85

6.88

ug/l

0.74

217

2138

Antenatal screening

368

1932

1.07

0.61

1.7

1.8

4.77

6.30

ug/l

0.85

335

1695

Autoimmune hepatitis

192

1.33

0.61

2.0

2.2

5.91

4.98

ug/l

0.15

166

Malignant neoplasm of head and neck

305

2846

1.08

0.61

2.3

2.4

5.94

8.06

ug/l

2.00

265

2489

Cerebral amyloid angiopathy

158

1.38

0.61

1.8

2.4

7.34

6.16

ug/l

0.20

137

Uterine polyps

231

2131

1.09

0.61

2.2

6.59

6.83

ug/l

0.05

192

1853

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

128

1148

1.12

0.61

2.3

4.90

7.44

ug/l

1.62

120

1026

Kissing spine

1.57

0.61

3.8

2.6

4.79

5.96

ug/l

—

Lyme disease

945

9820

0.96

0.60

2.0

2.3

8.02

7.29

ug/l

0.37

788

8631

Benign neoplasm: Bladder

273

1.27

0.60

2.5

5.45

8.56

ug/l

0.83

239

Guttate psoriasis

318

1.24

0.60

2.5

2.3

7.18

7.74

ug/l

0.11

286

Allergic contact dermatitis

342

3204

1.07

0.60

2.2

2.1

6.22

6.56

ug/l

0.16

288

2811

Other articular cartilage disorders

641

1.17

0.60

2.2

2.4

6.58

8.10

ug/l

0.27

568

Fasciculation

255

1.28

0.60

1.9

2.3

4.80

6.65

ug/l

0.60

227

Tooth eruption problems

231

2078

1.09

0.60

2.0

2.1

8.01

6.61

ug/l

0.38

211

1804

Congenital malformations of breast

197

0.71

0.59

1.6

2.2

13.46

5.10

ug/l

0.35

170

Accidental poisoning by and exposure to pesticides

1.53

0.59

1.9

2.3

1.83

5.41

ug/l

—

Other degenerative disorders of eyelid and periocular area

1.57

0.59

5.4

2.6

3.30

5.88

ug/l

1.20

Endometriosis diagnosis and infertility diagnosis occurring together

179

1635

1.10

0.59

1.8

2.0

3.85

4.87

ug/l

0.58

151

1442

Recurrent cholesteatoma of postmastoidectomy cavity

0.55

0.59

2.2

2.7

15.20

5.64

ug/l

—

Presbycusis

548

5701

0.95

0.59

2.2

2.4

5.20

6.44

ug/l

2.06

427

4729

Non-small cell lung cancer, adenocarcinoma, helper endpoint

199

2161

0.91

0.59

2.1

2.5

4.45

7.55

ug/l

4.28

173

1864

Failure in dosage during surgical and medical care

1.71

0.58

4.3

2.5

3.25

4.83

ug/l

—

Degeneration of the brain due to alcohol

663

1.16

0.57

3.0

2.5

5.85

8.24

ug/l

1.22

589

Postpolio syndrome

1.60

0.57

3.4

2.4

3.23

4.83

ug/l

—

Carcinoma in situ of other and unspecified sites

140

1270

1.11

0.57

2.9

2.5

6.30

7.12

ug/l

0.26

124

1129

Erosion and ectropion of cervix uteri

625

1.16

0.57

1.8

2.3

5.05

6.68

ug/l

0.85

542

Chronic suppurative otitis media

197

1813

1.09

0.57

2.2

2.4

6.93

ug/l

0.00

168

1601

Benign neoplasm: Connective and other soft tissue of abdomen

1.58

0.57

3.6

2.1

5.07

5.00

ug/l

—

Other corneal oedema

249

1.27

0.56

3.5

2.4

3.81

6.85

ug/l

1.39

222

Radiodermatitis

1.56

0.56

2.9

2.3

11.27

5.48

ug/l

—

Polycythaemia vera

126

1137

1.12

0.56

2.1

2.5

4.51

7.73

ug/l

3.06

995

Carcinoma in situ of skin of lower limb, including hip

712

1.15

0.56

2.2

2.6

10.51

6.44

ug/l

0.91

609

Burn and corrosion of wrist and hand

804

1.14

0.56

2.1

2.3

4.86

8.36

ug/l

1.86

727

Degeneration of nervous system due to alcohol

665

1.16

0.56

3.0

2.5

5.85

8.27

ug/l

1.25

594

Generalized epilepsy, strict definition

394

1.20

0.56

2.0

2.2

12.21

7.92

ug/l

0.20

354

Familial benign pemphigus (Hailey-Hailey disease)

1.51

0.55

1.3

2.8

9.09

4.85

ug/l

—

Traumatic amputation of shoulder and upper arm

1.62

0.55

6.5

2.3

2.70

4.92

ug/l

—

Clear cell adenocarcinoma of kidney

167

1532

1.10

0.54

2.2

2.4

5.99

7.87

ug/l

0.61

150

1355

Benign neoplasm: Skin of lower limb, including hip

694

1.15

0.54

2.5

2.4

7.43

7.26

ug/l

0.03

612

Generalized pustular psoriasis

0.60

0.54

5.0

2.7

5.25

6.36

ug/l

—

Benign neoplasm: Short bones of upper limb

341

1.22

0.54

1.8

2.3

3.43

7.92

ug/l

3.01

310

Myotonic dystrophy (Steinert)

1.46

0.54

1.2

2.3

4.79

5.31

ug/l

—

Congenital retinoschisis

1.45

0.53

2.3

2.6

4.71

8.46

ug/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

348

3685

0.94

0.53

2.0

2.4

6.22

7.61

ug/l

0.74

297

3225

Spirochaetal infections, other/unspecified

955

9888

0.96

0.53

2.0

2.3

8.00

7.28

ug/l

0.36

797

8688

Convergent concomitant strabismus

122

1102

1.11

0.53

2.2

7.16

7.41

ug/l

0.05

106

989

Alzheimer’s disease (Early onset)

170

1563

1.10

0.52

2.6

2.5

6.77

6.35

ug/l

0.08

113

1272

Migraine, unspecified, drug-induced

135

1.36

0.52

3.2

2.0

8.02

4.23

ug/l

0.51

119

Other abnormal findings in urine

463

1.18

0.52

2.1

2.6

4.17

7.06

ug/l

1.70

402

Other protozoal intestinal diseases

425

1.19

0.52

2.7

2.0

4.37

7.75

ug/l

1.36

380

Adenocarcinoma and Papillary adenocarcinoma of kidney

362

1.21

0.52

2.6

2.7

5.72

8.33

ug/l

1.01

320

Malignant neoplasm of small intestine

689

1.15

0.51

2.3

2.4

3.85

7.42

ug/l

4.47

601

Family history of malignant neoplasm

229

2135

1.08

0.49

1.6

2.0

4.45

5.08

ug/l

0.38

191

1862

Malignant neoplasm of gallbladder

154

0.70

0.49

2.7

2.4

1.61

7.07

ug/l

2.39

136

Pedal cyclist injured in other and unspecified transport accidents

320

3019

1.06

0.49

2.2

2.3

11.69

7.47

ug/l

0.70

266

2680

Benign neoplasm: Nasopharynx

245

1.25

0.49

2.4

6.79

7.92

ug/l

0.18

210

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

922

0.89

0.48

1.6

1.8

11.11

4.58

ug/l

0.86

813

Malignant cancer of tonsil and base of tongue, including Hilmo

771

0.87

0.48

2.5

8.64

8.94

ug/l

0.05

689

Other and unspecified disorders of lacrimal system

1.51

0.48

2.6

2.9

8.86

3.47

ug/l

—

Other and unspecified disease of Bartholin gland

654

1.14

0.48

1.9

2.3

4.73

6.41

ug/l

0.76

569

Benign neoplasm of other and unspecified female genital organs

116

1053

1.11

0.48

2.4

2.3

4.82

5.46

ug/l

0.31

905

Malignant neoplasm of stomach, including Hilmo

226

2112

1.08

0.48

2.6

2.4

5.54

7.68

ug/l

1.65

179

1808

Malignant neoplasm of renal pelvis, including Hilmo

384

1.19

0.48

2.8

3.37

7.71

ug/l

4.14

330

Congenital ovarian cysts

613

0.86

0.48

1.6

2.0

3.36

5.22

ug/l

1.13

547

Other endophthalmitis

156

1.31

0.47

1.6

2.5

6.34

5.52

ug/l

0.15

135

Benign neoplasm: Spinal meninges

292

1.22

0.47

3.0

2.6

3.69

4.95

ug/l

0.75

260

Foreign body in ear

393

1.18

0.47

3.0

2.3

4.38

7.75

ug/l

1.83

356

Neuroendocrine tumor and carcinoma of pancreas

165

1.30

0.47

2.2

2.4

6.04

8.05

ug/l

0.30

144

Suppurative otitis media, unspecified

533

1.15

0.46

1.9

2.4

10.43

6.30

ug/l

0.63

470

Haemophilus septicemia

1.44

0.46

2.1

2.8

4.54

5.78

ug/l

—

Benign neoplasm: Choroid

173

1865

0.92

0.46

2.5

2.4

6.49

6.71

ug/l

0.07

140

1653

Non-small cell lung cancer, adenocarcinoma

199

2133

0.93

0.46

2.1

2.4

4.45

7.47

ug/l

4.38

173

1839

Pedestrian injured in other and unspecified transport accidents

274

1.22

0.46

2.9

2.3

2.44

6.88

ug/l

2.71

249

Obstructed labour due to malposition and malpresentation of fetus

354

3129

1.06

0.46

1.9

5.01

5.48

ug/l

0.18

309

2751

Malignant melanoma of skin

413

3938

1.05

0.46

2.4

2.5

7.77

7.55

ug/l

0.07

354

3425

Diseases caused by chlamydiae

192

1.26

0.45

2.1

2.2

2.62

4.72

ug/l

1.43

171

Chronic iridocyclitis

134

1230

1.10

0.45

2.5

2.4

4.36

7.63

ug/l

4.22

112

1087

Peripheral retinal degeneration

791

1.12

0.45

2.5

2.4

6.30

7.51

ug/l

0.29

692

Essential (haemorrhagic) thrombocythaemia

129

1184

1.10

0.44

2.6

2.5

4.96

7.50

ug/l

1.73

113

1035

Other and unspecified degenerative diseases of nervous system

869

1.12

0.44

2.4

2.6

7.03

6.01

ug/l

0.29

751

Malignant neoplasm of liver and intrahepatic bile ducts

105

955

1.11

0.44

2.3

2.5

6.75

7.44

ug/l

0.15

822

Disorders of adrenal gland, other and/or unspecified

113

1.36

0.44

2.0

2.3

11.03

4.96

ug/l

0.51

101

Corneal degeneration

415

1.17

0.44

1.5

2.2

9.25

7.17

ug/l

0.23

362

Undefined dementia

523

4626

1.05

0.44

2.7

2.5

5.88

5.86

ug/l

0.01

384

3679

Retinal breaks without detachment

499

5203

0.96

0.44

2.2

2.3

7.17

7.61

ug/l

0.20

433

4575

Lesion of medial popliteal nerve

1.41

0.44

4.8

2.6

6.05

7.93

ug/l

0.19

Other spirochaetal diseases

973

10024

0.97

0.44

2.0

2.3

8.17

7.33

ug/l

0.45

812

8807

Congenital malformations of ovaries, fallopian tubes and broad ligaments

840

0.89

0.43

1.6

2.0

3.06

5.47

ug/l

2.37

741

Phantom limb syndrome with pain

1.44

0.43

1.4

2.6

2.97

7.00

ug/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

510

1.15

0.43

2.2

2.4

5.21

6.90

ug/l

0.68

440

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

1.41

0.43

3.9

3.3

5.01

8.31

ug/l

—

Rapidly progressive nephritic syndrome

1.39

0.42

2.0

2.2

3.58

5.97

ug/l

—

Follicular lymphoma, hilmo

140

1294

1.09

0.42

2.2

2.5

5.37

7.16

ug/l

0.37

123

1134

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1104

8576

0.97

0.42

1.8

2.1

5.47

5.85

ug/l

0.19

961

7410

UC patients in KELA-register (code 208), prior to 1994

137

1265

1.09

0.42

2.9

2.3

7.59

7.27

ug/l

0.08

127

1139

Maternal care for known or suspected malpresentation of fetus

216

1669

0.94

0.41

1.6

2.0

3.68

5.45

ug/l

1.09

187

1443

Benign neoplasm: Cranial nerves

814

0.89

0.41

2.7

2.4

6.07

7.29

ug/l

0.57

723

Other specified and unspecified disorders of iris and ciliary body

1.40

0.41

2.9

2.4

6.05

5.56

ug/l

0.06

Adenocarcinoma and papilloma adenocarcinoma of rectum

335

3516

0.95

0.41

1.9

2.4

6.39

7.59

ug/l

0.57

285

3075

Congenital malformations of breast

183

0.76

0.41

1.6

2.2

13.46

5.25

ug/l

0.34

159

Postpartum haemorrhage due to retained placenta

158

1699

0.93

0.40

1.8

8.95

4.77

ug/l

0.39

141

1504

Carcinoma in situ of cervix uteri

154

1430

1.08

0.40

1.9

2.0

9.98

4.86

ug/l

0.52

139

1237

Acrodermatitis continua

1.46

0.40

1.8

2.6

2.22

6.20

ug/l

—

Sequelae of tuberculosis

589

1.13

0.40

3.0

2.6

4.42

5.87

ug/l

0.53

484

Other complications of labour and delivery, not elsewhere classified

109

1091

0.92

0.39

1.6

2.0

3.09

4.83

ug/l

0.96

939

Benign neoplasm: Vertebral column

1.36

0.39

2.4

2.3

3.17

4.88

ug/l

—

Hypospadias

1.37

0.39

4.3

2.1

5.84

5.36

ug/l

—

Pseudopolyposis of colon

1.35

0.39

4.8

2.1

16.53

5.53

ug/l

—

Malignant neoplasm of rectum

340

3559

0.95

0.38

1.9

2.4

5.66

7.56

ug/l

1.79

291

3116

Vertical strabismus

819

1.11

0.38

2.0

2.4

10.40

7.12

ug/l

0.34

728

Malignant neoplasm of eye and adnexa

253

1.21

0.38

1.8

2.4

5.29

6.87

ug/l

0.34

219

Malignant neoplasm of small intestine, including Hilmo

103

945

1.10

0.38

2.3

2.5

5.06

8.12

ug/l

2.10

834

Postpartum hemorraghe, all women as controls

361

3717

0.95

0.38

1.8

1.9

7.34

5.19

ug/l

0.45

325

3262

Optic neuritis

830

1.10

0.37

2.1

2.2

6.25

7.43

ug/l

0.33

741

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

217

1.22

0.37

2.0

2.7

7.34

8.19

ug/l

0.10

188

Sunburn

1.50

0.37

1.3

1.9

1.73

6.44

ug/l

—

Malignant neoplasm of pyriform sinus, including Hilmo

1.45

0.36

1.5

2.7

6.68

12.17

ug/l

—

Congenital malformations of nose

1.46

0.36

1.8

3.1

9.68

5.55

ug/l

—

Other diseases of blood and blood-forming organs

218

2061

1.06

0.36

2.5

2.4

7.81

7.41

ug/l

0.09

181

1831

Bullous keratopathy

264

1.19

0.36

2.0

2.6

5.48

6.38

ug/l

0.20

234

Contraceptive management

1048

7538

0.97

0.36

2.0

2.1

7.78

8.37

ug/l

0.28

946

6788

Other specified/unspecified diseases of inner ear

134

0.73

0.36

4.1

2.1

3.48

5.37

ug/l

—

118

Malignant neoplasm of other connective and soft tissue

737

1.11

0.36

2.3

2.5

6.15

7.22

ug/l

0.32

641

Caught, crushed, jammed or pinched in or between objects

128

1188

1.08

0.36

2.1

2.4

5.52

7.40

ug/l

1.38

111

1071

Other specified/unspecified hearing loss

283

2697

1.05

0.35

2.2

2.3

7.18

7.47

ug/l

0.06

251

2330

Use of cabergoline

287

0.83

0.35

1.9

2.4

13.08

8.12

ug/l

0.29

261

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

265

1.19

0.35

2.5

2.8

7.14

8.01

ug/l

0.08

232

Chronic myeloproliferative disease

446

0.86

0.35

2.4

2.5

6.35

6.91

ug/l

0.12

393

Other congenital malformations of urinary system

1.36

0.35

1.6

2.3

4.65

5.76

ug/l

0.20

Contact with nonpowered hand tool

125

1162

1.08

0.35

2.1

2.3

9.74

8.59

ug/l

0.28

111

1063

Hereditary lymphedema

1.36

0.34

1.8

2.1

13.07

3.72

ug/l

—

Macular cyst

893

1.10

0.34

2.5

2.6

6.19

6.58

ug/l

0.11

778

Mandibular prognathia

265

1.18

0.34

1.7

2.1

6.08

8.86

ug/l

0.37

237

Other nutritional anaemias

284

1.18

0.34

2.5

4.14

5.31

ug/l

0.43

244

Other diseases of appendix

303

1.17

0.34

2.2

2.4

10.83

7.03

ug/l

0.51

269

Myopia

274

2612

1.05

0.34

2.0

2.2

8.77

7.13

ug/l

0.54

241

2319

Infections of breast associated with childbirth

453

1.13

0.34

2.0

9.47

5.06

ug/l

0.34

409

Diseases of thymus

1.32

0.33

1.3

2.6

3.12

5.28

ug/l

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

132

0.74

0.33

1.9

2.6

3.88

7.63

ug/l

—

120

Benign neoplasm: Skin, unspecified

115

1068

1.08

0.33

2.1

2.3

6.66

7.20

ug/l

0.14

949

Ulcerative colitis (strict) with PSC

143

0.76

0.33

1.4

2.2

1.81

8.26

ug/l

2.55

133

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

418

1.14

0.32

2.4

2.6

4.47

6.07

ug/l

0.41

356

Malignant neoplasm of breast, including Hilmo

1281

8468

0.98

0.32

2.1

2.2

4.49

6.01

ug/l

3.98

1044

7228

Pleural plaque without asbestos

142

1333

1.07

0.32

2.7

2.6

6.52

6.59

ug/l

0.02

120

1155

Malignant neoplasm of breast, HER2-negative, including Hilmo

1281

8468

0.98

0.32

2.1

2.2

4.49

6.01

ug/l

3.98

1044

7228

Pedal cyclist injured in transport accident

622

6406

0.97

0.32

2.1

2.3

9.28

7.54

ug/l

0.49

523

5622

L02BX Other hormone antagonists and related agents

196

2065

0.94

0.32

2.7

2.4

5.09

8.29

ug/l

4.45

173

1823

Congenital malformation of biliary tract

1.35

0.31

1.7

2.5

8.60

5.42

ug/l

—

Hypogonadotropic hypogonadism

686

1.10

0.31

1.9

2.2

4.63

10.09

ug/l

3.61

627

Villonodular synovitis (pigmented)

175

1.21

0.31

2.6

3.20

8.61

ug/l

2.27

155

Malignant neoplasm of rectum, including Hilmo

457

4723

0.96

0.31

2.0

2.5

6.69

7.53

ug/l

0.41

389

4104

Failed induction of labour

600

0.90

0.30

1.5

2.3

3.88

4.62

ug/l

0.22

515

Use of rasagiline

813

1.09

0.30

2.6

6.67

7.16

ug/l

0.15

723

Malignant neoplasm of uterus, part unspecified, including Hilmo

148

1.24

0.30

1.8

2.4

2.77

3.66

ug/l

0.64

128

Malignant neoplasm of rectosigmoid junction, including Hilmo

103

958

1.08

0.30

2.0

2.5

9.37

7.41

ug/l

0.28

834

Malignant melanoma, including Hilmo

672

6541

1.03

0.30

2.2

2.4

7.41

7.70

ug/l

0.14

573

5660

Pedestrian injured in collision with pedal cycle

803

1.09

0.30

3.0

2.4

8.85

7.53

ug/l

0.20

717

Calcific tendinitis

222

1.18

0.30

2.4

2.2

11.36

7.81

ug/l

0.32

201

Certain zoonotic bacterial diseases

755

1.09

0.30

2.6

2.5

8.24

7.05

ug/l

0.24

669

Carcinoma in situ of larynx

1.31

0.29

1.6

2.6

4.29

5.88

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

128

1364

0.94

0.29

2.1

2.0

11.98

4.84

ug/l

1.23

112

1208

Non-small cell lung cancer, squamous, helper endpoint

158

1670

0.94

0.29

2.2

2.5

5.95

6.69

ug/l

0.21

140

1418

Malignant neoplasm of palate

1.32

0.29

1.6

2.5

2.64

12.29

ug/l

—

Unspecified renal colic

149

1.23

0.29

2.0

2.5

14.69

7.62

ug/l

0.33

136

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

787

1.09

0.28

2.2

2.4

4.08

6.06

ug/l

1.09

678

Premenstrual syndrome

112

1.26

0.28

2.0

1.9

2.56

6.33

ug/l

—

Benign neoplasm: Testis

118

0.75

0.28

2.1

2.3

6.90

8.94

ug/l

—

104

Papillary adenocarcinoma of thyroid gland

136

1281

1.07

0.28

2.0

2.3

8.76

7.13

ug/l

0.24

116

1136

Labour and delivery complicated by fetal stress [distress]

289

1971

0.96

0.27

1.6

1.9

4.97

5.50

ug/l

0.14

252

1712

Use of donepezil

930

8715

1.02

0.27

2.2

2.5

6.49

5.88

ug/l

0.35

653

7198

Intrahepatic Cholestasis of Pregnancy (ICP)

886

0.92

0.27

1.6

1.8

11.11

4.79

ug/l

0.82

776

Overexertion and strenuous or repetitive movements

278

2671

1.04

0.27

2.3

11.54

8.12

ug/l

0.51

237

2390

Benign neoplasm: Thymus

1.30

0.27

1.2

2.8

28.59

8.19

ug/l

—

Qualitative platelet defects

1.30

0.27

3.6

2.7

6.36

4.98

ug/l

0.12

Hydrocephalus in other diseases

141

1.22

0.27

1.5

2.2

7.72

5.07

ug/l

0.22

121

Cervical root disorders

169

1.20

0.26

1.9

2.7

3.84

7.38

ug/l

1.23

151

Mumps

634

0.91

0.26

2.4

2.2

5.93

6.98

ug/l

0.31

571

Benign neoplasm: Tongue

771

1.08

0.26

2.3

2.5

8.59

7.15

ug/l

0.24

678

Unspecified multiple injuries

1.27

0.26

1.7

2.2

7.99

4.31

ug/l

—

Benign neoplasm of thyroid gland

858

1.08

0.26

2.3

2.4

4.82

7.20

ug/l

0.84

748

Viral conjunctivitis

761

1.08

0.26

2.1

2.2

7.52

6.46

ug/l

0.15

675

LSIL lesion of the vagina

263

1.15

0.26

2.5

2.2

5.38

5.72

ug/l

0.06

231

Unequal limb length (acquired)

105

1.25

0.25

2.3

4.96

6.99

ug/l

0.29

Testicular dysfunction

107

1006

1.07

0.25

2.8

2.2

8.69

10.34

ug/l

0.29

917

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.31

0.25

2.1

2.5

6.49

5.17

ug/l

—

Infliximab

264

1.14

0.25

1.8

2.2

3.83

8.75

ug/l

1.69

245

Exophthalmic conditions

274

1.14

0.25

1.9

2.3

6.30

6.32

ug/l

0.01

251

Adenocarcinoma and papillary adenocarcinoma of stomach

910

0.93

0.24

2.3

2.5

4.61

7.44

ug/l

1.43

783

Colorectal adenocarcinoma

817

7983

1.02

0.24

2.2

2.5

5.48

7.78

ug/l

3.40

694

6851

Malignant neoplasm, without specification of site, including Hilmo

170

1621

1.05

0.24

2.1

2.5

3.78

7.13

ug/l

7.36

145

1375

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

294

1.13

0.24

1.9

2.7

6.02

7.76

ug/l

0.30

255

Cholangitis (primary sclerosing, PSC), with reimbursement 202

389

1.11

0.24

1.8

2.3

1.80

7.33

ug/l

7.19

352

Hereditary lymphedema

1.35

0.24

1.8

2.2

15.28

3.51

ug/l

—

Brain glioblastoma and astrocytoma

495

1.10

0.24

1.4

2.5

3.67

7.90

ug/l

3.95

439

Follicular adenocarcinoma of thyroid gland, including Hilmo

275

1.14

0.24

1.7

2.5

4.47

6.03

ug/l

0.38

241

Brain glioblastoma

409

1.11

0.23

1.4

2.5

2.43

7.95

ug/l

7.32

360

Other disorders of choroid

390

1.11

0.23

2.7

2.4

12.61

7.11

ug/l

0.42

340

Other obstetric trauma

630

1.08

0.23

1.7

1.8

4.41

5.16

ug/l

0.26

547

Pustulosis palmaris et plantaris

108

1019

1.06

0.23

2.4

2.3

3.41

6.89

ug/l

6.80

908

Disorders of acoustic nerve

732

0.92

0.23

2.6

2.4

5.61

7.95

ug/l

1.37

652

Multiple delivery

138

1452

0.95

0.23

1.9

2.0

4.73

7.11

ug/l

1.30

128

1239

Crushing injury of shoulder and upper arm

0.00

0.22

0.0

4.2

—

9.02

—

Refsum disease

0.00

0.22

0.0

3.8

—

6.62

—

Benign neoplasm of eye and adnexa

328

3180

1.03

0.22

2.4

2.3

7.59

7.00

ug/l

0.20

268

2792

Malignant neoplasm of tonsil

461

0.90

0.22

2.4

2.5

7.75

8.64

ug/l

0.12

412

Other fluke infections

0.00

0.22

0.0

2.1

—

5.15

—

Pterygium

925

0.94

0.22

3.9

2.5

8.38

6.99

ug/l

0.28

817

Crushing injuries involving multiple body regions

0.00

0.21

0.0

2.7

—

4.26

—

Benign neoplasm: Anus and anal canal

828

1.07

0.21

2.2

2.6

7.48

6.91

ug/l

0.14

723

Carrier of infectious disease

537

1.09

0.21

4.7

2.5

6.83

6.25

ug/l

0.09

477

Defect, injury or illness of skull

0.00

0.21

0.0

2.2

—

5.27

—

Malignant neoplasm of stomach

187

1797

1.04

0.21

2.4

5.39

7.73

ug/l

1.54

144

1544

Spontaneous abortion

1072

7344

0.98

0.21

2.0

2.1

4.28

5.82

ug/l

3.32

938

6368

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.21

0.0

2.1

—

4.30

—

Butylpyrazolidines

0.00

0.21

0.0

3.7

—

15.34

—

Malignant neoplasm of oropharynx

500

0.91

0.20

2.3

2.6

7.27

8.77

ug/l

0.26

449

Bacterial sepsis of newborn

1.26

0.20

4.2

2.8

17.08

7.91

ug/l

—

Normotensive glaucoma

316

3070

1.03

0.20

2.3

2.5

5.86

6.69

ug/l

0.81

263

2605

Contact with venomous snakes and lizards

250

1.13

0.20

1.9

2.4

6.08

6.13

ug/l

0.01

217

Chronic mastoiditis

772

1.07

0.20

2.0

2.6

4.56

6.43

ug/l

1.05

682

Pulmonary eosinophilia, not elsewhere classified

327

1.11

0.20

2.9

2.5

6.86

7.07

ug/l

0.03

287

Effects of other deprivation

1.19

0.20

1.3

1.9

1.43

4.77

ug/l

—

LSIL lesion of the cervix uteri

183

1763

1.04

0.18

1.9

2.0

4.84

5.06

ug/l

0.10

162

1537

Traumatic cerebral oedema

1.22

0.18

2.0

2.7

8.70

8.68

ug/l

—

Calcaneal spur

271

1.11

0.18

1.9

2.2

16.59

6.38

ug/l

0.48

237

Graves ophthalmopathy, strict

497

0.92

0.18

2.2

2.4

7.09

5.68

ug/l

0.28

441

Hypothyroidism, autoimmune, DX-based

1.17

0.18

1.6

2.3

2.17

4.89

ug/l

—

Eustachian salpingitis and obstruction

139

1449

0.96

0.18

1.8

2.1

6.54

6.44

ug/l

0.02

120

1296

Early syphilis

289

0.89

0.18

1.8

2.3

7.13

9.21

ug/l

0.47

263

Adenocarcinoma of small intestine

1.25

0.18

1.8

2.5

5.75

6.47

ug/l

—

Maternal care for known or suspected disproportion

538

0.93

0.18

1.4

1.9

3.64

5.51

ug/l

0.83

470

Traumatic amputation of wrist and hand

134

1287

1.04

0.17

2.4

8.73

8.61

ug/l

0.03

124

1170

Other or unspecified immunodeficiency

0.70

0.17

2.8

2.4

18.68

5.43

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

128

1334

0.96

0.17

2.1

2.0

11.98

5.11

ug/l

1.16

112

1178

Other osteochondropathies

179

1731

1.04

0.16

2.7

2.3

14.16

8.24

ug/l

0.75

157

1560

Malignant neoplasm of endocrine gland

192

1860

1.03

0.16

1.9

2.3

7.99

7.18

ug/l

0.15

165

1627

Meningitis, viral

0.77

0.16

1.7

1.9

5.67

2.90

ug/l

—

Brain astrocytoma

1.16

0.15

1.7

2.3

8.77

10.14

ug/l

—

Brain astrocytoma, including Hilmo

1.16

0.15

1.7

2.3

8.77

10.14

ug/l

—

Hereditary hypogammaglobulinemia

1.15

0.15

2.2

2.4

7.62

4.91

ug/l

—

Accessory breast

0.74

0.15

1.3

2.1

3.10

4.15

ug/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1628

15664

1.01

0.15

2.1

2.2

7.62

6.75

ug/l

0.57

1357

13608

Malignant neoplasm of other and unspecified female genital organs

430

1.08

0.15

2.6

2.4

4.07

6.24

ug/l

0.68

375

Malignant neoplasm of palate, including Hilmo

181

0.88

0.15

1.8

2.4

8.31

7.61

ug/l

0.06

159

Non-small cell lung cancer, squamous

158

1632

0.97

0.14

2.2

2.4

5.95

7.04

ug/l

0.34

140

1373

Crushing injury of wrist and hand

411

1.08

0.14

2.0

2.3

5.48

7.39

ug/l

0.63

368

Other secondary gonarthrosis

161

1559

1.04

0.14

2.4

4.95

7.41

ug/l

2.66

144

1375

Malignant neoplasm of breast, HER2-negative

1264

8360

0.99

0.14

2.1

2.2

4.47

6.02

ug/l

4.08

1032

7136

Other osteochondrodysplasias

233

0.90

0.14

2.9

2.3

3.15

5.97

ug/l

2.23

213

L01XX Other antineoplastic agents

187

1924

0.97

0.14

2.3

2.5

4.74

7.40

ug/l

2.71

150

1677

Meningococcal infection

141

1.14

0.14

1.9

2.3

2.76

8.82

ug/l

—

127

Biological medicines for asthma

367

0.92

0.14

2.3

2.1

2.15

8.21

ug/l

7.04

334

Varicella [chickenpox]

122

1175

1.04

0.14

2.6

2.2

12.49

9.75

ug/l

0.32

113

1066

Benign neoplasm: Vulva

490

0.93

0.14

2.0

2.2

4.39

6.17

ug/l

0.87

421

Open bite that required surgery (Lefort1 or BSSO)

122

1.15

0.14

1.2

1.9

3.44

6.63

ug/l

0.92

111

Carcinoma in situ of other and unspecified digestive organs

103

1071

0.96

0.14

2.5

6.03

6.93

ug/l

0.25

950

Placenta praevia

519

1.06

0.13

1.8

2.0

3.71

5.24

ug/l

0.76

451

Malignant neoplasm of breast

1276

8406

0.99

0.13

2.1

2.2

4.48

6.02

ug/l

4.02

1038

7175

Localized scleroderma [morphea]

326

1.08

0.12

1.9

2.2

44.25

5.77

ug/l

0.68

278

Tooth agenesis EXCLUDE clefts and syndromes

437

0.94

0.12

1.9

8.98

6.51

ug/l

0.47

378

Varicella [chickenpox]

111

1071

1.04

0.12

2.4

2.2

12.73

9.97

ug/l

0.29

104

973

Pregnancy, childbirth and the puerperium

958

5060

0.99

0.12

2.4

2.3

4.98

5.54

ug/l

0.60

804

4075

Defect, injury or illness of neck

104

1.16

0.12

1.8

2.3

4.25

5.82

ug/l

0.65

Amoebiasis

133

1.14

0.12

1.7

2.2

3.39

5.96

ug/l

1.08

118

Maternal care for cervical incompetence

752

0.96

0.12

2.3

2.2

7.00

5.73

ug/l

0.15

664

Bus occupant injured in other and unspecified transport accidents

143

1.13

0.12

2.8

2.2

4.04

7.37

ug/l

0.81

126

Systemic atrophies primarily affecting the central nervous system

131

1271

1.03

0.11

2.7

2.4

7.20

6.96

ug/l

0.03

117

1102

1006

0.96

0.11

1.4

1.7

8.02

4.04

ug/l

1.13

868

Disorder of the sleep-wake schedule

337

1.07

0.11

2.8

2.4

2.46

7.80

ug/l

5.34

303

Struck by thrown, projected or falling objec

130

1261

1.03

0.11

2.3

7.67

7.83

ug/l

0.03

116

1134

6-mercaptopurine

578

0.95

0.11

1.9

2.1

6.71

7.06

ug/l

0.03

527

Glaucoma-related operations

191

1956

0.97

0.11

2.4

2.5

4.92

6.25

ug/l

1.47

162

1670

Other and unspecified diseases of blood and blood-forming organs

720

0.96

0.11

2.2

2.4

7.24

6.89

ug/l

0.08

632

Allergic conjunctivitis

1711

16544

1.01

0.11

2.1

2.2

7.63

6.73

ug/l

0.62

1433

14365

Carcinoma in situ of rectum

342

0.93

0.11

2.2

2.6

7.00

6.84

ug/l

0.03

308

Demyelinating diseases of the central nervous system

182

1777

1.03

0.11

2.0

2.1

6.02

6.86

ug/l

0.37

154

1579

Chondromalacia

678

0.96

0.10

1.8

2.3

6.88

7.02

ug/l

0.02

610

Melanoma in situ of trunk

484

0.95

0.10

1.5

2.5

8.37

7.48

ug/l

0.14

433

Abnormalities of forces of labour

150

1539

0.97

0.10

1.8

1.9

6.40

5.74

ug/l

0.10

132

1362

Malignant neoplasm of thyroid gland, including Hilmo

203

1987

1.02

0.10

2.0

2.3

7.62

7.02

ug/l

0.11

175

1736

Diffuse (eosinophilic) fasciitis

1.15

0.10

3.8

2.3

4.56

5.08

ug/l

—

Testicular hypofunction

900

0.96

0.10

2.7

2.2

9.90

10.05

ug/l

0.02

823

Thoracic root disorders

1.12

0.10

1.6

2.1

3.84

6.40

ug/l

—

Viral conjunctivitis

398

1.06

0.10

2.2

2.3

11.55

6.34

ug/l

0.45

357

Chronic lymphocytic leukaemia, helper endpoint

960

1.03

0.10

2.2

2.5

5.01

8.11

ug/l

1.46

832

Chronic lymphocytic leukaemia

960

1.03

0.10

2.2

2.5

5.01

8.11

ug/l

1.46

832

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

960

1.03

0.10

2.2

2.5

5.01

8.11

ug/l

1.46

832

Knuckle pads

1.07

0.09

1.0

2.4

4.70

10.51

ug/l

—

Secondary malignant neoplasm of respiratory and digestive organs

564

0.95

0.09

2.1

2.6

2.56

7.34

ug/l

5.45

483

Use of levodopa decarbox-comt-inhibitor

110

1069

1.03

0.09

2.6

6.55

6.64

ug/l

0.02

937

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.07

0.09

1.6

2.6

3.72

4.13

ug/l

—

MS-disease / Multiple Sclerosis

140

1435

0.97

0.09

2.0

2.1

5.53

7.09

ug/l

0.95

118

1274

Complications of labour and delivery

1561

8737

0.99

0.09

2.0

2.1

5.03

6.00

ug/l

1.42

1383

7513

Keratoconus

563

0.96

0.09

2.0

2.3

7.39

8.44

ug/l

0.21

512

Carcinoma in situ of penis

1.06

0.09

2.8

11.95

10.32

ug/l

—

Benign neoplasm: Lymph nodes

1.08

0.08

1.9

2.4

5.71

4.88

ug/l

—

Malignant neoplasm of thyroid gland

178

1746

1.02

0.08

1.9

2.3

8.28

7.07

ug/l

0.21

152

1533

Benign neoplasm: Connective and other soft tissue, unspecified

287

0.94

0.08

1.4

2.5

12.55

7.23

ug/l

0.48

253

Helminthiases

764

0.97

0.08

2.2

2.3

8.26

7.44

ug/l

0.14

677

Sequelae of other accidents

411

1.05

0.08

2.9

2.5

5.35

7.53

ug/l

0.79

361

Lichen planopilaris

0.80

0.08

1.5

2.6

1.57

4.55

ug/l

—

Other specified/unspecified disorders of ear

1.09

0.07

2.1

2.2

4.38

9.18

ug/l

—

Other demyelinating diseases of the central nervous system

662

0.97

0.07

1.9

2.1

7.29

7.00

ug/l

0.05

599

Pedal cyclist injured in collision with motor vehicle

692

0.97

0.07

2.0

2.3

4.79

7.68

ug/l

2.21

617

Single delivery by caesarean section

260

1514

0.98

0.07

1.7

2.0

2.80

7.48

ug/l

8.20

231

1299

Glaucoma secondary to drugs

1.08

0.07

2.0

2.4

9.43

5.90

ug/l

—

Malignant melanoma

537

5321

1.01

0.07

2.2

2.5

7.76

7.90

ug/l

0.05

458

4613

Osteosarcoma, including Hilmo

1.08

0.07

2.0

3.0

3.19

6.46

ug/l

—

Chromomycosis and phaeomycotic abscess

1.06

0.07

1.4

2.5

11.62

5.89

ug/l

—

Contact with machinery

361

3571

1.01

0.07

2.7

2.4

8.54

8.80

ug/l

0.09

326

3210

Chorioretinal scars

102

0.87

0.06

3.2

2.6

4.53

8.23

ug/l

—

Foreign body or object entering through skin

160

1573

1.02

0.06

2.1

2.4

6.43

7.47

ug/l

0.50

135

1414

Malignant neoplasm of anus and anal canal

148

1.09

0.06

1.8

2.7

4.76

6.49

ug/l

0.25

131

Intentional self-harm by hanging, strangulation and suffocation

152

0.92

0.06

2.0

2.5

7.05

9.94

ug/l

—

136

Malignant neoplasm of oropharynx, including Hilmo

658

0.97

0.06

2.5

6.45

8.13

ug/l

0.42

592

Early syphilis

304

0.95

0.06

1.9

2.2

7.16

9.08

ug/l

0.46

276

Spermatocele

282

2851

0.99

0.06

2.5

2.3

7.14

8.41

ug/l

0.87

248

2536

Other congenital malformations of face and neck

564

1.03

0.05

2.1

2.3

5.09

7.61

ug/l

0.64

508

Malignant neoplasm of tongue

624

1.03

0.05

2.2

2.6

5.83

8.00

ug/l

0.76

549

Polypectomy (DHB20)

205

2074

0.99

0.05

2.2

2.4

6.08

8.73

ug/l

1.84

194

1869

Malignant neoplasm of other and ill-defined digestive organs

258

1.05

0.04

1.7

2.5

3.06

7.34

ug/l

2.36

223

Desensitization to allergens

776

0.98

0.04

1.7

2.0

4.13

7.07

ug/l

1.89

698

Benign neoplasm: Bronchus and lung

362

0.96

0.04

2.4

2.7

6.39

8.38

ug/l

0.57

320

Twin gestation

115

1167

0.99

0.04

1.9

5.85

6.20

ug/l

0.07

108

1013

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

225

2271

0.99

0.04

2.2

2.3

6.19

6.95

ug/l

0.34

198

2025

Disorders of lacrimal system and orbit in diseases classified elsewhere

557

1.02

0.04

2.1

2.3

6.19

6.25

ug/l

0.01

492

Contact with sharp glass

754

0.98

0.03

1.8

2.1

7.83

8.27

ug/l

0.10

681

Sequelae of injuries of upper limb

259

2611

0.99

0.03

2.1

2.3

9.77

7.85

ug/l

0.32

218

2344

Laparoscopic left hemicolectomy

508

1.03

0.03

2.4

2.6

4.23

7.96

ug/l

2.54

450

Other and unspecified papulosquamous disorders

151

1.06

0.03

2.9

2.3

8.69

5.20

ug/l

0.28

133

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

161

1.06

0.03

1.9

2.7

5.55

6.92

ug/l

0.23

142

Multiple gestation

120

1215

0.99

0.03

1.9

5.72

6.15

ug/l

0.09

112

1058

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

579

1.02

0.03

2.2

2.5

7.92

6.21

ug/l

0.35

493

Malignant neoplasm of other connective and soft tissue, including Hilmo

129

1303

0.99

0.02

2.3

2.4

7.14

7.54

ug/l

0.12

115

1136

Malignant neoplasm of larynx

510

0.98

0.02

2.1

2.7

3.96

8.32

ug/l

4.26

440

Malignant neoplasm of rectosigmoid junction

510

1.02

0.02

2.1

2.5

13.55

6.97

ug/l

0.53

445

Graves ophthalmopathy

560

0.98

0.02

2.1

2.3

6.18

5.79

ug/l

0.08

496

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

182

1.05

0.02

1.3

2.4

2.36

7.64

ug/l

2.77

165

Maternal care for other known or suspected fetal problems

303

1928

0.99

0.02

1.7

1.9

3.81

5.47

ug/l

1.31

274

1664

Malaria

107

0.93

0.02

1.6

2.3

11.95

9.34

ug/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

137

1362

1.01

0.01

2.1

2.2

6.17

7.00

ug/l

0.37

122

1218

Neuroendocrine tumor and carcinoma of stomach

154

1.04

0.00

1.8

2.5

2.13

8.14

ug/l

2.62

131

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

186

0.96

0.00

2.1

2.6

8.29

8.37

ug/l

0.01

164

Disorders of parathyroid gland, other and/or unspecified

196

0.97

0.00

3.1

2.5

2.63

4.72

ug/l

2.79

172

Use of amantadine

426

0.98

0.00

1.9

2.4

4.61

7.07

ug/l

1.10

375

Colorectal neuroendocrine tumor and carcinoma

375

1.01

0.00

2.8

2.4

8.69

6.94

ug/l

0.20

327

Marginal zone B-cell lymphoma, including Hilmo

505

0.99

0.00

1.9

2.4

4.18

7.94

ug/l

2.30

436

Malignant neoplasm of tonsil, including Hilmo

535

0.99

0.00

2.6

2.5

7.07

8.58

ug/l

0.30

479

Cleft palate

128

1.02

0.00

1.9

7.37

6.09

ug/l

0.16

117

Crystalline deposits in vitreous body

272

0.99

0.00

3.3

2.5

3.99

8.10

ug/l

1.79

237

Congenital malformations of genital organs

148

1476

1.00

0.00

2.3

2.0

5.61

5.80

ug/l

0.05

121

1296

Carcinoma in situ of breast

111

0.99

0.00

1.6

2.2

3.07

4.38

ug/l

0.60

100

Drowning and submersion while in natural water

119

1.01

0.00

3.3

2.4

4.61

10.26

ug/l

1.34

107

Chronic myeloid leukaemia

129

1.01

0.00

2.2

2.4

4.42

9.26

ug/l

1.24

115

Malignant neoplasm of gum

141

0.99

0.00

3.3

2.8

3.54

6.44

ug/l

0.93

129

Benign neoplasm of male genital organs

662

1.00

0.00

1.9

2.5

7.50

8.58

ug/l

0.29

593

Pustular psoriasis

117

1168

1.00

0.00

2.4

2.3

3.49

6.82

ug/l

7.08

1036

Carcinoma in situ of skin of lip

101

0.99

0.00

3.1

2.7

12.13

6.34

ug/l

—

Carcinoma in situ of rectosigmoid junction

0.00

0.0

2.0

—

2.62

—

Other and unspecified syphilis

1.00

0.00

1.3

2.1

6.16

6.54

ug/l

—

Major histocompatibility complex class I deficiency

0.00

0.0

2.2

—

8.12

—

Unspecified early complication of trauma

0.00

0.0

1.6

—

6.80

—

Birth injury to scalp

0.00

0.0

4.3

—

2.37

—

Pinta [carate]

0.00

0.0

3.0

—

14.20

—

Multiple sites

0.00

0.0

1.1

—

2.13

—

Other disorders originating in the perinatal period

1.00

-0.00

2.1

2.4

8.63

6.80

ug/l

—

Plasmodium falciparum malaria

1.00

-0.00

1.0

2.6

2.40

6.11

ug/l

—

Congenital malformations of lung

0.94

-0.00

3.6

2.2

1.54

5.13

ug/l

—

Peutz-Jeghers syndrome

0.00

-0.00

0.0

1.0

—

2.24

—

Atrophoderma of Pasini and Pierini

0.00

-0.00

0.0

1.8

—

2.14

—

Acquired keratosis follicularis

0.00

-0.00

0.0

2.1

—

6.40

—

Fibrothorax

0.86

-0.00

5.0

2.5

3.68

6.57

ug/l

—

Air embolism (traumatic)

0.00

-0.00

0.0

1.7

—

3.83

—

Other disorders of middle ear and mastoid in diseases classified elsewhere

0.00

-0.00

0.0

3.2

—

3.27

—

Disorders of other visual pathways

0.00

-0.00

0.0

1.7

—

9.22

—

Phantom limb syndrome

1.00

-0.00

1.4

2.4

2.97

6.19

ug/l

—

Gastric ulcer - Acute with haemorrhage, drug-induced

0.85

-0.00

2.4

2.1

4.36

4.92

ug/l

—

Smallpox

0.00

-0.00

0.0

2.7

—

8.00

—

Polyglandular hyperfunction

0.00

-0.00

0.0

2.0

—

2.98

—

Maple-syrup-urine disease

0.00

-0.00

0.0

4.0

—

6.36

—

Dietary calcium deficiency

0.00

-0.00

0.0

3.1

—

7.39

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

2.7

—

9.73

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

4.70

—

Other disorders of intestinal carbohydrate absorption

0.00

-0.00

0.0

2.8

—

8.30

—

Other parasitologically confirmed or unspecified malaria

1.00

-0.00

2.2

2.1

21.50

8.36

ug/l

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.97

-0.00

4.2

2.5

7.96

9.22

ug/l

—

Drug-induced folate deficiency anaemia

0.00

-0.00

0.0

4.0

—

11.85

—

Hypervitaminosis D

0.00

-0.00

0.0

2.3

—

8.11

—

Malignant neoplasm of oropharyng

0.96

-0.00

2.0

2.7

3.64

13.23

ug/l

—

Benign neoplasm: Extrahepatic bile ducts

0.88

-0.00

1.7

2.0

1.64

5.05

ug/l

—

Congenital hydrocephalus

1.02

-0.00

2.5

1.7

8.67

4.05

ug/l

—

Adenosine deaminase [ADA] deficiency

0.00

-0.00

0.0

2.4

—

4.36

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.9

—

9.24

—

Use of metixene

0.00

-0.00

0.0

2.7

—

3.20

—

Anthrax

0.00

-0.00

0.0

3.0

—

2.89

—

Other birth injuries

0.00

-0.00

0.0

2.3

—

4.34

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

2.6

—

1.86

—

Yellow fever

0.00

-0.00

0.0

2.8

—

12.40

—

Relapsing panniculitis [Weber-Christian]

0.00

-0.00

0.0

1.5

—

4.15

—

Epiphyseal arrest

0.00

-0.00

0.0

3.3

—

6.60

—

Microcephaly

0.00

-0.00

0.0

5.0

—

4.60

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Creatine kinase.MB [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS